{"items": "182", "sentiment_score_definition": "x <= -0.35: Bearish; -0.35 < x <= -0.15: Somewhat-Bearish; -0.15 < x < 0.15: Neutral; 0.15 <= x < 0.35: Somewhat_Bullish; x >= 0.35: Bullish", "relevance_score_definition": "0 < x <= 1, with a higher score indicating higher relevance.", "feed": [{"title": "Nasdaq Jumps 100 Points, US Initial Jobless Claims Decline - Snow Lake Resources  ( NASDAQ:LITM ) , Bio-Path Hldgs  ( NASDAQ:BPTH ) ", "url": "https://www.benzinga.com/24/12/42601428/nasdaq-jumps-100-points-us-initial-jobless-claims-decline", "time_published": "20241219T192509", "authors": ["Avi Kapoor"], "summary": "U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 100 points on Thursday. The Dow traded up 0.55% to 42,557.62 while the NASDAQ rose 0.52% to 19,492.93. The S&P 500 also rose, gaining, 0.46% to 5,899.14. Utilities shares rose by 1.3% on Thursday.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/12/19/jobless-shutter.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.904684"}], "overall_sentiment_score": 0.038892, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MU", "relevance_score": "0.15347", "ticker_sentiment_score": "0.126617", "ticker_sentiment_label": "Neutral"}, {"ticker": "LW", "relevance_score": "0.15347", "ticker_sentiment_score": "0.042931", "ticker_sentiment_label": "Neutral"}, {"ticker": "BPTH", "relevance_score": "0.15347", "ticker_sentiment_score": "0.271795", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "LITM", "relevance_score": "0.15347", "ticker_sentiment_score": "0.164885", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "OMER", "relevance_score": "0.15347", "ticker_sentiment_score": "0.155834", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Gold Falls Sharply, Lamb Weston Shares Plunge - Snow Lake Resources  ( NASDAQ:LITM ) , Bio-Path Hldgs  ( NASDAQ:BPTH ) ", "url": "https://www.benzinga.com/24/12/42598636/gold-falls-sharply-lamb-weston-shares-plunge", "time_published": "20241219T172452", "authors": ["Avi Kapoor"], "summary": "U.S. stocks traded higher midway through trading, with the S&P 500 gaining around 0.4% on Thursday. The Dow traded up 0.39% to 42,493.51 while the NASDAQ rose 0.39% to 19,468.70. The S&P 500 also rose, gaining, 0.38% to 5,894.42. Utilities shares rose by 1.1% on Thursday.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/12/19/Turning-to-Gold.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.904684"}], "overall_sentiment_score": 0.043763, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MU", "relevance_score": "0.154951", "ticker_sentiment_score": "0.127387", "ticker_sentiment_label": "Neutral"}, {"ticker": "LW", "relevance_score": "0.154951", "ticker_sentiment_score": "0.043196", "ticker_sentiment_label": "Neutral"}, {"ticker": "BPTH", "relevance_score": "0.154951", "ticker_sentiment_score": "0.27334", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "LITM", "relevance_score": "0.154951", "ticker_sentiment_score": "0.165857", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "OMER", "relevance_score": "0.154951", "ticker_sentiment_score": "0.156754", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "US Stocks Higher, Micron Reports Downbeat Sales - Aethlon Medical  ( NASDAQ:AEMD ) , Bio-Path Hldgs  ( NASDAQ:BPTH ) ", "url": "https://www.benzinga.com/24/12/42594440/us-stocks-higher-micron-reports-downbeat-sales", "time_published": "20241219T153009", "authors": ["Avi Kapoor"], "summary": "U.S. stocks traded higher this morning, with the Dow Jones index gaining around 200 points on Thursday. Following the market opening Thursday, the Dow traded up 0.47% to 42,525.10 while the NASDAQ rose 0.84% to 19,554.71. The S&P 500 also rose, gaining, 0.62% to 5,908.52.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/12/19/Wall-Street--New-York.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.795202"}], "overall_sentiment_score": 0.082377, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MU", "relevance_score": "0.169676", "ticker_sentiment_score": "0.157424", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PRFX", "relevance_score": "0.169676", "ticker_sentiment_score": "0.326757", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "WLGS", "relevance_score": "0.169676", "ticker_sentiment_score": "-0.255244", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "AEMD", "relevance_score": "0.169676", "ticker_sentiment_score": "0.295885", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BPTH", "relevance_score": "0.169676", "ticker_sentiment_score": "0.289139", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "LITM", "relevance_score": "0.169676", "ticker_sentiment_score": "0.175844", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Bio-Path Holdings Announces Preclinical Testing of BP1001-A as Potential Treatment for Obesity in Type 2 Diabetes Patients Enhances Insulin Sensitivity", "url": "https://www.globenewswire.com/news-release/2024/12/19/2999715/0/en/Bio-Path-Holdings-Announces-Preclinical-Testing-of-BP1001-A-as-Potential-Treatment-for-Obesity-in-Type-2-Diabetes-Patients-Enhances-Insulin-Sensitivity.html", "time_published": "20241219T120000", "authors": ["Bio-Path Holdings", "Inc."], "summary": "Preclinical Studies Confirmed BP1001-A Mechanism of Action and Therapeutic Potential in Obesity and Type 2 Diabetes Preclinical Studies Confirmed BP1001-A Mechanism of Action and Therapeutic Potential in Obesity and Type 2 Diabetes ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/249fef91-7e82-4f67-b919-46c0c4d6fb17", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.165675, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.445179", "ticker_sentiment_score": "0.184941", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Bio-Path Holdings Outlines Rationale for Development of BP1001-A as Potential Treatment for Obesity in Type 2 Diabetes Patients", "url": "https://www.globenewswire.com/news-release/2024/12/11/2995241/0/en/Bio-Path-Holdings-Outlines-Rationale-for-Development-of-BP1001-A-as-Potential-Treatment-for-Obesity-in-Type-2-Diabetes-Patients.html", "time_published": "20241211T120000", "authors": ["Bio-Path Holdings", "Inc."], "summary": "Extensive Scientific Evidence Supporting Growth Factor Receptor Bound Protein-2 ( Grb2 ) as Fundamental Link in Insulin Resistance ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/249fef91-7e82-4f67-b919-46c0c4d6fb17", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": -0.009552, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.250153", "ticker_sentiment_score": "0.069017", "ticker_sentiment_label": "Neutral"}, {"ticker": "LRHC", "relevance_score": "0.023124", "ticker_sentiment_score": "-0.137518", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:VND", "relevance_score": "0.023124", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "All You Need to Know About Bio-Path  ( BPTH )  Rating Upgrade to Buy", "url": "https://www.zacks.com/stock/news/2372968/all-you-need-to-know-about-bio-path-bpth-rating-upgrade-to-buy", "time_published": "20241120T170010", "authors": ["Zacks Equity Research"], "summary": "Bio-Path (BPTH) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default3.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.997845"}, {"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.692272"}], "overall_sentiment_score": 0.307428, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.369685", "ticker_sentiment_score": "0.374383", "ticker_sentiment_label": "Bullish"}]}, {"title": "Bio-Path  ( BPTH )  Could Find a Support Soon, Here's Why You Should Buy the Stock Now", "url": "https://www.zacks.com/stock/news/2372806/bio-path-bpth-could-find-a-support-soon-heres-why-you-should-buy-the-stock-now", "time_published": "20241120T145506", "authors": ["Zacks Equity Research"], "summary": "Bio-Path (BPTH) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default164.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.875462"}, {"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}], "overall_sentiment_score": 0.223257, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.421485", "ticker_sentiment_score": "0.433507", "ticker_sentiment_label": "Bullish"}]}, {"title": "Bio-Path Holdings Reports Third Quarter 2024 Financial Results", "url": "https://www.globenewswire.com/news-release/2024/11/15/2981893/0/en/Bio-Path-Holdings-Reports-Third-Quarter-2024-Financial-Results.html", "time_published": "20241115T120000", "authors": ["Bio-Path Holdings", "Inc."], "summary": "Expands DNAbilize\u00ae Technology Beyond Oncology into Obesity ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/249fef91-7e82-4f67-b919-46c0c4d6fb17", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Earnings", "relevance_score": "0.451494"}, {"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.99737"}], "overall_sentiment_score": 0.139429, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.333142", "ticker_sentiment_score": "0.131565", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Path Holdings to Announce Third Quarter 2024 Financial Results on November 15, 2024", "url": "https://www.globenewswire.com/news-release/2024/11/08/2977548/0/en/Bio-Path-Holdings-to-Announce-Third-Quarter-2024-Financial-Results-on-November-15-2024.html", "time_published": "20241108T120000", "authors": ["Bio-Path Holdings", "Inc."], "summary": "HOUSTON, Nov. 08, 2024 ( GLOBE NEWSWIRE ) -- Bio-Path Holdings, Inc., ( NASDAQ: BPTH ) a biotechnology company leveraging its proprietary DNAbilize\u00ae antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced that it will host a live ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/249fef91-7e82-4f67-b919-46c0c4d6fb17", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "1.0"}], "overall_sentiment_score": 0.09368, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.651499", "ticker_sentiment_score": "0.116367", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Path Holdings Announces Closing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules", "url": "https://www.globenewswire.com/news-release/2024/10/10/2961738/0/en/Bio-Path-Holdings-Announces-Closing-of-4-0-Million-Private-Placement-Priced-At-the-Market-Under-Nasdaq-Rules.html", "time_published": "20241010T212400", "authors": ["Bio-Path Holdings", "Inc."], "summary": "HOUSTON, Oct. 10, 2024 ( GLOBE NEWSWIRE ) -- Bio-Path Holdings, Inc. ( NASDAQ:BPTH ) ( \"Bio-Path\" or the \"Company\" ) , a biotechnology company leveraging its proprietary DNAbilize\u00ae liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer drugs, today ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/249fef91-7e82-4f67-b919-46c0c4d6fb17", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "1.0"}], "overall_sentiment_score": 0.174506, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.291842", "ticker_sentiment_score": "0.101604", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Path Holdings Announces $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules - Bio-Path Hldgs  ( NASDAQ:BPTH ) ", "url": "https://www.benzinga.com/pressreleases/24/10/g41242061/bio-path-holdings-announces-4-0-million-private-placement-priced-at-the-market-under-nasdaq-rules", "time_published": "20241009T000000", "authors": ["Globe Newswire"], "summary": "HOUSTON, Oct. 08, 2024 ( GLOBE NEWSWIRE ) -- Bio-Path Holdings, Inc.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "1.0"}], "overall_sentiment_score": 0.192816, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.334762", "ticker_sentiment_score": "0.127085", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Path Holdings Announces $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules", "url": "https://www.globenewswire.com/news-release/2024/10/09/2960187/0/en/Bio-Path-Holdings-Announces-4-0-Million-Private-Placement-Priced-At-the-Market-Under-Nasdaq-Rules.html", "time_published": "20241009T000000", "authors": ["Bio-Path Holdings", "Inc."], "summary": "HOUSTON, Oct. 08, 2024 ( GLOBE NEWSWIRE ) -- Bio-Path Holdings, Inc. ( NASDAQ:BPTH ) ( \"Bio-Path\" or the \"Company\" ) , a biotechnology company leveraging its proprietary DNAbilize\u00ae liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer drugs, today ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/249fef91-7e82-4f67-b919-46c0c4d6fb17", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "1.0"}], "overall_sentiment_score": 0.195072, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.277658", "ticker_sentiment_score": "0.114047", "ticker_sentiment_label": "Neutral"}]}, {"title": "Nasdaq Surges Over 1%; DocuSign Shares Spike Higher - Alternus Clean Energy  ( NASDAQ:ALCE ) , Bio-Path Hldgs  ( NASDAQ:BPTH ) ", "url": "https://www.benzinga.com/markets/equities/24/10/41237197/nasdaq-surges-over-1-docusign-shares-spike-higher", "time_published": "20241008T183014", "authors": ["Avi Kapoor"], "summary": "U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining over 1% on Tuesday. The Dow traded up 0.20% to 42,038.02 while the NASDAQ rose 1.15% to 18,130.89. The S&P 500 also rose, gaining, 0.77% to 5,739.69. Information technology shares jumped by 1.6% on Tuesday.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/10/08/Wall-Street-US-stocks.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.065653, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "LU", "relevance_score": "0.162255", "ticker_sentiment_score": "-0.207034", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ZJK", "relevance_score": "0.162255", "ticker_sentiment_score": "0.438063", "ticker_sentiment_label": "Bullish"}, {"ticker": "ALCE", "relevance_score": "0.162255", "ticker_sentiment_score": "0.195969", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BPTH", "relevance_score": "0.162255", "ticker_sentiment_score": "0.149341", "ticker_sentiment_label": "Neutral"}, {"ticker": "DOCU", "relevance_score": "0.162255", "ticker_sentiment_score": "0.364523", "ticker_sentiment_label": "Bullish"}]}, {"title": "Crude Oil Falls Over 4%; US Trade Deficit Narrows In August - Cassava Sciences  ( NASDAQ:SAVA ) ", "url": "https://www.benzinga.com/markets/equities/24/10/41234113/crude-oil-falls-over-4-us-trade-deficit-narrows-in-august", "time_published": "20241008T161614", "authors": ["Avi Kapoor"], "summary": "U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 200 points on Tuesday. The Dow traded up 0.17% to 42,026.90 while the NASDAQ rose 1.15% to 18,130.79. The S&P 500 also rose, gaining, 0.75% to 5,738.42. Information technology shares jumped by 1.4% on ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/10/08/Crude-oil-4-logo.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.065569, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "LU", "relevance_score": "0.154951", "ticker_sentiment_score": "-0.201022", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ZJK", "relevance_score": "0.154951", "ticker_sentiment_score": "0.427141", "ticker_sentiment_label": "Bullish"}, {"ticker": "ALCE", "relevance_score": "0.154951", "ticker_sentiment_score": "0.190258", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BPTH", "relevance_score": "0.154951", "ticker_sentiment_score": "0.145049", "ticker_sentiment_label": "Neutral"}, {"ticker": "SAVA", "relevance_score": "0.2306", "ticker_sentiment_score": "0.323926", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "US Stocks Edge Higher; PepsiCo Cuts 2024 Revenue Outlook - PepsiCo  ( NASDAQ:PEP ) ", "url": "https://www.benzinga.com/news/earnings/24/10/41229548/us-stocks-edge-higher-pepsico-cuts-2024-revenue-outlook", "time_published": "20241008T135142", "authors": ["Avi Kapoor"], "summary": "U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 0.5% on Tuesday. Following the market opening Tuesday, the Dow traded up 0.08% to 41,986.44 while the NASDAQ rose 0.55% to 18,022.24. The S&P 500 also rose, gaining, 0.42% to 5,719.76.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/10/08/Wall-Street-dall.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.77141"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.087275, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ALCE", "relevance_score": "0.147818", "ticker_sentiment_score": "0.184814", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "NMHI", "relevance_score": "0.147818", "ticker_sentiment_score": "0.478653", "ticker_sentiment_label": "Bullish"}, {"ticker": "OCFT", "relevance_score": "0.147818", "ticker_sentiment_score": "0.272261", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PEP", "relevance_score": "0.147818", "ticker_sentiment_score": "0.046947", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZJK", "relevance_score": "0.147818", "ticker_sentiment_score": "0.416671", "ticker_sentiment_label": "Bullish"}, {"ticker": "BPTH", "relevance_score": "0.147818", "ticker_sentiment_score": "0.140996", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTC", "relevance_score": "0.147818", "ticker_sentiment_score": "-0.234531", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Why Is Bio-Path Holdings Stock Soaring On Tuesday? - Cassava Sciences  ( NASDAQ:SAVA ) ", "url": "https://www.benzinga.com/general/biotech/24/10/41228945/nano-cap-bio-path-takes-plunge-in-weight-loss-race-initiates-obesity-program-with-drug-candidate-", "time_published": "20241008T132713", "authors": ["Vandana Singh"], "summary": "Bio-Path Holdings, Inc., BPTH stock is trading higher on Tuesday with a strong session volume of 25.89 million compared to an average of 328.97K as per data from Benzinga Pro. The company initiated a therapeutic program to develop BP1001-A for treating obesity and related metabolic diseases.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/10/08/BPTH.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}], "overall_sentiment_score": 0.178856, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.555911", "ticker_sentiment_score": "0.24186", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ABBV", "relevance_score": "0.240489", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Path Holdings Initiates Development of Therapeutic Program for Treatment of Obesity", "url": "https://www.globenewswire.com/news-release/2024/10/08/2959544/0/en/Bio-Path-Holdings-Initiates-Development-of-Therapeutic-Program-for-Treatment-of-Obesity.html", "time_published": "20241008T110000", "authors": ["Bio-Path Holdings", "Inc."], "summary": "HOUSTON, Oct. 08, 2024 ( GLOBE NEWSWIRE ) -- Bio-Path Holdings, Inc., ( NASDAQ:BPTH ) , a biotechnology company leveraging its proprietary DNAbilize\u00ae liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced the initiation of a ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/249fef91-7e82-4f67-b919-46c0c4d6fb17", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.17826, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.396261", "ticker_sentiment_score": "0.166971", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Bio-Path Holdings to Present at H.C. Wainwright 26th Annual Global Investment Conference", "url": "https://www.globenewswire.com/news-release/2024/09/03/2939496/0/en/Bio-Path-Holdings-to-Present-at-H-C-Wainwright-26th-Annual-Global-Investment-Conference.html", "time_published": "20240903T110000", "authors": ["Bio-Path Holdings", "Inc."], "summary": "HOUSTON, Sept. 03, 2024 ( GLOBE NEWSWIRE ) -- Bio-Path Holdings, Inc., ( NASDAQ:BPTH ) , a biotechnology company leveraging its proprietary DNAbilize\u00ae liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced that Peter Nielsen, ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/249fef91-7e82-4f67-b919-46c0c4d6fb17", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.087532, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.434763", "ticker_sentiment_score": "0.089889", "ticker_sentiment_label": "Neutral"}]}, {"title": "What Happened With Bio-Path Stock Today? - Bio-Path Hldgs  ( NASDAQ:BPTH ) ", "url": "https://www.benzinga.com/general/biotech/24/08/40495366/what-happened-with-bio-path-stock-today", "time_published": "20240821T204950", "authors": ["Erica Kollmann"], "summary": "Bio-Path Holdings, Inc. BPTH shares closed slightly higher Wednesday after the company provided an update from its ongoing Phase 1/1b clinical trial of BP1001-A in solid tumor patients and reported continued patient progress from its ongoing Phase 2 triple combination study of prexigebersen in ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/08/21/Medicine-Doctor-Touching-Electronic-Medi.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.495866"}, {"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.413559"}], "overall_sentiment_score": 0.254316, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.790287", "ticker_sentiment_score": "0.374174", "ticker_sentiment_label": "Bullish"}]}, {"title": "Bio-Path Holdings Reports Solid Tumor Patient Response Supporting BP1001-A's Compelling Potential as Treatment for Advanced Solid Tumors - Bio-Path Hldgs  ( NASDAQ:BPTH ) ", "url": "https://www.benzinga.com/pressreleases/24/08/g40481410/bio-path-holdings-reports-solid-tumor-patient-response-supporting-bp1001-as-compelling-potential-a", "time_published": "20240821T110000", "authors": ["Globe Newswire"], "summary": "First Solid Tumor Patient Treated with Second, Higher Dose in Phase 1/1b BP1001-A Clinical Trial Experienced Tumor Reduction and Continued Stable Disease Reports Continued Patient Progress from Phase 2 Triple Combination Study of Prexigebersen in Acute Myeloid Leukemia ( AML )", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.218332, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.327728", "ticker_sentiment_score": "0.130221", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Path Holdings to Announce Second Quarter 2024 Financial Results on August 15, 2024 - Bio-Path Hldgs  ( NASDAQ:BPTH ) ", "url": "https://www.benzinga.com/pressreleases/24/08/g40247076/bio-path-holdings-to-announce-second-quarter-2024-financial-results-on-august-15-2024", "time_published": "20240808T110000", "authors": ["Globe Newswire"], "summary": "HOUSTON , Aug. 08, 2024 ( GLOBE NEWSWIRE ) -- Bio-Path Holdings, Inc., BPTH a biotechnology company leveraging its proprietary DNAbilize\u00ae antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced that it will host a live conference call ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "1.0"}], "overall_sentiment_score": 0.112773, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.651499", "ticker_sentiment_score": "0.109042", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why Bio-Path Stock Is Climbing Today - Bio-Path Hldgs  ( NASDAQ:BPTH ) ", "url": "https://www.benzinga.com/news/24/06/39331958/why-bio-path-stock-is-climbing-today", "time_published": "20240614T130008", "authors": ["Erica Kollmann"], "summary": "Bio-Path Holdings, Inc. BPTH shares are trading higher Friday after the company announced interim results from its Phase 2 study of prexigebersen in combination with decitabine and venetoclax for the treatment of acute myeloid leukemia.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/06/14/untitled.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}], "overall_sentiment_score": 0.396831, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.805471", "ticker_sentiment_score": "0.657267", "ticker_sentiment_label": "Bullish"}]}, {"title": "Bio-Path Holdings Presents Data from Ongoing Phase 2 Combination Study of Prexigebersen for Treatment of Acute Myeloid Leukemia at European Hematology Association Congress - Bio-Path Hldgs  ( NASDAQ:BPTH ) ", "url": "https://www.benzinga.com/pressreleases/24/06/g39329287/bio-path-holdings-presents-data-from-ongoing-phase-2-combination-study-of-prexigebersen-for-treatm", "time_published": "20240614T110000", "authors": ["Globe Newswire"], "summary": "HOUSTON, June 14, 2024 ( GLOBE NEWSWIRE ) -- Bio-Path Holdings, Inc., BPTH, a biotechnology company leveraging its proprietary DNAbilize\u00ae liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer drugs, presented interim results from the Company's Phase 2 ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.18414, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.400052", "ticker_sentiment_score": "0.174541", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Bio-Path Holdings Presents Data from Ongoing Phase 2 Combination Study of Prexigebersen for Treatment of Acute Myeloid Leukemia at European Hematology Association Congress", "url": "https://www.globenewswire.com/news-release/2024/06/14/2898892/0/en/Bio-Path-Holdings-Presents-Data-from-Ongoing-Phase-2-Combination-Study-of-Prexigebersen-for-Treatment-of-Acute-Myeloid-Leukemia-at-European-Hematology-Association-Congress.html", "time_published": "20240614T110000", "authors": ["Inc.", "Bio-Path Holdings"], "summary": "Encore Presentation Highlights Positive Results from Interim Analysis Demonstrating Significant Clinical Improvement and Tolerable Safety Profile for Prexigebersen Combination in High-Risk Patients Encore Presentation Highlights Positive Results from Interim Analysis Demonstrating Significant ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/249fef91-7e82-4f67-b919-46c0c4d6fb17", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.193654, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.344473", "ticker_sentiment_score": "0.16418", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Bio-Path Holdings Announces Closing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules", "url": "https://www.globenewswire.com/news-release/2024/06/05/2894340/0/en/Bio-Path-Holdings-Announces-Closing-of-4-0-Million-Private-Placement-Priced-At-the-Market-Under-Nasdaq-Rules.html", "time_published": "20240605T214600", "authors": ["Bio-Path Holdings", "Inc."], "summary": "HOUSTON, June 05, 2024 ( GLOBE NEWSWIRE ) -- Bio-Path Holdings, Inc. ( NASDAQ:BPTH ) ( \"Bio-Path\" or the \"Company\" ) , a biotechnology company leveraging its proprietary DNAbilize\u00ae liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer drugs, today ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/249fef91-7e82-4f67-b919-46c0c4d6fb17", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.999998"}], "overall_sentiment_score": 0.141733, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.310283", "ticker_sentiment_score": "0.052288", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Path Holdings Announces $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules", "url": "https://www.globenewswire.com/news-release/2024/06/04/2892970/0/en/Bio-Path-Holdings-Announces-4-0-Million-Private-Placement-Priced-At-the-Market-Under-Nasdaq-Rules.html", "time_published": "20240604T120000", "authors": ["Inc.", "Bio-Path Holdings"], "summary": "HOUSTON, June 04, 2024 ( GLOBE NEWSWIRE ) -- Bio-Path Holdings, Inc. ( NASDAQ:BPTH ) ( \"Bio-Path\" or the \"Company\" ) , a biotechnology company leveraging its proprietary DNAbilize\u00ae liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer drugs, today ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/249fef91-7e82-4f67-b919-46c0c4d6fb17", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.999998"}], "overall_sentiment_score": 0.153182, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.29792", "ticker_sentiment_score": "0.074697", "ticker_sentiment_label": "Neutral"}]}, {"title": "Dow Dips Over 300 Points; GameStop Shares Spike Higher - Science Applications Intl  ( NASDAQ:SAIC ) ", "url": "https://www.benzinga.com/news/earnings/24/06/39144239/dow-dips-over-300-points-gamestop-shares-spike-higher", "time_published": "20240603T183514", "authors": ["Avi Kapoor"], "summary": "U.S. stocks traded mostly lower toward the end of trading, with the Dow Jones falling more than 300 points on Monday. The Dow traded down 0.81% to 38,371.77 while the NASDAQ climbed 0.04% to 16,741.41. The S&P 500 also fell, dropping, 0.38% to 5,257.50. Health care shares rose by 0.4% on Monday.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/06/03/wall-street-ai9.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.108179"}, {"topic": "Technology", "relevance_score": "0.25"}], "overall_sentiment_score": 0.112443, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ANDE", "relevance_score": "0.06697", "ticker_sentiment_score": "0.12833", "ticker_sentiment_label": "Neutral"}, {"ticker": "LSCC", "relevance_score": "0.13347", "ticker_sentiment_score": "0.152521", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "RDDT", "relevance_score": "0.06697", "ticker_sentiment_score": "0.271286", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CNSP", "relevance_score": "0.199037", "ticker_sentiment_score": "-0.330952", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SPGI", "relevance_score": "0.13347", "ticker_sentiment_score": "0.042635", "ticker_sentiment_label": "Neutral"}, {"ticker": "BPTH", "relevance_score": "0.13347", "ticker_sentiment_score": "0.068812", "ticker_sentiment_label": "Neutral"}, {"ticker": "CAMP", "relevance_score": "0.13347", "ticker_sentiment_score": "0.247129", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GME", "relevance_score": "0.13347", "ticker_sentiment_score": "0.322297", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MBOT", "relevance_score": "0.13347", "ticker_sentiment_score": "0.318738", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SAIC", "relevance_score": "0.13347", "ticker_sentiment_score": "-0.207679", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session - Science Applications Intl  ( NASDAQ:SAIC ) ", "url": "https://www.benzinga.com/news/24/06/39143340/why-science-applications-international-shares-are-trading-lower-by-11-here-are-other-stocks-moving-i", "time_published": "20240603T175653", "authors": ["Avi Kapoor"], "summary": "Shares of Science Applications International Corporation SAIC declined 11% to $119.91 following first-quarter results. SAIC reported a 9% revenue decline year over year in the fiscal first quarter of 2025 to $1.847 billion, marginally beating the analyst consensus estimate of $1.844 billion.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/06/03/Movers_0.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Energy & Transportation", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "0.744043"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}], "overall_sentiment_score": 0.113974, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MGNX", "relevance_score": "0.074926", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MOLN", "relevance_score": "0.074926", "ticker_sentiment_score": "0.203456", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "LSCC", "relevance_score": "0.074926", "ticker_sentiment_score": "-0.006136", "ticker_sentiment_label": "Neutral"}, {"ticker": "PGEN", "relevance_score": "0.074926", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "WBUY", "relevance_score": "0.074926", "ticker_sentiment_score": "-0.381107", "ticker_sentiment_label": "Bearish"}, {"ticker": "CRKN", "relevance_score": "0.074926", "ticker_sentiment_score": "0.168892", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GRTX", "relevance_score": "0.112182", "ticker_sentiment_score": "-0.237232", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SAIC", "relevance_score": "0.149192", "ticker_sentiment_score": "-0.04133", "ticker_sentiment_label": "Neutral"}, {"ticker": "UTHR", "relevance_score": "0.037504", "ticker_sentiment_score": "-0.002999", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRTG", "relevance_score": "0.074926", "ticker_sentiment_score": "0.117462", "ticker_sentiment_label": "Neutral"}, {"ticker": "YGMZ", "relevance_score": "0.074926", "ticker_sentiment_score": "0.065945", "ticker_sentiment_label": "Neutral"}, {"ticker": "IPDN", "relevance_score": "0.112182", "ticker_sentiment_score": "0.184808", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "OLMA", "relevance_score": "0.074926", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "WM", "relevance_score": "0.037504", "ticker_sentiment_score": "0.219588", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AMC", "relevance_score": "0.074926", "ticker_sentiment_score": "0.119185", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNSP", "relevance_score": "0.112182", "ticker_sentiment_score": "-0.347475", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "NVAX", "relevance_score": "0.074926", "ticker_sentiment_score": "0.34734", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CGON", "relevance_score": "0.074926", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BPTH", "relevance_score": "0.112182", "ticker_sentiment_score": "0.060479", "ticker_sentiment_label": "Neutral"}, {"ticker": "CAMP", "relevance_score": "0.112182", "ticker_sentiment_score": "0.249727", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "DELL", "relevance_score": "0.074926", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "DOGZ", "relevance_score": "0.074926", "ticker_sentiment_score": "0.248269", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GME", "relevance_score": "0.112182", "ticker_sentiment_score": "0.165867", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GSK", "relevance_score": "0.074926", "ticker_sentiment_score": "-0.096246", "ticker_sentiment_label": "Neutral"}, {"ticker": "MBOT", "relevance_score": "0.074926", "ticker_sentiment_score": "0.141487", "ticker_sentiment_label": "Neutral"}, {"ticker": "LQDA", "relevance_score": "0.074926", "ticker_sentiment_score": "-0.003166", "ticker_sentiment_label": "Neutral"}, {"ticker": "TDS", "relevance_score": "0.074926", "ticker_sentiment_score": "0.129319", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSNL", "relevance_score": "0.074926", "ticker_sentiment_score": "0.34734", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "RDDT", "relevance_score": "0.074926", "ticker_sentiment_score": "0.151633", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ADSK", "relevance_score": "0.074926", "ticker_sentiment_score": "0.013283", "ticker_sentiment_label": "Neutral"}, {"ticker": "VWE", "relevance_score": "0.074926", "ticker_sentiment_score": "-0.381107", "ticker_sentiment_label": "Bearish"}, {"ticker": "BNAI", "relevance_score": "0.074926", "ticker_sentiment_score": "-0.051112", "ticker_sentiment_label": "Neutral"}, {"ticker": "CCM", "relevance_score": "0.074926", "ticker_sentiment_score": "-0.215669", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SMG", "relevance_score": "0.074926", "ticker_sentiment_score": "-0.338135", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SRCL", "relevance_score": "0.074926", "ticker_sentiment_score": "0.227888", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ANDE", "relevance_score": "0.037504", "ticker_sentiment_score": "-0.005885", "ticker_sentiment_label": "Neutral"}, {"ticker": "PAC", "relevance_score": "0.074926", "ticker_sentiment_score": "-0.381107", "ticker_sentiment_label": "Bearish"}, {"ticker": "ONEW", "relevance_score": "0.037504", "ticker_sentiment_score": "0.217593", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "DHAC", "relevance_score": "0.074926", "ticker_sentiment_score": "0.125397", "ticker_sentiment_label": "Neutral"}, {"ticker": "GPCR", "relevance_score": "0.074926", "ticker_sentiment_score": "-0.02357", "ticker_sentiment_label": "Neutral"}, {"ticker": "FFIE", "relevance_score": "0.074926", "ticker_sentiment_score": "0.43946", "ticker_sentiment_label": "Bullish"}, {"ticker": "HZO", "relevance_score": "0.112182", "ticker_sentiment_score": "0.247274", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SAM", "relevance_score": "0.149192", "ticker_sentiment_score": "0.132817", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISPC", "relevance_score": "0.074926", "ticker_sentiment_score": "-0.084072", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZIM", "relevance_score": "0.074926", "ticker_sentiment_score": "-0.381107", "ticker_sentiment_label": "Bearish"}]}, {"title": "Crude Oil Down Over 3%; US Construction Spending Falls In May - Lattice Semiconductor  ( NASDAQ:LSCC ) ", "url": "https://www.benzinga.com/news/earnings/24/06/39141026/crude-oil-down-over-3-us-construction-spending-falls-in-may", "time_published": "20240603T160007", "authors": ["Avi Kapoor"], "summary": "U.S. stocks traded mostly lower midway through trading, with the Dow Jones falling more than 200 points on Monday. The Dow traded down 0.57% to 38,466.36 while the NASDAQ climbed 0.15% to 16,760.36. The S&P 500 also fell, dropping, 0.20% to 5,266.90. Health care shares rose by 0.7% on Monday.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/06/03/oil-ai.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.140642, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ANDE", "relevance_score": "0.072655", "ticker_sentiment_score": "0.128972", "ticker_sentiment_label": "Neutral"}, {"ticker": "LSCC", "relevance_score": "0.144708", "ticker_sentiment_score": "0.159283", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "RDDT", "relevance_score": "0.072655", "ticker_sentiment_score": "0.272934", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CNSP", "relevance_score": "0.215574", "ticker_sentiment_score": "-0.350204", "ticker_sentiment_label": "Bearish"}, {"ticker": "SPGI", "relevance_score": "0.144708", "ticker_sentiment_score": "0.044538", "ticker_sentiment_label": "Neutral"}, {"ticker": "BPTH", "relevance_score": "0.144708", "ticker_sentiment_score": "0.071885", "ticker_sentiment_label": "Neutral"}, {"ticker": "CAMP", "relevance_score": "0.144708", "ticker_sentiment_score": "0.25837", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GME", "relevance_score": "0.144708", "ticker_sentiment_score": "0.335729", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MBOT", "relevance_score": "0.144708", "ticker_sentiment_score": "0.332049", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "What's Going On With Bio-Path Stock? - Bio-Path Hldgs  ( NASDAQ:BPTH ) ", "url": "https://www.benzinga.com/news/24/06/39138161/whats-going-on-with-bio-path-stock", "time_published": "20240603T140804", "authors": ["Erica Kollmann"], "summary": "Bio-Path Holdings, Inc. BPTH shares are trading higher Monday after the company announced the presentation of interim results from its Phase 2 study of prexigebersen ( BP1001 ) in combination with decitabine and venetoclax for the treatment of acute myeloid leukemia ( AML ) .", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/06/03/Medicine-Doctor-Touching-Electronic-Medi.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}], "overall_sentiment_score": 0.281666, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.595343", "ticker_sentiment_score": "0.372254", "ticker_sentiment_label": "Bullish"}]}, {"title": "Nasdaq Surges 150 Points; US Manufacturing PMI Rises In May - CalAmp  ( NASDAQ:CAMP ) ", "url": "https://www.benzinga.com/news/earnings/24/06/39137733/nasdaq-surges-150-points-us-manufacturing-pmi-rises-in-may", "time_published": "20240603T135410", "authors": ["Avi Kapoor"], "summary": "U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining around 150 points on Monday. The Dow traded down 0.07% to 38,657.77 while the NASDAQ climbed 0.92% to 16,888.59. The S&P 500 also rose, gaining, 0.35% to 5,296.20. Information technology shares rose by 1% on Monday.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/06/03/manufacturing-ai2.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.2637, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "RDDT", "relevance_score": "0.083251", "ticker_sentiment_score": "0.277648", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CNSP", "relevance_score": "0.246167", "ticker_sentiment_score": "-0.38529", "ticker_sentiment_label": "Bearish"}, {"ticker": "SPGI", "relevance_score": "0.165598", "ticker_sentiment_score": "0.048436", "ticker_sentiment_label": "Neutral"}, {"ticker": "BPTH", "relevance_score": "0.246167", "ticker_sentiment_score": "0.096516", "ticker_sentiment_label": "Neutral"}, {"ticker": "CAMP", "relevance_score": "0.246167", "ticker_sentiment_score": "0.494673", "ticker_sentiment_label": "Bullish"}, {"ticker": "GME", "relevance_score": "0.165598", "ticker_sentiment_score": "0.362476", "ticker_sentiment_label": "Bullish"}, {"ticker": "MBOT", "relevance_score": "0.165598", "ticker_sentiment_score": "0.358568", "ticker_sentiment_label": "Bullish"}]}, {"title": "Bio-Path Holdings Presents Data from Ongoing Phase 2 Combination Study of Prexigebersen for Treatment of Acute Myeloid Leukemia at American Society of Clinical Oncology  ( ASCO )  Annual Meeting", "url": "https://www.globenewswire.com/news-release/2024/06/03/2892094/0/en/Bio-Path-Holdings-Presents-Data-from-Ongoing-Phase-2-Combination-Study-of-Prexigebersen-for-Treatment-of-Acute-Myeloid-Leukemia-at-American-Society-of-Clinical-Oncology-ASCO-Annual.html", "time_published": "20240603T110000", "authors": ["Inc.", "Bio-Path Holdings"], "summary": "Positive Results from Interim Analysis Demonstrate Significant Clinical Improvement and Tolerable Safety Profile for Prexigebersen Combination in High-Risk Patients Positive Results from Interim Analysis Demonstrate Significant Clinical Improvement and Tolerable Safety Profile for Prexigebersen ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/249fef91-7e82-4f67-b919-46c0c4d6fb17", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.124111, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.349329", "ticker_sentiment_score": "0.067666", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Path Holdings to Present Data at 2024 European Hematology Association Congress - Bio-Path Hldgs  ( NASDAQ:BPTH ) ", "url": "https://www.benzinga.com/pressreleases/24/05/g39004731/bio-path-holdings-to-present-data-at-2024-european-hematology-association-congress", "time_published": "20240524T110000", "authors": ["Globe Newswire"], "summary": "HOUSTON, May 24, 2024 ( GLOBE NEWSWIRE ) -- Bio-Path Holdings, Inc., BPTH, a biotechnology company leveraging its proprietary DNAbilize\u00ae liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced an upcoming poster presentation at ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.197224, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.458708", "ticker_sentiment_score": "0.1933", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Bio-Path Holdings to Present Data at 2024 European Hematology Association Congress", "url": "https://www.globenewswire.com/news-release/2024/05/24/2887897/0/en/Bio-Path-Holdings-to-Present-Data-at-2024-European-Hematology-Association-Congress.html", "time_published": "20240524T110000", "authors": ["Bio-Path Holdings", "Inc."], "summary": "Presentation Includes Positive Results from Interim Analysis of Phase 2 Clinical Trial of Prexigebersen in Acute Myeloid Leukemia ( AML ) Presentation Includes Positive Results from Interim Analysis of Phase 2 Clinical Trial of Prexigebersen in Acute Myeloid Leukemia ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/249fef91-7e82-4f67-b919-46c0c4d6fb17", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.176294, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.395903", "ticker_sentiment_score": "0.180587", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Bio-Path Holdings Reports First Quarter 2024 Financial Results", "url": "https://www.globenewswire.com/news-release/2024/05/15/2882254/0/en/Bio-Path-Holdings-Reports-First-Quarter-2024-Financial-Results.html", "time_published": "20240515T110000", "authors": ["Bio-Path Holdings", "Inc."], "summary": "Marks Progress Across Key Clinical and Corporate Goals ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/249fef91-7e82-4f67-b919-46c0c4d6fb17", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Earnings", "relevance_score": "0.451494"}, {"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.891286"}], "overall_sentiment_score": 0.177669, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.470555", "ticker_sentiment_score": "0.236496", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Research Coverage Started at StockNews.com", "url": "https://www.defenseworld.net/2024/05/06/bio-path-nasdaqbpth-research-coverage-started-at-stocknews-com.html", "time_published": "20240506T090900", "authors": ["Defense World Staff"], "summary": "StockNews.com initiated coverage on shares of Bio-Path ( NASDAQ:BPTH - Free Report ) in a report released on Thursday morning. The brokerage issued a sell rating on the stock. Separately, Roth Mkm restated a buy rating and set a $40.00 price objective on shares of Bio-Path in a research report ...", "banner_image": "https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}, {"topic": "Earnings", "relevance_score": "0.917436"}], "overall_sentiment_score": 0.321941, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.861522", "ticker_sentiment_score": "0.524909", "ticker_sentiment_label": "Bullish"}]}, {"title": "Looking Into Bio-Path Hldgs's Recent Short Interest - Bio-Path Hldgs  ( NASDAQ:BPTH ) ", "url": "https://www.benzinga.com/insights/short-sellers/24/05/38561107/looking-into-bio-path-hldgss-recent-short-interest", "time_published": "20240501T180029", "authors": ["Benzinga Insights"], "summary": "Bio-Path Hldgs's BPTH short percent of float has fallen 4.27% since its last report. The company recently reported that it has 67 thousand shares sold short, which is 8.96% of all regular shares that are available for trading.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}], "overall_sentiment_score": 0.266706, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.404563", "ticker_sentiment_score": "0.243674", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Bio-Path Holdings, Inc. Announces Closing of $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - Bio-Path Hldgs  ( NASDAQ:BPTH ) ", "url": "https://www.benzinga.com/pressreleases/24/04/g38338145/bio-path-holdings-inc-announces-closing-of-1-2-million-registered-direct-offering-priced-at-the-ma", "time_published": "20240419T161404", "authors": ["Globe Newswire"], "summary": "HOUSTON, April 19, 2024 ( GLOBE NEWSWIRE ) -- Bio-Path Holdings, Inc., BPTH ( the \"Company\" or \"Bio-Path\" ) , a biotechnology company leveraging its proprietary DNAbilize\u00ae antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced the ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.999998"}], "overall_sentiment_score": 0.154811, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.472672", "ticker_sentiment_score": "0.145676", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Path Holdings, Inc. Announces Closing of $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules", "url": "https://www.globenewswire.com/news-release/2024/04/19/2866293/0/en/Bio-Path-Holdings-Inc-Announces-Closing-of-1-2-Million-Registered-Direct-Offering-Priced-At-the-Market-Under-Nasdaq-Rules.html", "time_published": "20240419T161400", "authors": ["Inc.", "Bio-Path Holdings"], "summary": "HOUSTON, April 19, 2024 ( GLOBE NEWSWIRE ) -- Bio-Path Holdings, Inc., ( Nasdaq: BPTH ) ( the \"Company\" or \"Bio-Path\" ) , a biotechnology company leveraging its proprietary DNAbilize\u00ae antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, today ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/249fef91-7e82-4f67-b919-46c0c4d6fb17", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.999992"}], "overall_sentiment_score": 0.15918, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.461006", "ticker_sentiment_score": "0.149334", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Path  ( BPTH )  Rises on Upbeat Updates From Blood Cancer Study", "url": "https://www.zacks.com/stock/news/2258537/bio-path-bpth-rises-on-upbeat-updates-from-blood-cancer-study", "time_published": "20240419T141400", "authors": ["Zacks Equity Research"], "summary": "Bio-Path (BPTH) gains 30% on encouraging developmental updates from the early-stage study of its investigational candidate, BP1002, to treat acute myeloid leukemia patients.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/67/1932.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.858979"}, {"topic": "Earnings", "relevance_score": "0.947132"}], "overall_sentiment_score": 0.204665, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ADMA", "relevance_score": "0.275867", "ticker_sentiment_score": "0.133785", "ticker_sentiment_label": "Neutral"}, {"ticker": "FGEN", "relevance_score": "0.231332", "ticker_sentiment_score": "0.01449", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANVS", "relevance_score": "0.231332", "ticker_sentiment_score": "-0.027341", "ticker_sentiment_label": "Neutral"}, {"ticker": "BPTH", "relevance_score": "0.482406", "ticker_sentiment_score": "0.356503", "ticker_sentiment_label": "Bullish"}]}, {"title": "Why Wang & Lee Group Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket - Adaptive Biotechnologies  ( NASDAQ:ADPT ) , AGBA Group Holding  ( NASDAQ:AGBA ) ", "url": "https://www.benzinga.com/news/24/04/38330517/why-wang-lee-group-shares-are-trading-higher-by-38-here-are-20-stocks-moving-premarket", "time_published": "20240419T094548", "authors": ["Avi Kapoor"], "summary": "Shares of Wang & Lee Group, Inc. WLGS rose sharply in today's pre-market trading after the company reported a year-over-year increase in FY23 financial results. Wang & Lee Group posted a FY23 loss of 2 cents per share, versus a year-ago loss of 5 cents per share.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/04/19/Image-7.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "0.882182"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "0.495866"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}], "overall_sentiment_score": 0.156956, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "NFLX", "relevance_score": "0.185781", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNTG", "relevance_score": "0.124486", "ticker_sentiment_score": "0.432285", "ticker_sentiment_label": "Bullish"}, {"ticker": "BGLC", "relevance_score": "0.185781", "ticker_sentiment_score": "0.148769", "ticker_sentiment_label": "Neutral"}, {"ticker": "PARA", "relevance_score": "0.185781", "ticker_sentiment_score": "0.271352", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "LTRN", "relevance_score": "0.124486", "ticker_sentiment_score": "-0.076199", "ticker_sentiment_label": "Neutral"}, {"ticker": "WLGS", "relevance_score": "0.245959", "ticker_sentiment_score": "0.153608", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ZCMD", "relevance_score": "0.124486", "ticker_sentiment_score": "0.338748", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SNGX", "relevance_score": "0.185781", "ticker_sentiment_score": "-0.071696", "ticker_sentiment_label": "Neutral"}, {"ticker": "HUBC", "relevance_score": "0.124486", "ticker_sentiment_score": "0.043601", "ticker_sentiment_label": "Neutral"}, {"ticker": "APOS", "relevance_score": "0.062434", "ticker_sentiment_score": "0.186161", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SNEJF", "relevance_score": "0.062434", "ticker_sentiment_score": "0.186161", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "KA", "relevance_score": "0.185781", "ticker_sentiment_score": "0.025315", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADPT", "relevance_score": "0.185781", "ticker_sentiment_score": "-0.036651", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPCB", "relevance_score": "0.185781", "ticker_sentiment_score": "0.092296", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGBA", "relevance_score": "0.185781", "ticker_sentiment_score": "0.022419", "ticker_sentiment_label": "Neutral"}, {"ticker": "RWOD", "relevance_score": "0.124486", "ticker_sentiment_score": "0.199755", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TIRX", "relevance_score": "0.124486", "ticker_sentiment_score": "-0.217199", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "BPTH", "relevance_score": "0.185781", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPEC", "relevance_score": "0.185781", "ticker_sentiment_score": "0.164681", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISPC", "relevance_score": "0.124486", "ticker_sentiment_score": "-0.01375", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Path Holdings, Inc. Announces $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules", "url": "https://www.globenewswire.com/news-release/2024/04/18/2865747/0/en/Bio-Path-Holdings-Inc-Announces-1-2-Million-Registered-Direct-Offering-Priced-At-the-Market-Under-Nasdaq-Rules.html", "time_published": "20240418T175700", "authors": ["Inc.", "Bio-Path Holdings"], "summary": "HOUSTON, April 18, 2024 ( GLOBE NEWSWIRE ) -- Bio-Path Holdings, Inc., ( Nasdaq: BPTH ) ( the \"Company\" or \"Bio-Path\" ) , a biotechnology company leveraging its proprietary DNAbilize\u00ae antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, today ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/249fef91-7e82-4f67-b919-46c0c4d6fb17", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "1.0"}], "overall_sentiment_score": 0.17285, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.449045", "ticker_sentiment_score": "0.172771", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Crude Oil Edges Lower; Bio-Path Holdings Shares Spike Higher - AGBA Group Holding  ( NASDAQ:AGBA ) , Bio-Path Hldgs  ( NASDAQ:BPTH ) ", "url": "https://www.benzinga.com/news/earnings/24/04/38319117/crude-oil-edges-lower-bio-path-holdings-shares-spike-higher", "time_published": "20240418T160824", "authors": ["Avi Kapoor"], "summary": "U.S. stocks traded higher midway through trading, with the S&P 500 gaining around 0.5% on Thursday. The Dow traded up 0.64% to 37,996.39 while the NASDAQ rose 0.41% to 15,747.36. The S&P 500 also rose, gaining, 0.46% to 5,045.07. Communication services shares climbed by 1.3% on Thursday.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Energy & Transportation", "relevance_score": "0.25"}, {"topic": "IPO", "relevance_score": "0.576289"}, {"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.796627"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Earnings", "relevance_score": "0.108179"}, {"topic": "Real Estate & Construction", "relevance_score": "0.25"}], "overall_sentiment_score": 0.209014, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "TSLA", "relevance_score": "0.070105", "ticker_sentiment_score": "0.114543", "ticker_sentiment_label": "Neutral"}, {"ticker": "ME", "relevance_score": "0.070105", "ticker_sentiment_score": "0.170993", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "NRXP", "relevance_score": "0.208166", "ticker_sentiment_score": "0.031308", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPCB", "relevance_score": "0.208166", "ticker_sentiment_score": "0.203728", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AGBA", "relevance_score": "0.139669", "ticker_sentiment_score": "0.169883", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BPTH", "relevance_score": "0.139669", "ticker_sentiment_score": "0.265218", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "LAC", "relevance_score": "0.139669", "ticker_sentiment_score": "0.140241", "ticker_sentiment_label": "Neutral"}]}, {"title": "Dow Surges Over 100 Points; D.R. Horton Posts Upbeat Earnings - AGBA Group Holding  ( NASDAQ:AGBA ) , iLearningEngines  ( NASDAQ:AILE ) ", "url": "https://www.benzinga.com/news/earnings/24/04/38315588/dow-surges-over-100-points-d-r-horton-posts-upbeat-earnings", "time_published": "20240418T140448", "authors": ["Avi Kapoor"], "summary": "U.S. stocks traded mixed this morning, with the Dow Jones index gaining more than 100 points on Thursday. Following the market opening Thursday, the Dow traded up 0.34% to 37,880.89 while the NASDAQ fell 0.16% to 15,658.94. The S&P 500 also rose, gaining, 0.03% to 5,023.87.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/04/18/image45.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Energy & Transportation", "relevance_score": "0.2"}, {"topic": "Finance", "relevance_score": "0.2"}, {"topic": "IPO", "relevance_score": "0.576289"}, {"topic": "Retail & Wholesale", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.684621"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Earnings", "relevance_score": "0.108179"}, {"topic": "Real Estate & Construction", "relevance_score": "0.2"}], "overall_sentiment_score": 0.205353, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "NRXP", "relevance_score": "0.221481", "ticker_sentiment_score": "0.032876", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGBA", "relevance_score": "0.148731", "ticker_sentiment_score": "0.176278", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TSLA", "relevance_score": "0.074692", "ticker_sentiment_score": "0.1151", "ticker_sentiment_label": "Neutral"}, {"ticker": "TIRX", "relevance_score": "0.148731", "ticker_sentiment_score": "0.444481", "ticker_sentiment_label": "Bullish"}, {"ticker": "BPTH", "relevance_score": "0.148731", "ticker_sentiment_score": "0.274467", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "LAC", "relevance_score": "0.148731", "ticker_sentiment_score": "0.145316", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Coverage Initiated by Analysts at StockNews.com", "url": "https://www.defenseworld.net/2024/04/16/bio-path-nasdaqbpth-coverage-initiated-by-analysts-at-stocknews-com.html", "time_published": "20240416T062842", "authors": ["Defense World Staff"], "summary": "Research analysts at StockNews.com started coverage on shares of Bio-Path ( NASDAQ:BPTH - Get Free Report ) in a research report issued on Tuesday. The firm set a \"sell\" rating on the stock.", "banner_image": "https://www.marketbeat.com/logos/bio-path-holdings-inc-logo-1200x675.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.796627"}, {"topic": "Earnings", "relevance_score": "0.905476"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.296341, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "SCHW", "relevance_score": "0.092569", "ticker_sentiment_score": "0.17103", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "COST", "relevance_score": "0.092569", "ticker_sentiment_score": "0.17103", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BPTH", "relevance_score": "0.869371", "ticker_sentiment_score": "0.489546", "ticker_sentiment_label": "Bullish"}, {"ticker": "VIRT", "relevance_score": "0.092569", "ticker_sentiment_score": "0.136031", "ticker_sentiment_label": "Neutral"}, {"ticker": "WMT", "relevance_score": "0.092569", "ticker_sentiment_score": "0.17103", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Bio-Path Holdings Expands Global Patent Portfolio - Bio-Path Hldgs  ( NASDAQ:BPTH ) ", "url": "https://www.benzinga.com/pressreleases/24/04/g38244784/bio-path-holdings-expands-global-patent-portfolio", "time_published": "20240415T110000", "authors": ["Globe Newswire"], "summary": "HOUSTON, April 15, 2024 ( GLOBE NEWSWIRE ) -- Bio-Path Holdings, Inc., BPTH, a biotechnology company leveraging its proprietary DNAbilize\u00ae liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced the receipt of newly issued patents ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.538269"}], "overall_sentiment_score": 0.111258, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.498188", "ticker_sentiment_score": "0.144912", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Path Holdings Expands Global Patent Portfolio", "url": "https://www.globenewswire.com/news-release/2024/04/15/2862615/0/en/Bio-Path-Holdings-Expands-Global-Patent-Portfolio.html", "time_published": "20240415T110000", "authors": ["Inc.", "Bio-Path Holdings"], "summary": "Builds on Global Intellectual Property Portfolio to Protect DNAbilize\u00ae Platform Builds on Global Intellectual Property Portfolio to Protect DNAbilize\u00ae Platform ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/249fef91-7e82-4f67-b919-46c0c4d6fb17", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.104109, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.4499", "ticker_sentiment_score": "0.138868", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Path Holdings Provides 2024 Clinical and Operational Update - Bio-Path Hldgs  ( NASDAQ:BPTH ) ", "url": "https://www.benzinga.com/pressreleases/24/04/g38041424/bio-path-holdings-provides-2024-clinical-and-operational-update", "time_published": "20240402T110000", "authors": ["Globe Newswire"], "summary": "HOUSTON, April 02, 2024 ( GLOBE NEWSWIRE ) -- Bio-Path Holdings, Inc., BPTH, a biotechnology company leveraging its proprietary DNAbilize\u00ae liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer drugs, today provides a clinical development and ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.126334, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.342685", "ticker_sentiment_score": "0.066235", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Now Covered by StockNews.com", "url": "https://www.defenseworld.net/2024/03/31/bio-path-nasdaqbpth-now-covered-by-stocknews-com.html", "time_published": "20240331T071242", "authors": ["Defense World Staff"], "summary": "Research analysts at StockNews.com began coverage on shares of Bio-Path ( NASDAQ:BPTH - Get Free Report ) in a research note issued on Sunday. The firm set a \"sell\" rating on the stock. Separately, Roth Mkm increased their price target on Bio-Path from $12.00 to $40.00 and gave the stock a ...", "banner_image": "https://www.marketbeat.com/logos/bio-path-holdings-inc-logo-1200x675.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}, {"topic": "Earnings", "relevance_score": "0.96136"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.369443, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.891493", "ticker_sentiment_score": "0.594877", "ticker_sentiment_label": "Bullish"}, {"ticker": "VIRT", "relevance_score": "0.098255", "ticker_sentiment_score": "0.16422", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "FL", "relevance_score": "0.098255", "ticker_sentiment_score": "0.233965", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "StockNews.com Begins Coverage on Bio-Path  ( NASDAQ:BPTH ) ", "url": "https://www.defenseworld.net/2024/03/15/stocknews-com-begins-coverage-on-bio-path-nasdaqbpth.html", "time_published": "20240315T070843", "authors": ["Defense World Staff"], "summary": "Research analysts at StockNews.com initiated coverage on shares of Bio-Path ( NASDAQ:BPTH - Get Free Report ) in a research report issued on Friday. The brokerage set a \"sell\" rating on the stock. Shares of Bio-Path stock opened at $5.12 on Friday.", "banner_image": "https://www.marketbeat.com/logos/bio-path-holdings-inc-logo-1200x675.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.962106"}, {"topic": "Earnings", "relevance_score": "0.857896"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.32518, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.900454", "ticker_sentiment_score": "0.535205", "ticker_sentiment_label": "Bullish"}, {"ticker": "VIRT", "relevance_score": "0.093653", "ticker_sentiment_score": "0.16515", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Why Bio-Path Holdings Shares Are Falling Today - Bio-Path Hldgs  ( NASDAQ:BPTH ) ", "url": "https://www.benzinga.com/news/earnings/24/03/37564342/why-bio-path-holdings-shares-are-falling-today", "time_published": "20240308T171719", "authors": ["Nabaparna Bhattacharya"], "summary": "The company reported fourth-quarter earnings per share of $4.23 loss, narrower than the estimate of $5.40 loss. Bio-Path reported a net loss of $33.63 per share for the year ended Dec. 31, 2023, lower than $38.12 per share in the year-ago period.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/bz-pharma-briefs_7.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.576289"}, {"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.007221, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.729067", "ticker_sentiment_score": "0.085705", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Path Holdings Reports Full Year 2023 Financial Results", "url": "https://www.globenewswire.com/news-release/2024/03/08/2843016/0/en/Bio-Path-Holdings-Reports-Full-Year-2023-Financial-Results.html", "time_published": "20240308T120000", "authors": ["Bio-Path Holdings", "Inc."], "summary": "Conference Call to be Held Today at 8:30 A.M. ET Conference Call to be Held Today at 8:30 A.M. ET ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/249fef91-7e82-4f67-b919-46c0c4d6fb17", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Earnings", "relevance_score": "0.451494"}, {"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.144052, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.35106", "ticker_sentiment_score": "0.136584", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Now Covered by StockNews.com", "url": "https://www.defenseworld.net/2024/03/07/bio-path-nasdaqbpth-now-covered-by-stocknews-com.html", "time_published": "20240307T075841", "authors": ["Defense World Staff"], "summary": "Equities researchers at StockNews.com initiated coverage on shares of Bio-Path ( NASDAQ:BPTH - Get Free Report ) in a note issued to investors on Thursday. The brokerage set a \"sell\" rating on the stock. Shares of NASDAQ BPTH opened at $6.44 on Thursday.", "banner_image": "https://www.marketbeat.com/logos/bio-path-holdings-inc-logo-1200x675.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.214378"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.30787, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "AWON", "relevance_score": "0.114137", "ticker_sentiment_score": "0.00112", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVAV", "relevance_score": "0.114137", "ticker_sentiment_score": "0.214981", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BPTH", "relevance_score": "0.937963", "ticker_sentiment_score": "0.516093", "ticker_sentiment_label": "Bullish"}, {"ticker": "VIRT", "relevance_score": "0.114137", "ticker_sentiment_score": "0.163647", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "StockNews.com Initiates Coverage on Bio-Path  ( NASDAQ:BPTH ) ", "url": "https://www.defenseworld.net/2024/03/01/stocknews-com-initiates-coverage-on-bio-path-nasdaqbpth-2.html", "time_published": "20240301T092442", "authors": ["Defense World Staff"], "summary": "Research analysts at StockNews.com assumed coverage on shares of Bio-Path ( NASDAQ:BPTH - Get Free Report ) in a note issued to investors on Wednesday. The firm set a \"sell\" rating on the stock. NASDAQ:BPTH opened at $6.08 on Wednesday.", "banner_image": "https://www.marketbeat.com/logos/bio-path-holdings-inc-logo-1200x675.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.87644"}, {"topic": "Earnings", "relevance_score": "0.360215"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.214378"}, {"topic": "Finance", "relevance_score": "0.5"}, {"topic": "Blockchain", "relevance_score": "0.310843"}], "overall_sentiment_score": 0.333137, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.857533", "ticker_sentiment_score": "0.539504", "ticker_sentiment_label": "Bullish"}, {"ticker": "VIRT", "relevance_score": "0.10607", "ticker_sentiment_score": "0.211986", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TJX", "relevance_score": "0.10607", "ticker_sentiment_score": "0.181049", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Receives New Coverage from Analysts at StockNews.com", "url": "https://www.americanbankingnews.com/2024/02/28/bio-path-nasdaqbpth-receives-new-coverage-from-analysts-at-stocknews-com.html", "time_published": "20240228T072128", "authors": ["ABMN Staff"], "summary": "Bio-Path ( NASDAQ:BPTH ) Receives New Coverage from Analysts at ...", "banner_image": "https://www.marketbeat.com/logos/bio-path-holdings-inc-logo-1200x675.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.americanbankingnews.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Finance", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.54554"}], "overall_sentiment_score": 0.269819, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.922387", "ticker_sentiment_score": "0.458187", "ticker_sentiment_label": "Bullish"}, {"ticker": "VIRT", "relevance_score": "0.107978", "ticker_sentiment_score": "0.10518", "ticker_sentiment_label": "Neutral"}, {"ticker": "AZO", "relevance_score": "0.107978", "ticker_sentiment_score": "0.197747", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Receives New Coverage from Analysts at StockNews.com", "url": "https://www.defenseworld.net/2024/02/28/bio-path-nasdaqbpth-receives-new-coverage-from-analysts-at-stocknews-com.html", "time_published": "20240228T072045", "authors": ["Defense World Staff"], "summary": "Analysts at StockNews.com began coverage on shares of Bio-Path ( NASDAQ:BPTH - Get Free Report ) in a research report issued on Wednesday. The firm set a \"sell\" rating on the stock. BPTH stock opened at $5.11 on Wednesday. Bio-Path has a one year low of $5.06 and a one year high of $44.80.", "banner_image": "https://www.marketbeat.com/logos/bio-path-holdings-inc-logo-1200x675.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Finance", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.413559"}], "overall_sentiment_score": 0.279348, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.907478", "ticker_sentiment_score": "0.47003", "ticker_sentiment_label": "Bullish"}, {"ticker": "VIRT", "relevance_score": "0.111488", "ticker_sentiment_score": "0.154144", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AZO", "relevance_score": "0.111488", "ticker_sentiment_score": "0.173272", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Bio-Path Holdings Announces 1-for-20 Reverse Stock Split - Bio-Path Hldgs  ( NASDAQ:BPTH ) ", "url": "https://www.benzinga.com/pressreleases/24/02/g37232519/bio-path-holdings-announces-1-for-20-reverse-stock-split", "time_published": "20240221T120000", "authors": ["Globe Newswire"], "summary": "HOUSTON, Feb. 21, 2024 ( GLOBE NEWSWIRE ) -- Bio-Path Holdings, Inc.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "1.0"}], "overall_sentiment_score": 0.193928, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.411176", "ticker_sentiment_score": "0.134025", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Path Holdings Announces 1-for-20 Reverse Stock Split", "url": "https://www.globenewswire.com/news-release/2024/02/21/2832603/0/en/Bio-Path-Holdings-Announces-1-for-20-Reverse-Stock-Split.html", "time_published": "20240221T120000", "authors": ["Bio-Path Holdings", "Inc."], "summary": "Shares of Common Stock Will Begin Trading on a Split-Adjusted Basis on February 23, 2024 Shares of Common Stock Will Begin Trading on a Split-Adjusted Basis on February ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/249fef91-7e82-4f67-b919-46c0c4d6fb17", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "1.0"}], "overall_sentiment_score": 0.207867, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.348103", "ticker_sentiment_score": "0.121472", "ticker_sentiment_label": "Neutral"}]}, {"title": "StockNews.com Initiates Coverage on Bio-Path  ( NASDAQ:BPTH ) ", "url": "https://www.defenseworld.net/2024/02/20/stocknews-com-initiates-coverage-on-bio-path-nasdaqbpth.html", "time_published": "20240220T073641", "authors": ["Defense World Staff"], "summary": "StockNews.com initiated coverage on shares of Bio-Path ( NASDAQ:BPTH - Get Free Report ) in a report issued on Tuesday. The brokerage set a \"sell\" rating on the stock. Bio-Path stock opened at $0.43 on Tuesday. The business has a fifty day moving average of $0.47 and a two-hundred day moving ...", "banner_image": "https://www.marketbeat.com/logos/bio-path-holdings-inc-logo-1200x675.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.87644"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.161647"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.375545, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.929012", "ticker_sentiment_score": "0.60774", "ticker_sentiment_label": "Bullish"}, {"ticker": "VIRT", "relevance_score": "0.110462", "ticker_sentiment_score": "0.234299", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Bio-Path Holdings Announces Completion of First Dose Cohort in Phase 1 Clinical Trial Evaluating BP1002 to Treat Refractory/Relapsed Lymphoma and Refractory/Relapsed Chronic Lymphocytic Leukemia Patients - Bio-Path Hldgs  ( NASDAQ:BPTH ) ", "url": "https://www.benzinga.com/pressreleases/24/01/g36573014/bio-path-holdings-announces-completion-of-first-dose-cohort-in-phase-1-clinical-trial-evaluating-b", "time_published": "20240110T120000", "authors": ["Globe Newswire"], "summary": "HOUSTON, Jan. 10, 2024 ( GLOBE NEWSWIRE ) -- Bio-Path Holdings, Inc., BPTH, a biotechnology company leveraging its proprietary DNAbilize\u00ae antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced completion of the first dose cohort of ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.059868, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.474688", "ticker_sentiment_score": "0.108075", "ticker_sentiment_label": "Neutral"}]}, {"title": "StockNews.com Begins Coverage on Bio-Path  ( NASDAQ:BPTH ) ", "url": "https://www.defenseworld.net/2024/01/03/stocknews-com-begins-coverage-on-bio-path-nasdaqbpth.html", "time_published": "20240103T063446", "authors": ["Defense World Staff"], "summary": "Investment analysts at StockNews.com initiated coverage on shares of Bio-Path ( NASDAQ:BPTH - Get Free Report ) in a research report issued to clients and investors on Wednesday. The brokerage set a \"sell\" rating on the stock. Shares of BPTH stock opened at $0.49 on Wednesday.", "banner_image": "https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Earnings", "relevance_score": "0.928769"}, {"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}], "overall_sentiment_score": 0.299799, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.887767", "ticker_sentiment_score": "0.497965", "ticker_sentiment_label": "Bullish"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Coverage Initiated at StockNews.com", "url": "https://www.defenseworld.net/2023/12/26/bio-path-nasdaqbpth-coverage-initiated-at-stocknews-com.html", "time_published": "20231226T062646", "authors": ["Defense World Staff"], "summary": "Analysts at StockNews.com started coverage on shares of Bio-Path ( NASDAQ:BPTH - Get Free Report ) in a research report issued to clients and investors on Tuesday. The brokerage set a \"sell\" rating on the stock. BPTH opened at $0.51 on Tuesday.", "banner_image": "https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Earnings", "relevance_score": "0.890401"}, {"topic": "Retail & Wholesale", "relevance_score": "1.0"}], "overall_sentiment_score": 0.275776, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.877135", "ticker_sentiment_score": "0.461025", "ticker_sentiment_label": "Bullish"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Now Covered by StockNews.com", "url": "https://www.defenseworld.net/2023/12/18/bio-path-nasdaqbpth-now-covered-by-stocknews-com.html", "time_published": "20231218T063244", "authors": ["Defense World Staff"], "summary": "Equities research analysts at StockNews.com initiated coverage on shares of Bio-Path ( NASDAQ:BPTH - Get Free Report ) in a report released on Monday. The firm set a \"sell\" rating on the stock. NASDAQ:BPTH opened at $0.47 on Monday.", "banner_image": "https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Earnings", "relevance_score": "0.938238"}, {"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}], "overall_sentiment_score": 0.247903, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.859085", "ticker_sentiment_score": "0.415652", "ticker_sentiment_label": "Bullish"}]}, {"title": "Texas Biotech Advances Lead Candidate in Resistant AML", "url": "https://www.investorideas.com/news/2023/biotech/12151Texas-Biotech.asp", "time_published": "20231215T164742", "authors": [], "summary": "Texas Biotech Advances Lead Candidate in Resistant ...", "banner_image": "https://www.streetwisereports.com/images/amy-hirschi-K0c8ko3e6AA-unsplash.jpg", "source": "Investor Ideas", "category_within_source": "n/a", "source_domain": "www.investorideas.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "1.0"}], "overall_sentiment_score": 0.229175, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.497391", "ticker_sentiment_score": "0.341557", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Bio-Path Holdings Successfully Completes First Dose Cohort of Phase 1/1b Clinical Trial of BP1002 in Refractory/Relapsed Acute Myeloid Leukemia", "url": "https://www.globenewswire.com/news-release/2023/12/14/2796128/0/en/Bio-Path-Holdings-Successfully-Completes-First-Dose-Cohort-of-Phase-1-1b-Clinical-Trial-of-BP1002-in-Refractory-Relapsed-Acute-Myeloid-Leukemia.html", "time_published": "20231214T120000", "authors": ["Inc.", "Bio-Path Holdings"], "summary": "BP1002 Offers Unique Opportunity for Venetoclax-Resistant Patients by Utilizing RNAi to Limit Cells' Ability to Produce Bcl-2 Protein BP1002 Offers Unique Opportunity for Venetoclax-Resistant Patients by Utilizing RNAi to Limit Cells' Ability to Produce Bcl-2 Protein ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/249fef91-7e82-4f67-b919-46c0c4d6fb17", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.149073, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.319414", "ticker_sentiment_score": "0.136644", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Now Covered by Analysts at StockNews.com", "url": "https://www.defenseworld.net/2023/12/02/bio-path-nasdaqbpth-now-covered-by-analysts-at-stocknews-com.html", "time_published": "20231202T062241", "authors": ["Defense World Staff"], "summary": "Bio-Path ( NASDAQ:BPTH ) Now Covered by Analysts at StockNews ... Defense World ...", "banner_image": "https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Earnings", "relevance_score": "0.857896"}, {"topic": "Retail & Wholesale", "relevance_score": "1.0"}], "overall_sentiment_score": 0.299326, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.900307", "ticker_sentiment_score": "0.498238", "ticker_sentiment_label": "Bullish"}]}, {"title": "Why UP Fintech Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket - AgriFORCE Growing Systems  ( NASDAQ:AGRI ) , Apollomics  ( NASDAQ:APLM ) ", "url": "https://www.benzinga.com/news/23/11/35956771/why-up-fintech-shares-are-trading-higher-by-around-7-here-are-20-stocks-moving-premarket", "time_published": "20231127T131025", "authors": ["Lisa Levin"], "summary": "Shares of UP Fintech Holding Limited TIGR surged in pre-market trading after the company results for the third quarter. UP Fintech Holding posted adjusted EPADS of 10 cents up from 4 cents in the year-ago period. The company's quarterly sales came in at $70.10 million versus, $55.41 million a ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/11/27/image_5.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Finance", "relevance_score": "0.2"}, {"topic": "Retail & Wholesale", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.865346"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Real Estate & Construction", "relevance_score": "0.2"}], "overall_sentiment_score": 0.12545, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CNEY", "relevance_score": "0.145145", "ticker_sentiment_score": "0.311641", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "IMPL", "relevance_score": "0.216215", "ticker_sentiment_score": "0.321438", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BGLC", "relevance_score": "0.145145", "ticker_sentiment_score": "-0.234624", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PGY", "relevance_score": "0.145145", "ticker_sentiment_score": "-0.005138", "ticker_sentiment_label": "Neutral"}, {"ticker": "CUEN", "relevance_score": "0.145145", "ticker_sentiment_score": "-0.238661", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "FLJ", "relevance_score": "0.216215", "ticker_sentiment_score": "0.34477", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TIGR", "relevance_score": "0.285526", "ticker_sentiment_score": "0.088074", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRKN", "relevance_score": "0.145145", "ticker_sentiment_score": "0.220884", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "APLM", "relevance_score": "0.145145", "ticker_sentiment_score": "0.069925", "ticker_sentiment_label": "Neutral"}, {"ticker": "HKIT", "relevance_score": "0.145145", "ticker_sentiment_score": "-0.219635", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "TRVN", "relevance_score": "0.216215", "ticker_sentiment_score": "-0.062431", "ticker_sentiment_label": "Neutral"}, {"ticker": "INBS", "relevance_score": "0.145145", "ticker_sentiment_score": "-0.053273", "ticker_sentiment_label": "Neutral"}, {"ticker": "MOBQ", "relevance_score": "0.145145", "ticker_sentiment_score": "0.327663", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MIND", "relevance_score": "0.072876", "ticker_sentiment_score": "0.215095", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CYN", "relevance_score": "0.145145", "ticker_sentiment_score": "0.385071", "ticker_sentiment_label": "Bullish"}, {"ticker": "ATXI", "relevance_score": "0.145145", "ticker_sentiment_score": "0.33381", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MVLA", "relevance_score": "0.145145", "ticker_sentiment_score": "-0.372932", "ticker_sentiment_label": "Bearish"}, {"ticker": "BPTH", "relevance_score": "0.216215", "ticker_sentiment_score": "-0.008842", "ticker_sentiment_label": "Neutral"}, {"ticker": "CAPT", "relevance_score": "0.145145", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMND", "relevance_score": "0.216215", "ticker_sentiment_score": "-0.048479", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Coverage Initiated by Analysts at StockNews.com", "url": "https://www.defenseworld.net/2023/11/24/bio-path-nasdaqbpth-coverage-initiated-by-analysts-at-stocknews-com-2.html", "time_published": "20231124T081442", "authors": ["Defense World Staff"], "summary": "Bio-Path ( NASDAQ:BPTH ) Coverage Initiated by Analysts at ... Defense World ...", "banner_image": "https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Earnings", "relevance_score": "0.904684"}], "overall_sentiment_score": 0.287666, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.85773", "ticker_sentiment_score": "0.474984", "ticker_sentiment_label": "Bullish"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Coverage Initiated by Analysts at StockNews.com", "url": "https://www.defenseworld.net/2023/11/16/bio-path-nasdaqbpth-coverage-initiated-by-analysts-at-stocknews-com.html", "time_published": "20231116T090050", "authors": ["Defense World Staff"], "summary": "Bio-Path ( NASDAQ:BPTH ) Coverage Initiated by Analysts at ... Defense World ...", "banner_image": "https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Earnings", "relevance_score": "0.818451"}, {"topic": "Retail & Wholesale", "relevance_score": "1.0"}], "overall_sentiment_score": 0.265969, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.854205", "ticker_sentiment_score": "0.442106", "ticker_sentiment_label": "Bullish"}]}, {"title": "Bio-Path Holdings to Announce Third Quarter 2023 Financial Results on November 15, 2023 - Bio-Path Hldgs  ( NASDAQ:BPTH ) ", "url": "https://www.benzinga.com/pressreleases/23/11/g35669300/bio-path-holdings-to-announce-third-quarter-2023-financial-results-on-november-15-2023", "time_published": "20231108T120000", "authors": ["Globe Newswire"], "summary": "HOUSTON, Nov. 08, 2023 ( GLOBE NEWSWIRE ) -- Bio-Path Holdings, Inc., BPTH a biotechnology company leveraging its proprietary DNAbilize\u00ae antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced that it will host a live conference call ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "1.0"}], "overall_sentiment_score": 0.084178, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.696319", "ticker_sentiment_score": "0.112502", "ticker_sentiment_label": "Neutral"}]}, {"title": "StockNews.com Initiates Coverage on Bio-Path  ( NASDAQ:BPTH ) ", "url": "https://www.defenseworld.net/2023/11/08/stocknews-com-initiates-coverage-on-bio-path-nasdaqbpth-2.html", "time_published": "20231108T081843", "authors": ["Defense World Staff"], "summary": "Analysts at StockNews.com initiated coverage on shares of Bio-Path ( NASDAQ:BPTH - Get Free Report ) in a research report issued to clients and investors on Wednesday. The brokerage set a \"sell\" rating on the stock. NASDAQ BPTH opened at $0.60 on Wednesday.", "banner_image": "https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Earnings", "relevance_score": "0.947132"}, {"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.858979"}], "overall_sentiment_score": 0.177333, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.866386", "ticker_sentiment_score": "0.303597", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AWON", "relevance_score": "0.132368", "ticker_sentiment_score": "-0.042457", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Now Covered by Analysts at StockNews.com", "url": "https://www.defenseworld.net/2023/10/31/bio-path-nasdaqbpth-now-covered-by-analysts-at-stocknews-com-2.html", "time_published": "20231031T072647", "authors": ["Defense World Staff"], "summary": "Bio-Path ( NASDAQ:BPTH ) Now Covered by Analysts at StockNews ... Defense World ...", "banner_image": "https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Earnings", "relevance_score": "0.875462"}, {"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}], "overall_sentiment_score": 0.288022, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MDNDF", "relevance_score": "0.142565", "ticker_sentiment_score": "0.314791", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BPTH", "relevance_score": "0.894071", "ticker_sentiment_score": "0.480994", "ticker_sentiment_label": "Bullish"}]}, {"title": "Bio-Path Holdings to Host Virtual Key Opinion Leader Event to Discuss Prexigebersen and Advances in the Treatment Landscape for Acute Myeloid Leukemia - Bio-Path Hldgs  ( NASDAQ:BPTH ) ", "url": "https://www.benzinga.com/pressreleases/23/10/g35389753/bio-path-holdings-to-host-virtual-key-opinion-leader-event-to-discuss-prexigebersen-and-advances-i", "time_published": "20231024T110000", "authors": ["Globe Newswire"], "summary": "HOUSTON, Oct. 24, 2023 ( GLOBE NEWSWIRE ) -- Bio-Path Holdings, Inc., BPTH a biotechnology company leveraging its proprietary DNAbilize\u00ae antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced it will host a virtual key opinion leader ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "1.0"}], "overall_sentiment_score": 0.033344, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.678102", "ticker_sentiment_score": "0.18755", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "StockNews.com Initiates Coverage on Bio-Path  ( NASDAQ:BPTH ) ", "url": "https://www.defenseworld.net/2023/10/23/stocknews-com-initiates-coverage-on-bio-path-nasdaqbpth.html", "time_published": "20231023T072447", "authors": ["Defense World Staff"], "summary": "Stock analysts at StockNews.com initiated coverage on shares of Bio-Path ( NASDAQ:BPTH - Get Free Report ) in a research report issued to clients and investors on Monday. The firm set a \"sell\" rating on the stock. NASDAQ:BPTH opened at $0.69 on Monday.", "banner_image": "https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Earnings", "relevance_score": "0.938238"}, {"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.684621"}], "overall_sentiment_score": 0.232538, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.846873", "ticker_sentiment_score": "0.38999", "ticker_sentiment_label": "Bullish"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Now Covered by Analysts at StockNews.com", "url": "https://www.defenseworld.net/2023/10/23/bio-path-nasdaqbpth-now-covered-by-analysts-at-stocknews-com.html", "time_published": "20231023T072446", "authors": ["Defense World Staff"], "summary": "Bio-Path ( NASDAQ:BPTH ) Now Covered by Analysts at StockNews ... Defense World ...", "banner_image": "https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Earnings", "relevance_score": "0.917436"}, {"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.276968, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.894071", "ticker_sentiment_score": "0.464651", "ticker_sentiment_label": "Bullish"}, {"ticker": "AWON", "relevance_score": "0.142565", "ticker_sentiment_score": "0.00125", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why Talaris Therapeutics Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket - Biocept  ( NASDAQ:BIOC ) , Advent Technologies Hldgs  ( NASDAQ:ADN ) ", "url": "https://www.benzinga.com/news/23/10/35305719/why-talaris-therapeutics-shares-are-trading-higher-by-around-8-here-are-20-stocks-moving-premarket", "time_published": "20231018T121855", "authors": ["Lisa Levin"], "summary": "Biocept, Inc. BIOC shares surged 91.8% to $0.98 in pre-market trading after falling over 6% on Tuesday. Biocept recently filed for Chapter 7 bankruptcy in the U.S. Bankruptcy Court for the District of Delaware. Shift Technologies, Inc. SFT shares rose 74.4% to $0.1878 in pre-market trading.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/18/image16_0.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Real Estate & Construction", "relevance_score": "0.2"}], "overall_sentiment_score": 0.034134, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "SFT", "relevance_score": "0.213048", "ticker_sentiment_score": "0.048059", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIOC", "relevance_score": "0.213048", "ticker_sentiment_score": "-0.269644", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "BKYI", "relevance_score": "0.213048", "ticker_sentiment_score": "-0.200348", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CMRA", "relevance_score": "0.142989", "ticker_sentiment_score": "0.168155", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SPRC", "relevance_score": "0.142989", "ticker_sentiment_score": "-0.025416", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADN", "relevance_score": "0.142989", "ticker_sentiment_score": "0.303022", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CNXA", "relevance_score": "0.142989", "ticker_sentiment_score": "0.452378", "ticker_sentiment_label": "Bullish"}, {"ticker": "RVLP", "relevance_score": "0.213048", "ticker_sentiment_score": "0.026662", "ticker_sentiment_label": "Neutral"}, {"ticker": "BSFC", "relevance_score": "0.142989", "ticker_sentiment_score": "0.128755", "ticker_sentiment_label": "Neutral"}, {"ticker": "VKTX", "relevance_score": "0.213048", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVVE", "relevance_score": "0.142989", "ticker_sentiment_score": "-0.058568", "ticker_sentiment_label": "Neutral"}, {"ticker": "SXTC", "relevance_score": "0.213048", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "TALS", "relevance_score": "0.142989", "ticker_sentiment_score": "0.119006", "ticker_sentiment_label": "Neutral"}, {"ticker": "INBS", "relevance_score": "0.142989", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NUZE", "relevance_score": "0.142989", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "UK", "relevance_score": "0.213048", "ticker_sentiment_score": "0.008962", "ticker_sentiment_label": "Neutral"}, {"ticker": "TPST", "relevance_score": "0.281422", "ticker_sentiment_score": "0.078493", "ticker_sentiment_label": "Neutral"}, {"ticker": "BPTH", "relevance_score": "0.142989", "ticker_sentiment_score": "-0.389355", "ticker_sentiment_label": "Bearish"}]}, {"title": "Why Streamline Health Solutions Shares Are Trading Lower By Over 68%? Here Are Other Stocks Moving In Monday's Mid-Day Session - Aldeyra Therapeutics  ( NASDAQ:ALDX ) , Alignment Healthcare  ( NASDAQ:ALHC ) ", "url": "https://www.benzinga.com/news/23/10/35272489/why-streamline-health-solutions-shares-are-trading-lower-by-over-68-here-are-other-stocks-moving-in", "time_published": "20231016T170953", "authors": ["Lisa Levin"], "summary": "MingZhu Logistics Holdings Limited YGMZ shares gained 64% to $0.7798 after gaining more than 10% on Friday. PCTEL, Inc. PCTI climbed 47.3% to $6.86. On Friday, Amphenol Corp APH inked a deal to acquire PCTEL for around $139.7 million. Almacenes \u00c9xito S.A. EXTO shares rose 32.6% to $6.66.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/16/image19.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Blockchain", "relevance_score": "0.158519"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "0.962106"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Earnings", "relevance_score": "0.108179"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": 0.0049, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "RERE", "relevance_score": "0.076236", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "SASI", "relevance_score": "0.076236", "ticker_sentiment_score": "-0.234441", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "FAZE", "relevance_score": "0.076236", "ticker_sentiment_score": "-0.051282", "ticker_sentiment_label": "Neutral"}, {"ticker": "MODD", "relevance_score": "0.076236", "ticker_sentiment_score": "0.348025", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PCTI", "relevance_score": "0.114137", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.076236", "ticker_sentiment_score": "-0.175071", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CLOV", "relevance_score": "0.076236", "ticker_sentiment_score": "-0.381861", "ticker_sentiment_label": "Bearish"}, {"ticker": "NFTG", "relevance_score": "0.076236", "ticker_sentiment_score": "-0.381861", "ticker_sentiment_label": "Bearish"}, {"ticker": "RDHL", "relevance_score": "0.076236", "ticker_sentiment_score": "0.044686", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRZO", "relevance_score": "0.076236", "ticker_sentiment_score": "-0.054605", "ticker_sentiment_label": "Neutral"}, {"ticker": "YGMZ", "relevance_score": "0.076236", "ticker_sentiment_score": "0.289453", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CNSP", "relevance_score": "0.076236", "ticker_sentiment_score": "0.348025", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SECO", "relevance_score": "0.076236", "ticker_sentiment_score": "-0.334701", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ENSC", "relevance_score": "0.076236", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNSL", "relevance_score": "0.076236", "ticker_sentiment_score": "0.12345", "ticker_sentiment_label": "Neutral"}, {"ticker": "GME", "relevance_score": "0.114137", "ticker_sentiment_score": "-0.02076", "ticker_sentiment_label": "Neutral"}, {"ticker": "PIXY", "relevance_score": "0.076236", "ticker_sentiment_score": "-0.381861", "ticker_sentiment_label": "Bearish"}, {"ticker": "ELYS", "relevance_score": "0.076236", "ticker_sentiment_score": "-0.381861", "ticker_sentiment_label": "Bearish"}, {"ticker": "PCSA", "relevance_score": "0.076236", "ticker_sentiment_score": "0.169195", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "NOTV", "relevance_score": "0.076236", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MREO", "relevance_score": "0.114137", "ticker_sentiment_score": "-0.071984", "ticker_sentiment_label": "Neutral"}, {"ticker": "OMER", "relevance_score": "0.076236", "ticker_sentiment_score": "-0.080856", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDLX", "relevance_score": "0.076236", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "EPIX", "relevance_score": "0.076236", "ticker_sentiment_score": "0.348025", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "VS", "relevance_score": "0.114137", "ticker_sentiment_score": "-0.209567", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "NXL", "relevance_score": "0.114137", "ticker_sentiment_score": "0.148778", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIOC", "relevance_score": "0.114137", "ticker_sentiment_score": "-0.09675", "ticker_sentiment_label": "Neutral"}, {"ticker": "MNTS", "relevance_score": "0.076236", "ticker_sentiment_score": "0.499776", "ticker_sentiment_label": "Bullish"}, {"ticker": "AMAM", "relevance_score": "0.114137", "ticker_sentiment_score": "-0.060629", "ticker_sentiment_label": "Neutral"}, {"ticker": "MLTX", "relevance_score": "0.076236", "ticker_sentiment_score": "0.092002", "ticker_sentiment_label": "Neutral"}, {"ticker": "INDI", "relevance_score": "0.114137", "ticker_sentiment_score": "0.088685", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRTA", "relevance_score": "0.076236", "ticker_sentiment_score": "0.348025", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TNGX", "relevance_score": "0.076236", "ticker_sentiment_score": "-0.381861", "ticker_sentiment_label": "Bearish"}, {"ticker": "EXTO", "relevance_score": "0.076236", "ticker_sentiment_score": "0.242611", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ZAPP", "relevance_score": "0.076236", "ticker_sentiment_score": "0.07953", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNTX", "relevance_score": "0.076236", "ticker_sentiment_score": "-0.234441", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "VSTO", "relevance_score": "0.076236", "ticker_sentiment_score": "0.02304", "ticker_sentiment_label": "Neutral"}, {"ticker": "COST", "relevance_score": "0.038162", "ticker_sentiment_score": "0.063334", "ticker_sentiment_label": "Neutral"}, {"ticker": "MNY", "relevance_score": "0.076236", "ticker_sentiment_score": "-0.504896", "ticker_sentiment_label": "Bearish"}, {"ticker": "CBIO", "relevance_score": "0.076236", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVAX", "relevance_score": "0.076236", "ticker_sentiment_score": "-0.121926", "ticker_sentiment_label": "Neutral"}, {"ticker": "BPTH", "relevance_score": "0.076236", "ticker_sentiment_score": "-0.051282", "ticker_sentiment_label": "Neutral"}, {"ticker": "SFT", "relevance_score": "0.114137", "ticker_sentiment_score": "-0.027399", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALDX", "relevance_score": "0.076236", "ticker_sentiment_score": "-0.020405", "ticker_sentiment_label": "Neutral"}, {"ticker": "ETWO", "relevance_score": "0.114137", "ticker_sentiment_score": "0.133347", "ticker_sentiment_label": "Neutral"}, {"ticker": "LQR", "relevance_score": "0.114137", "ticker_sentiment_score": "0.073097", "ticker_sentiment_label": "Neutral"}, {"ticker": "RVLP", "relevance_score": "0.114137", "ticker_sentiment_score": "-0.118813", "ticker_sentiment_label": "Neutral"}, {"ticker": "LULU", "relevance_score": "0.076236", "ticker_sentiment_score": "0.122434", "ticker_sentiment_label": "Neutral"}, {"ticker": "PROC", "relevance_score": "0.076236", "ticker_sentiment_score": "-0.381861", "ticker_sentiment_label": "Bearish"}, {"ticker": "ALHC", "relevance_score": "0.076236", "ticker_sentiment_score": "0.362377", "ticker_sentiment_label": "Bullish"}, {"ticker": "MANU", "relevance_score": "0.076236", "ticker_sentiment_score": "0.038136", "ticker_sentiment_label": "Neutral"}, {"ticker": "APH", "relevance_score": "0.076236", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "TPST", "relevance_score": "0.076236", "ticker_sentiment_score": "0.348025", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "STRM", "relevance_score": "0.076236", "ticker_sentiment_score": "0.092981", "ticker_sentiment_label": "Neutral"}, {"ticker": "NAOV", "relevance_score": "0.076236", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why ContraFect Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket", "url": "https://markets.businessinsider.com/news/stocks/why-contrafect-shares-are-trading-higher-by-around-30-here-are-20-stocks-moving-premarket-1032708380", "time_published": "20231016T131535", "authors": [], "summary": "Why ContraFect Shares Are Trading Higher By Around 30%. Here Are 20 Stocks Moving Premarket - Markets Insider ...", "banner_image": "https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2023/10/16/image21.jpeg", "source": "Business Insider", "category_within_source": "GoogleRSS", "source_domain": "markets.businessinsider.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Energy & Transportation", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.752319"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "0.158519"}], "overall_sentiment_score": -0.002452, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "SFT", "relevance_score": "0.209365", "ticker_sentiment_score": "-0.036651", "ticker_sentiment_label": "Neutral"}, {"ticker": "SASI", "relevance_score": "0.105604", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PCSA", "relevance_score": "0.105604", "ticker_sentiment_score": "0.157008", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AMAM", "relevance_score": "0.105604", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "FAZE", "relevance_score": "0.105604", "ticker_sentiment_score": "-0.050283", "ticker_sentiment_label": "Neutral"}, {"ticker": "LQR", "relevance_score": "0.105604", "ticker_sentiment_score": "0.17774", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PCTI", "relevance_score": "0.105604", "ticker_sentiment_score": "0.106937", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.105604", "ticker_sentiment_score": "-0.240048", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "BNTX", "relevance_score": "0.105604", "ticker_sentiment_score": "-0.240048", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "RDHL", "relevance_score": "0.105604", "ticker_sentiment_score": "0.04295", "ticker_sentiment_label": "Neutral"}, {"ticker": "AQB", "relevance_score": "0.105604", "ticker_sentiment_score": "-0.326449", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "COST", "relevance_score": "0.105604", "ticker_sentiment_score": "0.17774", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PRZO", "relevance_score": "0.105604", "ticker_sentiment_score": "-0.052781", "ticker_sentiment_label": "Neutral"}, {"ticker": "YGMZ", "relevance_score": "0.105604", "ticker_sentiment_score": "0.273297", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CFRX", "relevance_score": "0.105604", "ticker_sentiment_score": "0.087402", "ticker_sentiment_label": "Neutral"}, {"ticker": "SECO", "relevance_score": "0.105604", "ticker_sentiment_score": "-0.298031", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "APH", "relevance_score": "0.105604", "ticker_sentiment_score": "0.106937", "ticker_sentiment_label": "Neutral"}, {"ticker": "EPIX", "relevance_score": "0.105604", "ticker_sentiment_score": "0.29475", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BPTH", "relevance_score": "0.105604", "ticker_sentiment_score": "-0.050283", "ticker_sentiment_label": "Neutral"}, {"ticker": "VS", "relevance_score": "0.209365", "ticker_sentiment_score": "-0.266018", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Why ContraFect Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket - Ambrx Biopharma  ( NASDAQ:AMAM ) , Amphenol  ( NYSE:APH ) ", "url": "https://www.benzinga.com/news/23/10/35266067/why-contrafect-shares-are-trading-higher-by-around-30-here-are-20-stocks-moving-premarket", "time_published": "20231016T124712", "authors": ["Lisa Levin"], "summary": "LQR House Inc. LQR shares surged 109% to $0.3602 in pre-market trading after the company delivered inaugural order to Costco, securing Von Payne Whiskey's presence on store shelves. Processa Pharmaceuticals, Inc. PCSA shares rose 84.4% to $0.8853 in pre-market trading after jumping 45% on Friday.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/16/image21.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Energy & Transportation", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.82617"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.014639, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "SFT", "relevance_score": "0.287762", "ticker_sentiment_score": "-0.047206", "ticker_sentiment_label": "Neutral"}, {"ticker": "SASI", "relevance_score": "0.194242", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PCSA", "relevance_score": "0.194242", "ticker_sentiment_score": "0.205479", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AMAM", "relevance_score": "0.194242", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "FAZE", "relevance_score": "0.194242", "ticker_sentiment_score": "-0.067054", "ticker_sentiment_label": "Neutral"}, {"ticker": "LQR", "relevance_score": "0.194242", "ticker_sentiment_score": "0.238419", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PCTI", "relevance_score": "0.287762", "ticker_sentiment_score": "0.187512", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "EXTO", "relevance_score": "0.194242", "ticker_sentiment_score": "0.271112", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PFE", "relevance_score": "0.097854", "ticker_sentiment_score": "-0.225147", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "BNTX", "relevance_score": "0.194242", "ticker_sentiment_score": "-0.318104", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "RDHL", "relevance_score": "0.194242", "ticker_sentiment_score": "0.058057", "ticker_sentiment_label": "Neutral"}, {"ticker": "AQB", "relevance_score": "0.194242", "ticker_sentiment_score": "-0.405247", "ticker_sentiment_label": "Bearish"}, {"ticker": "COST", "relevance_score": "0.097854", "ticker_sentiment_score": "0.167429", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PRZO", "relevance_score": "0.194242", "ticker_sentiment_score": "-0.072285", "ticker_sentiment_label": "Neutral"}, {"ticker": "YGMZ", "relevance_score": "0.194242", "ticker_sentiment_score": "0.380189", "ticker_sentiment_label": "Bullish"}, {"ticker": "CFRX", "relevance_score": "0.194242", "ticker_sentiment_score": "0.117902", "ticker_sentiment_label": "Neutral"}, {"ticker": "MANU", "relevance_score": "0.194242", "ticker_sentiment_score": "-0.10182", "ticker_sentiment_label": "Neutral"}, {"ticker": "SECO", "relevance_score": "0.194242", "ticker_sentiment_score": "-0.406644", "ticker_sentiment_label": "Bearish"}, {"ticker": "APH", "relevance_score": "0.194242", "ticker_sentiment_score": "0.137587", "ticker_sentiment_label": "Neutral"}, {"ticker": "EPIX", "relevance_score": "0.194242", "ticker_sentiment_score": "0.365696", "ticker_sentiment_label": "Bullish"}, {"ticker": "BPTH", "relevance_score": "0.194242", "ticker_sentiment_score": "-0.067054", "ticker_sentiment_label": "Neutral"}, {"ticker": "VS", "relevance_score": "0.287762", "ticker_sentiment_score": "-0.320657", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Earns Sell Rating from Analysts at StockNews.com", "url": "https://www.defenseworld.net/2023/10/15/bio-path-nasdaqbpth-earns-sell-rating-from-analysts-at-stocknews-com.html", "time_published": "20231015T070643", "authors": ["Defense World Staff"], "summary": "Bio-Path ( NASDAQ:BPTH ) Earns Sell Rating from Analysts at ... Defense World ...", "banner_image": "https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Earnings", "relevance_score": "0.875462"}, {"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.796627"}], "overall_sentiment_score": 0.249155, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.902368", "ticker_sentiment_score": "0.42297", "ticker_sentiment_label": "Bullish"}]}, {"title": "What's Going On With Bio-Path Holdings Stock? - Bio-Path Hldgs  ( NASDAQ:BPTH ) ", "url": "https://www.benzinga.com/news/23/10/35241983/whats-going-on-with-bio-path-holdings-stock", "time_published": "20231013T143210", "authors": ["Erica Kollmann"], "summary": "Bio-Path Holdings, Inc. BPTH shares are rocketing higher Friday on heavy trading volume. Here's a look at what's going on: Shares of BPTH are up over 90% on remarkably heavy volume Friday, and trading has been halted multiple times for volatility.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/13/bio-path_holdings_inc._stock_bpth_shares_up_today.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}], "overall_sentiment_score": 0.147782, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.88837", "ticker_sentiment_score": "0.23323", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Dow Jumps Over 200 Points; JPMorgan Earnings Top Estimates - Bellerophon Therapeutics  ( NASDAQ:BLPH ) , Bio-Path Hldgs  ( NASDAQ:BPTH ) ", "url": "https://www.benzinga.com/news/earnings/23/10/35241137/dow-jumps-over-200-points-jpmorgan-earnings-top-estimates", "time_published": "20231013T134849", "authors": ["Lisa Levin"], "summary": "U.S. stocks traded mostly higher this morning, with the Dow Jones gaining more than 200 points on Friday. Following the market opening Friday, the Dow traded up 0.74% to 33,880.85 while the NASDAQ rose 0.04% to 13,579.61. The S&P 500 also rose, gaining, 0.41% to 4,367.33.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/13/image17.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}, {"topic": "Economy - Monetary", "relevance_score": "0.451494"}, {"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Earnings", "relevance_score": "0.891286"}], "overall_sentiment_score": -0.048611, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "SASI", "relevance_score": "0.173333", "ticker_sentiment_score": "0.264363", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "JPM", "relevance_score": "0.257442", "ticker_sentiment_score": "-0.085989", "ticker_sentiment_label": "Neutral"}, {"ticker": "WBA", "relevance_score": "0.087185", "ticker_sentiment_score": "-0.167326", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SECO", "relevance_score": "0.173333", "ticker_sentiment_score": "-0.45489", "ticker_sentiment_label": "Bearish"}, {"ticker": "BLPH", "relevance_score": "0.173333", "ticker_sentiment_score": "0.299989", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BPTH", "relevance_score": "0.173333", "ticker_sentiment_score": "0.462523", "ticker_sentiment_label": "Bullish"}, {"ticker": "VS", "relevance_score": "0.173333", "ticker_sentiment_score": "0.34603", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "OM", "relevance_score": "0.173333", "ticker_sentiment_score": "0.112769", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why Comtech Telecommunications Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket - Blue Star Foods  ( NASDAQ:BSFC ) , Bio-Path Hldgs  ( NASDAQ:BPTH ) ", "url": "https://www.benzinga.com/news/23/10/35238161/why-comtech-telecommunications-shares-are-trading-higher-by-around-17-here-are-20-stocks-moving-prem", "time_published": "20231013T113538", "authors": ["Lisa Levin"], "summary": "Oblong, Inc. OBLG shares rose 295.7% to $1.16 in pre-market trading. Bio-Path Holdings, Inc. BPTH shares gained 70% to $0.67 in pre-market trading after gaining more than 6% on Thursday. Blue Star Foods Corp. BSFC shares climbed 64% to $0.3296 in pre-market trading. Versus Systems Inc.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/13/image45.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "0.846708"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "0.360215"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}], "overall_sentiment_score": 0.092431, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "SFT", "relevance_score": "0.162802", "ticker_sentiment_score": "0.082394", "ticker_sentiment_label": "Neutral"}, {"ticker": "MNTS", "relevance_score": "0.162802", "ticker_sentiment_score": "-0.008456", "ticker_sentiment_label": "Neutral"}, {"ticker": "OBLG", "relevance_score": "0.162802", "ticker_sentiment_score": "0.261828", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SOPA", "relevance_score": "0.242084", "ticker_sentiment_score": "0.058259", "ticker_sentiment_label": "Neutral"}, {"ticker": "EDSA", "relevance_score": "0.242084", "ticker_sentiment_score": "0.298707", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "RSLS", "relevance_score": "0.162802", "ticker_sentiment_score": "-0.235254", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "DTSS", "relevance_score": "0.242084", "ticker_sentiment_score": "-0.065076", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDHL", "relevance_score": "0.242084", "ticker_sentiment_score": "0.003828", "ticker_sentiment_label": "Neutral"}, {"ticker": "BSFC", "relevance_score": "0.162802", "ticker_sentiment_score": "0.261828", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BYSI", "relevance_score": "0.162802", "ticker_sentiment_score": "-0.063674", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRZO", "relevance_score": "0.162802", "ticker_sentiment_score": "0.148024", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGH", "relevance_score": "0.162802", "ticker_sentiment_score": "-0.263153", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SJ", "relevance_score": "0.162802", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "LGMK", "relevance_score": "0.162802", "ticker_sentiment_score": "-0.059063", "ticker_sentiment_label": "Neutral"}, {"ticker": "TIRX", "relevance_score": "0.162802", "ticker_sentiment_score": "-0.267128", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "BPTH", "relevance_score": "0.162802", "ticker_sentiment_score": "0.462461", "ticker_sentiment_label": "Bullish"}, {"ticker": "CMTL", "relevance_score": "0.162802", "ticker_sentiment_score": "0.426366", "ticker_sentiment_label": "Bullish"}, {"ticker": "GETR", "relevance_score": "0.162802", "ticker_sentiment_score": "0.369115", "ticker_sentiment_label": "Bullish"}, {"ticker": "VS", "relevance_score": "0.162802", "ticker_sentiment_score": "0.161733", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SAVA", "relevance_score": "0.242084", "ticker_sentiment_score": "-0.432213", "ticker_sentiment_label": "Bearish"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Now Covered by StockNews.com", "url": "https://www.defenseworld.net/2023/10/07/bio-path-nasdaqbpth-now-covered-by-stocknews-com-2.html", "time_published": "20231007T073245", "authors": ["Defense World Staff"], "summary": "Investment analysts at StockNews.com started coverage on shares of Bio-Path ( NASDAQ:BPTH - Get Free Report ) in a note issued to investors on Saturday. The firm set a \"sell\" rating on the stock. Shares of BPTH stock opened at $0.37 on Friday.", "banner_image": "https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Earnings", "relevance_score": "0.875462"}, {"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}], "overall_sentiment_score": 0.275539, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "SBUX", "relevance_score": "0.129516", "ticker_sentiment_score": "0.221991", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BPTH", "relevance_score": "0.85773", "ticker_sentiment_score": "0.456528", "ticker_sentiment_label": "Bullish"}, {"ticker": "AWON", "relevance_score": "0.129516", "ticker_sentiment_score": "0.001187", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stocks That Hit 52-Week Lows On Wednesday - Bristol-Myers Squibb Company Common Stock  ( NYSE:BMY ) , SenesTech, Inc. - Common Stock  ( NASDAQ:SNES ) ", "url": "https://www.benzinga.com/markets/options/23/10/35092508/stocks-that-hit-52-week-lows-on-wednesday", "time_published": "20231004T160117", "authors": ["Benzinga Insights"], "summary": "On Wednesday, 311 stocks hit new 52-week lows. Bristol-Myers Squibb Company Common Stock BMY is the largest company in terms of market cap to set a new 52-week low this morning. SenesTech, Inc. - Common Stock SNES was the smallest company by market cap to set a new 52-week low. A10 Networks, ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.024373, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ATEN", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004379", "ticker_sentiment_label": "Neutral"}, {"ticker": "FLGC", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.097572", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRIP", "relevance_score": "0.006354", "ticker_sentiment_score": "0.104513", "ticker_sentiment_label": "Neutral"}, {"ticker": "NOVA", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.087032", "ticker_sentiment_label": "Neutral"}, {"ticker": "CERE", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.07919", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASST", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.087508", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVST", "relevance_score": "0.012708", "ticker_sentiment_score": "0.003458", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGIC", "relevance_score": "0.012708", "ticker_sentiment_score": "0.003516", "ticker_sentiment_label": "Neutral"}, {"ticker": "BALY", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.094831", "ticker_sentiment_label": "Neutral"}, {"ticker": "FLGT", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.07919", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVCR", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.066077", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTAIF", "relevance_score": "0.006354", "ticker_sentiment_score": "0.056254", "ticker_sentiment_label": "Neutral"}, {"ticker": "OTLY", "relevance_score": "0.012708", "ticker_sentiment_score": "0.081144", "ticker_sentiment_label": "Neutral"}, {"ticker": "VABK", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.103629", "ticker_sentiment_label": "Neutral"}, {"ticker": "BOXL", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004379", "ticker_sentiment_label": "Neutral"}, {"ticker": "DENN", "relevance_score": "0.012708", "ticker_sentiment_score": "0.003516", "ticker_sentiment_label": "Neutral"}, {"ticker": "FNLC", "relevance_score": "0.012708", "ticker_sentiment_score": "0.051167", "ticker_sentiment_label": "Neutral"}, {"ticker": "GME", "relevance_score": "0.012708", "ticker_sentiment_score": "0.003516", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMWL", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004379", "ticker_sentiment_label": "Neutral"}, {"ticker": "PASG", "relevance_score": "0.012708", "ticker_sentiment_score": "0.065668", "ticker_sentiment_label": "Neutral"}, {"ticker": "EHAB", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.08354", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNGO", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.103629", "ticker_sentiment_label": "Neutral"}, {"ticker": "SCNI", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004379", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASTR", "relevance_score": "0.012708", "ticker_sentiment_score": "0.058861", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARBB", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.082048", "ticker_sentiment_label": "Neutral"}, {"ticker": "RC", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.072267", "ticker_sentiment_label": "Neutral"}, {"ticker": "SEE", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.07919", "ticker_sentiment_label": "Neutral"}, {"ticker": "AEHL", "relevance_score": "0.012708", "ticker_sentiment_score": "0.014754", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTI", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.075723", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTTR", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.07967", "ticker_sentiment_label": "Neutral"}, {"ticker": "GNL", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.097572", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADXN", "relevance_score": "0.012708", "ticker_sentiment_score": "0.077302", "ticker_sentiment_label": "Neutral"}, {"ticker": "INDI", "relevance_score": "0.012708", "ticker_sentiment_score": "0.003458", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVEI", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.066789", "ticker_sentiment_label": "Neutral"}, {"ticker": "REXR", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.094831", "ticker_sentiment_label": "Neutral"}, {"ticker": "KIDS", "relevance_score": "0.012708", "ticker_sentiment_score": "0.00349", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACET", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.087032", "ticker_sentiment_label": "Neutral"}, {"ticker": "PENN", "relevance_score": "0.012708", "ticker_sentiment_score": "0.005375", "ticker_sentiment_label": "Neutral"}, {"ticker": "CWH", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.075723", "ticker_sentiment_label": "Neutral"}, {"ticker": "RAPT", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.087032", "ticker_sentiment_label": "Neutral"}, {"ticker": "CWK", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.023051", "ticker_sentiment_label": "Neutral"}, {"ticker": "FREQ", "relevance_score": "0.012708", "ticker_sentiment_score": "0.065668", "ticker_sentiment_label": "Neutral"}, {"ticker": "SEER", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004349", "ticker_sentiment_label": "Neutral"}, {"ticker": "LHX", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.097572", "ticker_sentiment_label": "Neutral"}, {"ticker": "MCRB", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004349", "ticker_sentiment_label": "Neutral"}, {"ticker": "PULM", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.087032", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLSD", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004379", "ticker_sentiment_label": "Neutral"}, {"ticker": "GDEN", "relevance_score": "0.012708", "ticker_sentiment_score": "0.003516", "ticker_sentiment_label": "Neutral"}, {"ticker": "BRQS", "relevance_score": "0.012708", "ticker_sentiment_score": "0.084108", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRDN", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.093233", "ticker_sentiment_label": "Neutral"}, {"ticker": "LSDI", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.087032", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNES", "relevance_score": "0.025413", "ticker_sentiment_score": "-0.047554", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATXS", "relevance_score": "0.012708", "ticker_sentiment_score": "0.003516", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRFX", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004379", "ticker_sentiment_label": "Neutral"}, {"ticker": "IOVA", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004433", "ticker_sentiment_label": "Neutral"}, {"ticker": "SEDG", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.087032", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLRN", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.103629", "ticker_sentiment_label": "Neutral"}, {"ticker": "CFFN", "relevance_score": "0.012708", "ticker_sentiment_score": "0.003468", "ticker_sentiment_label": "Neutral"}, {"ticker": "FNA", "relevance_score": "0.012708", "ticker_sentiment_score": "0.00349", "ticker_sentiment_label": "Neutral"}, {"ticker": "WOLF", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004379", "ticker_sentiment_label": "Neutral"}, {"ticker": "AONC", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.07919", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALIT", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.072267", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBNK", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004349", "ticker_sentiment_label": "Neutral"}, {"ticker": "DQ", "relevance_score": "0.012708", "ticker_sentiment_score": "0.07063", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDHL", "relevance_score": "0.012708", "ticker_sentiment_score": "0.088031", "ticker_sentiment_label": "Neutral"}, {"ticker": "FENC", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.094831", "ticker_sentiment_label": "Neutral"}, {"ticker": "UI", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.072267", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBAC", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004349", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSA", "relevance_score": "0.012708", "ticker_sentiment_score": "0.065668", "ticker_sentiment_label": "Neutral"}, {"ticker": "EE", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.069682", "ticker_sentiment_label": "Neutral"}, {"ticker": "SAND", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004379", "ticker_sentiment_label": "Neutral"}, {"ticker": "AEMD", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.093233", "ticker_sentiment_label": "Neutral"}, {"ticker": "CIO", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.07919", "ticker_sentiment_label": "Neutral"}, {"ticker": "CCSI", "relevance_score": "0.012708", "ticker_sentiment_score": "0.00345", "ticker_sentiment_label": "Neutral"}, {"ticker": "OBLG", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004349", "ticker_sentiment_label": "Neutral"}, {"ticker": "NOK", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.023051", "ticker_sentiment_label": "Neutral"}, {"ticker": "MMM", "relevance_score": "0.012708", "ticker_sentiment_score": "0.003516", "ticker_sentiment_label": "Neutral"}, {"ticker": "JGGCR", "relevance_score": "0.006354", "ticker_sentiment_score": "0.003316", "ticker_sentiment_label": "Neutral"}, {"ticker": "LTHM", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.093233", "ticker_sentiment_label": "Neutral"}, {"ticker": "BRCC", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.07919", "ticker_sentiment_label": "Neutral"}, {"ticker": "PHUN", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004433", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARVN", "relevance_score": "0.012708", "ticker_sentiment_score": "0.003458", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMCI", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.103629", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHLS", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.096253", "ticker_sentiment_label": "Neutral"}, {"ticker": "AADI", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004414", "ticker_sentiment_label": "Neutral"}, {"ticker": "AFG", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.07919", "ticker_sentiment_label": "Neutral"}, {"ticker": "KZR", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.072267", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLGN", "relevance_score": "0.012708", "ticker_sentiment_score": "0.065668", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENV", "relevance_score": "0.012708", "ticker_sentiment_score": "0.003458", "ticker_sentiment_label": "Neutral"}, {"ticker": "NEXI", "relevance_score": "0.012708", "ticker_sentiment_score": "0.00349", "ticker_sentiment_label": "Neutral"}, {"ticker": "AHCO", "relevance_score": "0.012708", "ticker_sentiment_score": "0.003458", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONFO", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.07919", "ticker_sentiment_label": "Neutral"}, {"ticker": "HTZ", "relevance_score": "0.012708", "ticker_sentiment_score": "0.073595", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGMO", "relevance_score": "0.012708", "ticker_sentiment_score": "0.00349", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBSW", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004455", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLGL", "relevance_score": "0.012708", "ticker_sentiment_score": "0.065668", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCBP", "relevance_score": "0.012708", "ticker_sentiment_score": "0.003468", "ticker_sentiment_label": "Neutral"}, {"ticker": "NSTG", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.093233", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGMT", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.07919", "ticker_sentiment_label": "Neutral"}, {"ticker": "FLNG", "relevance_score": "0.012708", "ticker_sentiment_score": "0.003516", "ticker_sentiment_label": "Neutral"}, {"ticker": "RVNC", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.093233", "ticker_sentiment_label": "Neutral"}, {"ticker": "HUN", "relevance_score": "0.012708", "ticker_sentiment_score": "0.003458", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIG", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.087032", "ticker_sentiment_label": "Neutral"}, {"ticker": "OMCL", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.087032", "ticker_sentiment_label": "Neutral"}, {"ticker": "EXFY", "relevance_score": "0.012708", "ticker_sentiment_score": "0.00349", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALLR", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.087032", "ticker_sentiment_label": "Neutral"}, {"ticker": "NKSH", "relevance_score": "0.006354", "ticker_sentiment_score": "-0.099392", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLFD", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.097572", "ticker_sentiment_label": "Neutral"}, {"ticker": "DNB", "relevance_score": "0.012708", "ticker_sentiment_score": "0.003458", "ticker_sentiment_label": "Neutral"}, {"ticker": "OTRK", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004414", "ticker_sentiment_label": "Neutral"}, {"ticker": "DGII", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.07919", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLYQ", "relevance_score": "0.006354", "ticker_sentiment_score": "-0.090814", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASIX", "relevance_score": "0.012708", "ticker_sentiment_score": "0.003458", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTN", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004379", "ticker_sentiment_label": "Neutral"}, {"ticker": "MCQEF", "relevance_score": "0.006354", "ticker_sentiment_score": "0.035779", "ticker_sentiment_label": "Neutral"}, {"ticker": "SONX", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.087032", "ticker_sentiment_label": "Neutral"}, {"ticker": "BXRX", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.087032", "ticker_sentiment_label": "Neutral"}, {"ticker": "EDBL", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004349", "ticker_sentiment_label": "Neutral"}, {"ticker": "FGEN", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.07919", "ticker_sentiment_label": "Neutral"}, {"ticker": "RMNI", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004433", "ticker_sentiment_label": "Neutral"}, {"ticker": "PETS", "relevance_score": "0.012708", "ticker_sentiment_score": "0.003516", "ticker_sentiment_label": "Neutral"}, {"ticker": "CARA", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004433", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELBM", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004349", "ticker_sentiment_label": "Neutral"}, {"ticker": "YGMZ", "relevance_score": "0.012708", "ticker_sentiment_score": "0.015818", "ticker_sentiment_label": "Neutral"}, {"ticker": "KVUE", "relevance_score": "0.012708", "ticker_sentiment_score": "0.073595", "ticker_sentiment_label": "Neutral"}, {"ticker": "VERU", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.10115", "ticker_sentiment_label": "Neutral"}, {"ticker": "WSKEF", "relevance_score": "0.006354", "ticker_sentiment_score": "0.089086", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSNL", "relevance_score": "0.012708", "ticker_sentiment_score": "0.003458", "ticker_sentiment_label": "Neutral"}, {"ticker": "FLNT", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.087032", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSBX", "relevance_score": "0.012708", "ticker_sentiment_score": "0.065668", "ticker_sentiment_label": "Neutral"}, {"ticker": "MATV", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.075723", "ticker_sentiment_label": "Neutral"}, {"ticker": "CHPT", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.07919", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMXI", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004379", "ticker_sentiment_label": "Neutral"}, {"ticker": "SONN", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004414", "ticker_sentiment_label": "Neutral"}, {"ticker": "CARV", "relevance_score": "0.012708", "ticker_sentiment_score": "0.003516", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLK", "relevance_score": "0.006354", "ticker_sentiment_score": "0.093873", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGRX", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004379", "ticker_sentiment_label": "Neutral"}, {"ticker": "IONR", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004349", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNS", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.075835", "ticker_sentiment_label": "Neutral"}, {"ticker": "PINC", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004349", "ticker_sentiment_label": "Neutral"}, {"ticker": "HKIT", "relevance_score": "0.012708", "ticker_sentiment_score": "0.084108", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTCT", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.07919", "ticker_sentiment_label": "Neutral"}, {"ticker": "OCEA", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004349", "ticker_sentiment_label": "Neutral"}, {"ticker": "NEXPF", "relevance_score": "0.006354", "ticker_sentiment_score": "0.003316", "ticker_sentiment_label": "Neutral"}, {"ticker": "BPTH", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.087032", "ticker_sentiment_label": "Neutral"}, {"ticker": "INMD", "relevance_score": "0.012708", "ticker_sentiment_score": "0.003516", "ticker_sentiment_label": "Neutral"}, {"ticker": "STIM", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004455", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMBP", "relevance_score": "0.012708", "ticker_sentiment_score": "0.077302", "ticker_sentiment_label": "Neutral"}, {"ticker": "IGMS", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004414", "ticker_sentiment_label": "Neutral"}, {"ticker": "OCTO", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.093233", "ticker_sentiment_label": "Neutral"}, {"ticker": "SATS", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.07919", "ticker_sentiment_label": "Neutral"}, {"ticker": "BKKT", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004379", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.025413", "ticker_sentiment_score": "-0.094732", "ticker_sentiment_label": "Neutral"}, {"ticker": "OGI", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.087032", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYTK", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.087032", "ticker_sentiment_label": "Neutral"}, {"ticker": "DRRX", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004414", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLFPF", "relevance_score": "0.012708", "ticker_sentiment_score": "0.145721", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVGO", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.087032", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPRO", "relevance_score": "0.012708", "ticker_sentiment_score": "0.073595", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALK", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004433", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSIQ", "relevance_score": "0.012708", "ticker_sentiment_score": "0.09692", "ticker_sentiment_label": "Neutral"}, {"ticker": "TITN", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.097572", "ticker_sentiment_label": "Neutral"}, {"ticker": "CHCT", "relevance_score": "0.012708", "ticker_sentiment_score": "0.003458", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTKB", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.075723", "ticker_sentiment_label": "Neutral"}, {"ticker": "ME", "relevance_score": "0.006354", "ticker_sentiment_score": "0.004247", "ticker_sentiment_label": "Neutral"}, {"ticker": "UBCP", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.097572", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTLA", "relevance_score": "0.012708", "ticker_sentiment_score": "0.00349", "ticker_sentiment_label": "Neutral"}, {"ticker": "BOM", "relevance_score": "0.012708", "ticker_sentiment_score": "0.029644", "ticker_sentiment_label": "Neutral"}, {"ticker": "UDR", "relevance_score": "0.012708", "ticker_sentiment_score": "0.058861", "ticker_sentiment_label": "Neutral"}, {"ticker": "VFS", "relevance_score": "0.012708", "ticker_sentiment_score": "0.09692", "ticker_sentiment_label": "Neutral"}, {"ticker": "MP", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.087032", "ticker_sentiment_label": "Neutral"}, {"ticker": "VWE", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.07919", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMT", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.075723", "ticker_sentiment_label": "Neutral"}, {"ticker": "CAG", "relevance_score": "0.012708", "ticker_sentiment_score": "0.065668", "ticker_sentiment_label": "Neutral"}, {"ticker": "DSX", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004414", "ticker_sentiment_label": "Neutral"}, {"ticker": "KROS", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004349", "ticker_sentiment_label": "Neutral"}, {"ticker": "BOX", "relevance_score": "0.006354", "ticker_sentiment_score": "0.056254", "ticker_sentiment_label": "Neutral"}, {"ticker": "SAFE", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004455", "ticker_sentiment_label": "Neutral"}, {"ticker": "MED", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004379", "ticker_sentiment_label": "Neutral"}, {"ticker": "HIFS", "relevance_score": "0.012708", "ticker_sentiment_score": "0.00349", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANVS", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004414", "ticker_sentiment_label": "Neutral"}, {"ticker": "DISH", "relevance_score": "0.012708", "ticker_sentiment_score": "0.002574", "ticker_sentiment_label": "Neutral"}, {"ticker": "ESTA", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.015601", "ticker_sentiment_label": "Neutral"}, {"ticker": "GERN", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004349", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLPG", "relevance_score": "0.012708", "ticker_sentiment_score": "0.077302", "ticker_sentiment_label": "Neutral"}, {"ticker": "ERAS", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.094831", "ticker_sentiment_label": "Neutral"}, {"ticker": "MNTS", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.07919", "ticker_sentiment_label": "Neutral"}, {"ticker": "FFIN", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004414", "ticker_sentiment_label": "Neutral"}, {"ticker": "PARA", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.165618", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "VRAR", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004349", "ticker_sentiment_label": "Neutral"}, {"ticker": "LAND", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004349", "ticker_sentiment_label": "Neutral"}, {"ticker": "INM", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.10115", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANY", "relevance_score": "0.006354", "ticker_sentiment_score": "0.077621", "ticker_sentiment_label": "Neutral"}, {"ticker": "XNCR", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004414", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLP", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.024164", "ticker_sentiment_label": "Neutral"}, {"ticker": "HTOO", "relevance_score": "0.012708", "ticker_sentiment_score": "0.074399", "ticker_sentiment_label": "Neutral"}, {"ticker": "EXPR", "relevance_score": "0.006354", "ticker_sentiment_score": "0.004163", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRIX", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.07919", "ticker_sentiment_label": "Neutral"}, {"ticker": "STOK", "relevance_score": "0.012708", "ticker_sentiment_score": "0.065668", "ticker_sentiment_label": "Neutral"}, {"ticker": "DUO", "relevance_score": "0.012708", "ticker_sentiment_score": "0.077302", "ticker_sentiment_label": "Neutral"}, {"ticker": "LMFA", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.093233", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPGC", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004433", "ticker_sentiment_label": "Neutral"}, {"ticker": "PMD", "relevance_score": "0.012708", "ticker_sentiment_score": "0.003516", "ticker_sentiment_label": "Neutral"}, {"ticker": "PB", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.075723", "ticker_sentiment_label": "Neutral"}, {"ticker": "RZLT", "relevance_score": "0.012708", "ticker_sentiment_score": "0.055971", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACRV", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004379", "ticker_sentiment_label": "Neutral"}, {"ticker": "PI", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004414", "ticker_sentiment_label": "Neutral"}, {"ticker": "IPA", "relevance_score": "0.012708", "ticker_sentiment_score": "-0.087032", "ticker_sentiment_label": "Neutral"}, {"ticker": "NIU", "relevance_score": "0.012708", "ticker_sentiment_score": "0.092908", "ticker_sentiment_label": "Neutral"}, {"ticker": "JACK", "relevance_score": "0.012708", "ticker_sentiment_score": "0.058861", "ticker_sentiment_label": "Neutral"}, {"ticker": "SCL", "relevance_score": "0.012708", "ticker_sentiment_score": "0.004414", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Now Covered by StockNews.com", "url": "https://www.defenseworld.net/2023/09/29/bio-path-nasdaqbpth-now-covered-by-stocknews-com.html", "time_published": "20230929T072442", "authors": ["Defense World Staff"], "summary": "Stock analysts at StockNews.com started coverage on shares of Bio-Path ( NASDAQ:BPTH - Get Free Report ) in a report issued on Friday. The firm set a \"sell\" rating on the stock. Bio-Path stock opened at $0.37 on Friday.", "banner_image": "https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Earnings", "relevance_score": "0.976671"}, {"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}], "overall_sentiment_score": 0.236968, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.872847", "ticker_sentiment_score": "0.400637", "ticker_sentiment_label": "Bullish"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Receives New Coverage from Analysts at StockNews.com", "url": "https://www.defenseworld.net/2023/09/21/bio-path-nasdaqbpth-receives-new-coverage-from-analysts-at-stocknews-com.html", "time_published": "20230921T073445", "authors": ["Defense World Staff"], "summary": "Bio-Path ( NASDAQ:BPTH ) Receives New Coverage from Analysts ... Defense World ...", "banner_image": "https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Earnings", "relevance_score": "0.938238"}, {"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.796627"}], "overall_sentiment_score": 0.185497, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.832201", "ticker_sentiment_score": "0.311926", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AWON", "relevance_score": "0.136888", "ticker_sentiment_score": "-0.0444", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Path Receives Sell Rating from StockNews.com", "url": "https://www.claytoncountyregister.com/news2/bio-path-nasdaqbpth-now-covered-by-analysts-at-stocknews-com/431361/", "time_published": "20230917T064921", "authors": ["Lira Mercer"], "summary": "StockNews.com recently initiated coverage on the shares of Bio-Path Holdings, Inc. ( NASDAQ:BPTH ) with a sell rating. Bio-Path, a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company, operates in the United States.", "banner_image": "https://www.claytoncountyregister.com/wp-content/uploads/2023/07/mfrack_realistic_photo_of_UK_stock_exchange_f72ab651-4b91-4eb2-b6d0-bd7d35dc35ee.jpeg", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.claytoncountyregister.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}, {"topic": "Earnings", "relevance_score": "0.818451"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.023968, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.759278", "ticker_sentiment_score": "0.172444", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "VIRT", "relevance_score": "0.1331", "ticker_sentiment_score": "0.091713", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Now Covered by Analysts at StockNews.com", "url": "https://www.defenseworld.net/2023/09/14/bio-path-nasdaqbpth-now-covered-by-analysts-at-stocknews-com.html", "time_published": "20230914T084250", "authors": ["Defense World Staff"], "summary": "Bio-Path ( NASDAQ:BPTH ) Now Covered by Analysts at StockNews ... Defense World ...", "banner_image": "https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}, {"topic": "Earnings", "relevance_score": "0.917436"}, {"topic": "Energy & Transportation", "relevance_score": "0.5"}], "overall_sentiment_score": 0.24115, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ENB", "relevance_score": "0.147818", "ticker_sentiment_score": "0.209102", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BPTH", "relevance_score": "0.906461", "ticker_sentiment_score": "0.410508", "ticker_sentiment_label": "Bullish"}, {"ticker": "AWON", "relevance_score": "0.147818", "ticker_sentiment_score": "-0.047604", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Path Holdings to Present at H.C. Wainwright 25th Annual Global Investment Conference", "url": "https://www.globenewswire.com/news-release/2023/09/08/2740314/0/en/Bio-Path-Holdings-to-Present-at-H-C-Wainwright-25th-Annual-Global-Investment-Conference.html", "time_published": "20230908T200100", "authors": ["Bio-Path Holdings", "Inc."], "summary": "HOUSTON, Sept. 08, 2023 ( GLOBE NEWSWIRE ) -- Bio-Path Holdings, Inc., ( NASDAQ:BPTH ) , a biotechnology company leveraging its proprietary DNAbilize\u00ae liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced that Peter Nielsen, ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/249fef91-7e82-4f67-b919-46c0c4d6fb17", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.087529, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.433523", "ticker_sentiment_score": "0.089706", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Research Coverage Started at StockNews.com", "url": "https://www.defenseworld.net/2023/09/05/bio-path-nasdaqbpth-research-coverage-started-at-stocknews-com-2.html", "time_published": "20230905T072445", "authors": ["Defense World Staff"], "summary": "Bio-Path ( NASDAQ:BPTH ) Research Coverage Started at ... Defense World ...", "banner_image": "https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.87644"}, {"topic": "Manufacturing", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "0.904684"}], "overall_sentiment_score": 0.252604, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.883531", "ticker_sentiment_score": "0.426277", "ticker_sentiment_label": "Bullish"}, {"ticker": "TSLA", "relevance_score": "0.138464", "ticker_sentiment_score": "0.218957", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Research Coverage Started at StockNews.com", "url": "https://www.defenseworld.net/2023/08/28/bio-path-nasdaqbpth-research-coverage-started-at-stocknews-com.html", "time_published": "20230828T064244", "authors": ["Defense World Staff"], "summary": "Bio-Path ( NASDAQ:BPTH ) Research Coverage Started at ... Defense World ...", "banner_image": "https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Earnings", "relevance_score": "0.996675"}, {"topic": "Retail & Wholesale", "relevance_score": "1.0"}], "overall_sentiment_score": 0.31173, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.868543", "ticker_sentiment_score": "0.511394", "ticker_sentiment_label": "Bullish"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Receives New Coverage from Analysts at StockNews.com", "url": "https://www.defenseworld.net/2023/08/20/bio-path-nasdaqbpth-receives-new-coverage-from-analysts-at-stocknews-com.html", "time_published": "20230820T055243", "authors": ["Defense World Staff"], "summary": "Bio-Path ( NASDAQ:BPTH ) Receives New Coverage from Analysts ... Defense World ...", "banner_image": "https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Earnings", "relevance_score": "0.904684"}, {"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.858979"}], "overall_sentiment_score": 0.242726, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ROST", "relevance_score": "0.135347", "ticker_sentiment_score": "0.197854", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BPTH", "relevance_score": "0.874993", "ticker_sentiment_score": "0.409103", "ticker_sentiment_label": "Bullish"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Coverage Initiated by Analysts at StockNews.com", "url": "https://www.defenseworld.net/2023/08/12/bio-path-nasdaqbpth-coverage-initiated-by-analysts-at-stocknews-com.html", "time_published": "20230812T052247", "authors": ["Defense World Staff"], "summary": "StockNews.com began coverage on shares of Bio-Path ( NASDAQ:BPTH - Get Free Report ) in a research report issued on Saturday. The brokerage set a \"sell\" rating on the stock. Shares of Bio-Path stock opened at $0.41 on Friday. Bio-Path has a one year low of $0.37 and a one year high of $4.24.", "banner_image": "https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.650727"}, {"topic": "Earnings", "relevance_score": "0.904684"}, {"topic": "Blockchain", "relevance_score": "0.310843"}], "overall_sentiment_score": 0.285275, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.870696", "ticker_sentiment_score": "0.472445", "ticker_sentiment_label": "Bullish"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Research Coverage Started at StockNews.com", "url": "https://www.defenseworld.net/2023/08/04/bio-path-nasdaqbpth-research-coverage-started-at-stocknews-com.html", "time_published": "20230804T073844", "authors": ["Defense World Staff"], "summary": "Equities researchers at StockNews.com started coverage on shares of Bio-Path ( NASDAQ:BPTH - Get Free Report ) in a research note issued on Friday. The brokerage set a \"sell\" rating on the stock. Shares of Bio-Path stock opened at $0.41 on Friday. Bio-Path has a 1 year low of $0.37 and a 1 year ...", "banner_image": "https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.796627"}, {"topic": "Earnings", "relevance_score": "0.795202"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.265778, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.868543", "ticker_sentiment_score": "0.444156", "ticker_sentiment_label": "Bullish"}, {"ticker": "SYM", "relevance_score": "0.1331", "ticker_sentiment_score": "0.202603", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AWON", "relevance_score": "0.1331", "ticker_sentiment_score": "0.001202", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why Bio-Path Holdings  ( BPTH )  Stock Is Down 45% - Bio-Path Hldgs  ( NASDAQ:BPTH ) ", "url": "https://www.benzinga.com/news/23/08/33554961/why-bio-path-holdings-bpth-stock-is-down-45", "time_published": "20230803T173800", "authors": ["Henry Khederian"], "summary": "Bio Path Holdings Inc BPTH shares are trading lower by 45.95% to $0.41 Thursday afternoon after the company priced a 3.5 million unit offering at $0.60 per unit. The offering is expected to generate around $2.1 million in gross proceeds.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/08/03/1.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.684621"}], "overall_sentiment_score": -0.026184, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.83383", "ticker_sentiment_score": "-0.008275", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Path Holdings, Inc. Announces Pricing of $2.1 Million Public Offering - Bio-Path Hldgs  ( NASDAQ:BPTH ) ", "url": "https://www.benzinga.com/pressreleases/23/08/g33547210/bio-path-holdings-inc-announces-pricing-of-2-1-million-public-offering", "time_published": "20230803T122237", "authors": ["Globe Newswire"], "summary": "HOUSTON, Aug. 03, 2023 ( GLOBE NEWSWIRE ) -- Bio-Path Holdings, Inc., BPTH ( \"Bio-Path\" or the \"Company\" ) , a biotechnology company leveraging its proprietary DNAbilize\u00ae antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced the ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "IPO", "relevance_score": "0.310843"}, {"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.99999"}], "overall_sentiment_score": 0.136112, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.386875", "ticker_sentiment_score": "0.101269", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Path Holdings, Inc. Announces Pricing of $2.1 Million Public Offering", "url": "https://www.globenewswire.com/news-release/2023/08/03/2718012/0/en/Bio-Path-Holdings-Inc-Announces-Pricing-of-2-1-Million-Public-Offering.html", "time_published": "20230803T122200", "authors": ["Bio-Path Holdings", "Inc."], "summary": "HOUSTON, Aug. 03, 2023 ( GLOBE NEWSWIRE ) -- Bio-Path Holdings, Inc., ( Nasdaq:BPTH ) ( \"Bio-Path\" or the \"Company\" ) , a biotechnology company leveraging its proprietary DNAbilize\u00ae antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, today ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/249fef91-7e82-4f67-b919-46c0c4d6fb17", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "IPO", "relevance_score": "0.310843"}, {"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.999966"}], "overall_sentiment_score": 0.138514, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.352432", "ticker_sentiment_score": "0.097063", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Path Releases Early Cut Data From Mid-Stage Prexigebersen Trial In Acute Myeloid Leukemia - Bio-Path Hldgs  ( NASDAQ:BPTH ) ", "url": "https://www.benzinga.com/general/biotech/23/08/33495093/bio-path-releases-early-cut-data-from-mid-stage-prexigebersen-trial-in-acute-myeloid-leukemia", "time_published": "20230801T195426", "authors": ["Vandana Singh"], "summary": "Bio-Path Holdings Inc BPTH reported interim data from Stage 2 of the company's Phase 2 study of prexigebersen in combination with decitabine and venetoclax for acute myeloid leukemia ( AML ) .", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/08/01/bpth.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "1.0"}], "overall_sentiment_score": 0.305168, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.392948", "ticker_sentiment_score": "0.385146", "ticker_sentiment_label": "Bullish"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Coverage Initiated at StockNews.com", "url": "https://www.defenseworld.net/2023/07/27/bio-path-nasdaqbpth-coverage-initiated-at-stocknews-com.html", "time_published": "20230727T075244", "authors": ["Defense World Staff"], "summary": "Equities research analysts at StockNews.com started coverage on shares of Bio-Path ( NASDAQ:BPTH - Get Free Report ) in a research report issued to clients and investors on Thursday. The brokerage set a \"sell\" rating on the stock. Shares of BPTH stock opened at $0.88 on Thursday.", "banner_image": "https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.857896"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Blockchain", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.206383, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "KO", "relevance_score": "0.136888", "ticker_sentiment_score": "0.130698", "ticker_sentiment_label": "Neutral"}, {"ticker": "VZ", "relevance_score": "0.136888", "ticker_sentiment_score": "0.130698", "ticker_sentiment_label": "Neutral"}, {"ticker": "BPTH", "relevance_score": "0.879272", "ticker_sentiment_score": "0.352588", "ticker_sentiment_label": "Bullish"}, {"ticker": "BA", "relevance_score": "0.136888", "ticker_sentiment_score": "0.130698", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Research Coverage Started at StockNews.com", "url": "https://www.defenseworld.net/2023/07/19/bio-path-nasdaqbpth-research-coverage-started-at-stocknews-com-2.html", "time_published": "20230719T053642", "authors": ["Defense World Staff"], "summary": "Stock analysts at StockNews.com started coverage on shares of Bio-Path ( NASDAQ:BPTH - Get Free Report ) in a research note issued to investors on Wednesday. The brokerage set a \"sell\" rating on the stock. NASDAQ:BPTH opened at $1.31 on Wednesday.", "banner_image": "https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.795202"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}], "overall_sentiment_score": 0.243849, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "SCHW", "relevance_score": "0.146916", "ticker_sentiment_score": "0.224918", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "LMT", "relevance_score": "0.146916", "ticker_sentiment_score": "0.224918", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AWON", "relevance_score": "0.146916", "ticker_sentiment_score": "-0.044929", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBIX", "relevance_score": "0.146916", "ticker_sentiment_score": "0.224918", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BPTH", "relevance_score": "0.861522", "ticker_sentiment_score": "0.409553", "ticker_sentiment_label": "Bullish"}]}, {"title": "Bio-Path Holdings Announces Successful Completion of First Dose Cohort in Phase 1/1b Clinical Trial of BP1001-A in Solid Tumors", "url": "https://www.globenewswire.com/news-release/2023/07/17/2705155/0/en/Bio-Path-Holdings-Announces-Successful-Completion-of-First-Dose-Cohort-in-Phase-1-1b-Clinical-Trial-of-BP1001-A-in-Solid-Tumors.html", "time_published": "20230717T110000", "authors": ["Inc.", "Bio-Path Holdings"], "summary": "Advancing to Second Cohort of Phase 1/1b Clinical Trial Evaluating BP1001-A to Treat Patients with Solid Tumors, Including Ovarian, Endometrial, Pancreatic and Breast Cancer Advancing to Second Cohort of Phase 1/1b Clinical Trial Evaluating BP1001-A to Treat Patients with Solid Tumors, Including ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/249fef91-7e82-4f67-b919-46c0c4d6fb17", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.062616, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.29485", "ticker_sentiment_score": "0.070346", "ticker_sentiment_label": "Neutral"}]}, {"title": "StockNews.com Initiates Coverage on Bio-Path  ( NASDAQ:BPTH ) ", "url": "https://www.defenseworld.net/2023/07/11/stocknews-com-initiates-coverage-on-bio-path-nasdaqbpth.html", "time_published": "20230711T053850", "authors": ["Defense World Staff"], "summary": "Analysts at StockNews.com initiated coverage on shares of Bio-Path ( NASDAQ:BPTH - Get Free Report ) in a research report issued on Tuesday. The firm set a \"sell\" rating on the stock. Separately, Roth Capital reaffirmed a \"buy\" rating on shares of Bio-Path in a research note on Friday, March 17th.", "banner_image": "https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.161647"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.266533, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.917585", "ticker_sentiment_score": "0.451883", "ticker_sentiment_label": "Bullish"}, {"ticker": "VIRT", "relevance_score": "0.12546", "ticker_sentiment_score": "0.11962", "ticker_sentiment_label": "Neutral"}, {"ticker": "AWON", "relevance_score": "0.12546", "ticker_sentiment_score": "-0.045996", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Research Coverage Started at StockNews.com", "url": "https://www.defenseworld.net/2023/07/03/bio-path-nasdaqbpth-research-coverage-started-at-stocknews-com.html", "time_published": "20230703T052246", "authors": ["Defense World Staff"], "summary": "Bio-Path ( NASDAQ:BPTH ) Research Coverage Started at ... Defense World ...", "banner_image": "https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Finance", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.274636, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.962559", "ticker_sentiment_score": "0.470388", "ticker_sentiment_label": "Bullish"}, {"ticker": "VIRT", "relevance_score": "0.137671", "ticker_sentiment_score": "0.148625", "ticker_sentiment_label": "Neutral"}]}, {"title": "StockNews.com Begins Coverage on Bio-Path  ( NASDAQ:BPTH ) ", "url": "https://www.defenseworld.net/2023/06/25/stocknews-com-begins-coverage-on-bio-path-nasdaqbpth.html", "time_published": "20230625T051847", "authors": ["Defense World Staff"], "summary": "Stock analysts at StockNews.com began coverage on shares of Bio-Path ( NASDAQ:BPTH - Get Rating ) in a research note issued to investors on Sunday. The firm set a \"sell\" rating on the stock. Separately, Roth Capital restated a \"buy\" rating on shares of Bio-Path in a report on Friday, March 17th.", "banner_image": "https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.235401, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.949596", "ticker_sentiment_score": "0.407514", "ticker_sentiment_label": "Bullish"}, {"ticker": "VIRT", "relevance_score": "0.129516", "ticker_sentiment_score": "0.060195", "ticker_sentiment_label": "Neutral"}, {"ticker": "KMX", "relevance_score": "0.129516", "ticker_sentiment_score": "0.237736", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Earns Sell Rating from Analysts at StockNews.com", "url": "https://www.defenseworld.net/2023/06/17/bio-path-nasdaqbpth-earns-sell-rating-from-analysts-at-stocknews-com.html", "time_published": "20230617T052243", "authors": ["Defense World Staff"], "summary": "Bio-Path ( NASDAQ:BPTH ) Earns Sell Rating from Analysts at ... Defense World ...", "banner_image": "https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.281071, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.945787", "ticker_sentiment_score": "0.478074", "ticker_sentiment_label": "Bullish"}, {"ticker": "VIRT", "relevance_score": "0.127456", "ticker_sentiment_score": "0.191335", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AVGO", "relevance_score": "0.127456", "ticker_sentiment_score": "0.226578", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Receives New Coverage from Analysts at StockNews.com", "url": "https://www.defenseworld.net/2023/06/09/bio-path-nasdaqbpth-receives-new-coverage-from-analysts-at-stocknews-com.html", "time_published": "20230609T055843", "authors": ["Defense World Staff"], "summary": "Bio-Path ( NASDAQ:BPTH ) Receives New Coverage from Analysts ... Defense World ...", "banner_image": "https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}, {"topic": "Earnings", "relevance_score": "0.451494"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.161647"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.201323, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "KIRK", "relevance_score": "0.120431", "ticker_sentiment_score": "0.109866", "ticker_sentiment_label": "Neutral"}, {"ticker": "SFIX", "relevance_score": "0.120431", "ticker_sentiment_score": "0.109866", "ticker_sentiment_label": "Neutral"}, {"ticker": "BPTH", "relevance_score": "0.930964", "ticker_sentiment_score": "0.350716", "ticker_sentiment_label": "Bullish"}, {"ticker": "VIRT", "relevance_score": "0.120431", "ticker_sentiment_score": "0.154329", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Coverage Initiated at StockNews.com", "url": "https://www.defenseworld.net/2023/05/24/bio-path-nasdaqbpth-coverage-initiated-at-stocknews-com.html", "time_published": "20230524T053455", "authors": ["Defense World Staff"], "summary": "Stock analysts at StockNews.com initiated coverage on shares of Bio-Path ( NASDAQ:BPTH - Get Rating ) in a report issued on Wednesday. The brokerage set a \"sell\" rating on the stock. Separately, Roth Capital reissued a \"buy\" rating on shares of Bio-Path in a research note on Friday, March 17th.", "banner_image": "https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.239603, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "WSM", "relevance_score": "0.119235", "ticker_sentiment_score": "0.14047", "ticker_sentiment_label": "Neutral"}, {"ticker": "PETS", "relevance_score": "0.119235", "ticker_sentiment_score": "0.14047", "ticker_sentiment_label": "Neutral"}, {"ticker": "AWON", "relevance_score": "0.119235", "ticker_sentiment_score": "0.002284", "ticker_sentiment_label": "Neutral"}, {"ticker": "BPTH", "relevance_score": "0.948824", "ticker_sentiment_score": "0.414244", "ticker_sentiment_label": "Bullish"}, {"ticker": "VIRT", "relevance_score": "0.119235", "ticker_sentiment_score": "0.155503", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Now Covered by Analysts at StockNews.com", "url": "https://www.defenseworld.net/2023/05/16/bio-path-nasdaqbpth-now-covered-by-analysts-at-stocknews-com.html", "time_published": "20230516T054845", "authors": ["Defense World Staff"], "summary": "Bio-Path ( NASDAQ:BPTH ) Now Covered by Analysts at StockNews ... Defense World ...", "banner_image": "https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.161647"}, {"topic": "Energy & Transportation", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}], "overall_sentiment_score": 0.213107, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "APP", "relevance_score": "0.108958", "ticker_sentiment_score": "0.123288", "ticker_sentiment_label": "Neutral"}, {"ticker": "FREY", "relevance_score": "0.108958", "ticker_sentiment_score": "0.123288", "ticker_sentiment_label": "Neutral"}, {"ticker": "BPTH", "relevance_score": "0.925058", "ticker_sentiment_score": "0.368901", "ticker_sentiment_label": "Bullish"}, {"ticker": "EXAS", "relevance_score": "0.108958", "ticker_sentiment_score": "0.123288", "ticker_sentiment_label": "Neutral"}, {"ticker": "VIRT", "relevance_score": "0.108958", "ticker_sentiment_score": "0.115578", "ticker_sentiment_label": "Neutral"}, {"ticker": "GXO", "relevance_score": "0.108958", "ticker_sentiment_score": "0.123288", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Path Holdings Reports First Quarter 2023 Financial Results", "url": "https://www.globenewswire.com/news-release/2023/05/12/2667656/0/en/Bio-Path-Holdings-Reports-First-Quarter-2023-Financial-Results.html", "time_published": "20230512T110000", "authors": ["Inc.", "Bio-Path Holdings"], "summary": "Conference Call to be Held Today at 8:30 A.M. ET Conference Call to be Held Today at 8:30 A.M. ET ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/249fef91-7e82-4f67-b919-46c0c4d6fb17", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Earnings", "relevance_score": "0.451494"}, {"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.131858, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.346278", "ticker_sentiment_score": "0.151797", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Bio-Path Holdings to Announce First Quarter 2023 Financial Results on May 12, 2023 - Bio-Path Hldgs  ( NASDAQ:BPTH ) ", "url": "https://www.benzinga.com/pressreleases/23/05/g32235036/bio-path-holdings-to-announce-first-quarter-2023-financial-results-on-may-12-2023", "time_published": "20230505T110000", "authors": ["Globe Newswire"], "summary": "HOUSTON, May 05, 2023 ( GLOBE NEWSWIRE ) -- Bio-Path Holdings, Inc., BPTH a biotechnology company leveraging its proprietary DNAbilize\u00ae antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced that it will host a live conference call ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "1.0"}], "overall_sentiment_score": 0.084175, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.696319", "ticker_sentiment_score": "0.112499", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Path Holdings to Announce First Quarter 2023 Financial Results on May 12, 2023", "url": "https://www.globenewswire.com/news-release/2023/05/05/2662411/0/en/Bio-Path-Holdings-to-Announce-First-Quarter-2023-Financial-Results-on-May-12-2023.html", "time_published": "20230505T110000", "authors": ["Bio-Path Holdings", "Inc."], "summary": "HOUSTON, May 05, 2023 ( GLOBE NEWSWIRE ) -- Bio-Path Holdings, Inc., ( NASDAQ: BPTH ) a biotechnology company leveraging its proprietary DNAbilize\u00ae antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced that it will host a live ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/249fef91-7e82-4f67-b919-46c0c4d6fb17", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "1.0"}], "overall_sentiment_score": 0.093663, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.651499", "ticker_sentiment_score": "0.116352", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Now Covered by StockNews.com", "url": "https://www.defenseworld.net/2023/04/30/bio-path-nasdaqbpth-now-covered-by-stocknews-com.html", "time_published": "20230430T051244", "authors": ["Defense World Staff"], "summary": "Stock analysts at StockNews.com initiated coverage on shares of Bio-Path ( NASDAQ:BPTH - Get Rating ) in a note issued to investors on Sunday. The firm set a \"sell\" rating on the stock. Separately, Roth Capital reissued a \"buy\" rating on shares of Bio-Path in a research report on Friday, March ...", "banner_image": "https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Finance", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.27584, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.956537", "ticker_sentiment_score": "0.47074", "ticker_sentiment_label": "Bullish"}, {"ticker": "VIRT", "relevance_score": "0.114682", "ticker_sentiment_score": "0.178199", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Research Coverage Started at StockNews.com", "url": "https://www.defenseworld.net/2023/04/22/bio-path-nasdaqbpth-research-coverage-started-at-stocknews-com.html", "time_published": "20230422T053642", "authors": ["Defense World Staff"], "summary": "Bio-Path ( NASDAQ:BPTH ) Research Coverage Started at ... Defense World ...", "banner_image": "https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Finance", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}], "overall_sentiment_score": 0.244017, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "NFLX", "relevance_score": "0.115787", "ticker_sentiment_score": "0.087778", "ticker_sentiment_label": "Neutral"}, {"ticker": "BPTH", "relevance_score": "0.941669", "ticker_sentiment_score": "0.420374", "ticker_sentiment_label": "Bullish"}, {"ticker": "VIRT", "relevance_score": "0.115787", "ticker_sentiment_score": "0.221691", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "StockNews.com Begins Coverage on Bio-Path  ( NASDAQ:BPTH ) ", "url": "https://www.defenseworld.net/2023/04/14/stocknews-com-begins-coverage-on-bio-path-nasdaqbpth.html", "time_published": "20230414T054044", "authors": ["Defense World Staff"], "summary": "Equities research analysts at StockNews.com began coverage on shares of Bio-Path ( NASDAQ:BPTH - Get Rating ) in a research note issued on Friday. The brokerage set a \"sell\" rating on the stock. Separately, Roth Capital reaffirmed a \"buy\" rating on shares of Bio-Path in a research note on ...", "banner_image": "https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.144799, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.9545", "ticker_sentiment_score": "0.257517", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "NVO", "relevance_score": "0.175859", "ticker_sentiment_score": "0.104561", "ticker_sentiment_label": "Neutral"}, {"ticker": "AWON", "relevance_score": "0.175859", "ticker_sentiment_score": "-0.051889", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Earns Sell Rating from Analysts at StockNews.com", "url": "https://www.defenseworld.net/2023/04/06/bio-path-nasdaqbpth-earns-sell-rating-from-analysts-at-stocknews-com.html", "time_published": "20230406T053447", "authors": ["Defense World Staff"], "summary": "Bio-Path ( NASDAQ:BPTH ) Earns Sell Rating from Analysts at ... Defense World ...", "banner_image": "https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.205578, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.91848", "ticker_sentiment_score": "0.356447", "ticker_sentiment_label": "Bullish"}, {"ticker": "CAR", "relevance_score": "0.15347", "ticker_sentiment_score": "0.145735", "ticker_sentiment_label": "Neutral"}, {"ticker": "PINS", "relevance_score": "0.15347", "ticker_sentiment_score": "0.145735", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Path Holdings Reports Full Year 2022 Financial Results", "url": "https://www.globenewswire.com/news-release/2023/03/31/2638506/0/en/Bio-Path-Holdings-Reports-Full-Year-2022-Financial-Results.html", "time_published": "20230331T110000", "authors": ["Bio-Path Holdings", "Inc."], "summary": "Conference Call to be Held Today at 8:30 A.M. ET Conference Call to be Held Today at 8:30 A.M. ET ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/249fef91-7e82-4f67-b919-46c0c4d6fb17", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Earnings", "relevance_score": "0.451494"}, {"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.163945, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.351115", "ticker_sentiment_score": "0.157781", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Research Coverage Started at StockNews.com", "url": "https://www.defenseworld.net/2023/03/29/bio-path-nasdaqbpth-research-coverage-started-at-stocknews-com.html", "time_published": "20230329T052642", "authors": ["Defense World Staff"], "summary": "Bio-Path ( NASDAQ:BPTH ) Research Coverage Started at ... Defense World ...", "banner_image": "https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}, {"topic": "Earnings", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.18586, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.890401", "ticker_sentiment_score": "0.320659", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "VKTX", "relevance_score": "0.158519", "ticker_sentiment_score": "0.147596", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Path Holdings to Announce Fourth Quarter and Full Year 2022 Financial Results on March 31, 2023 - Bio-Path Holdings  ( NASDAQ:BPTH ) ", "url": "https://www.benzinga.com/pressreleases/23/03/g31497654/bio-path-holdings-to-announce-fourth-quarter-and-full-year-2022-financial-results-on-march-31-2023", "time_published": "20230324T200100", "authors": ["Globe Newswire"], "summary": "HOUSTON, March 24, 2023 ( GLOBE NEWSWIRE ) -- Bio-Path Holdings, Inc. BPTH, a biotechnology company leveraging its proprietary DNAbilize\u00ae antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced that it will host a live conference call ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "1.0"}], "overall_sentiment_score": 0.088786, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.677342", "ticker_sentiment_score": "0.118373", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Path Holdings to Announce Fourth Quarter and Full Year 2022 Financial Results on March 31, 2023", "url": "https://www.globenewswire.com/news-release/2023/03/24/2634308/0/en/Bio-Path-Holdings-to-Announce-Fourth-Quarter-and-Full-Year-2022-Financial-Results-on-March-31-2023.html", "time_published": "20230324T200100", "authors": ["Bio-Path Holdings", "Inc."], "summary": "HOUSTON, March 24, 2023 ( GLOBE NEWSWIRE ) -- Bio-Path Holdings, Inc. ( NASDAQ: BPTH ) , a biotechnology company leveraging its proprietary DNAbilize\u00ae antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced that it will host a live ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/249fef91-7e82-4f67-b919-46c0c4d6fb17", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "1.0"}], "overall_sentiment_score": 0.100586, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.630923", "ticker_sentiment_score": "0.125099", "ticker_sentiment_label": "Neutral"}]}, {"title": "StockNews.com Begins Coverage on Bio-Path  ( NASDAQ:BPTH ) ", "url": "https://www.defenseworld.net/2023/03/21/stocknews-com-begins-coverage-on-bio-path-nasdaqbpth.html", "time_published": "20230321T052649", "authors": ["Defense World Staff"], "summary": "Equities research analysts at StockNews.com began coverage on shares of Bio-Path ( NASDAQ:BPTH - Get Rating ) in a research report issued to clients and investors on Tuesday. The brokerage set a \"sell\" rating on the stock. Separately, Roth Capital restated a \"buy\" rating on shares of Bio-Path ...", "banner_image": "https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Finance", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.135397, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.939207", "ticker_sentiment_score": "0.240262", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "FRC", "relevance_score": "0.165031", "ticker_sentiment_score": "0.087148", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:USD", "relevance_score": "0.165031", "ticker_sentiment_score": "0.087148", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:BTC", "relevance_score": "0.165031", "ticker_sentiment_score": "0.087148", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Path Holdings Provides Clinical and Operational Update", "url": "https://www.globenewswire.com/news-release/2023/03/16/2628469/0/en/Bio-Path-Holdings-Provides-Clinical-and-Operational-Update.html", "time_published": "20230316T110000", "authors": ["Inc.", "Bio-Path Holdings"], "summary": "Company Expects to Achieve Several Near-Term Clinical Milestones Company Expects to Achieve Several Near-Term Clinical Milestones ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/249fef91-7e82-4f67-b919-46c0c4d6fb17", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.177319, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.278697", "ticker_sentiment_score": "0.150848", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Coverage Initiated at StockNews.com", "url": "https://www.defenseworld.net/2023/03/05/bio-path-nasdaqbpth-coverage-initiated-at-stocknews-com.html", "time_published": "20230305T082443", "authors": ["Defense World Staff"], "summary": "Stock analysts at StockNews.com assumed coverage on shares of Bio-Path ( NASDAQ:BPTH - Get Rating ) in a report released on Sunday. The brokerage set a \"sell\" rating on the stock. Shares of Bio-Path stock opened at $1.76 on Friday.", "banner_image": "https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.161647"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.262804, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.955602", "ticker_sentiment_score": "0.450609", "ticker_sentiment_label": "Bullish"}, {"ticker": "VIRT", "relevance_score": "0.122894", "ticker_sentiment_score": "0.174184", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ZS", "relevance_score": "0.122894", "ticker_sentiment_score": "0.159819", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Now Covered by StockNews.com", "url": "https://www.defenseworld.net/2023/02/17/bio-path-nasdaqbpth-now-covered-by-stocknews-com.html", "time_published": "20230217T082245", "authors": ["Defense World Staff"], "summary": "StockNews.com assumed coverage on shares of Bio-Path ( NASDAQ:BPTH - Get Rating ) in a report released on Friday. The brokerage set a \"sell\" rating on the stock. BPTH stock opened at $1.95 on Friday. The business has a 50-day moving average price of $1.77 and a 200 day moving average price of ...", "banner_image": "https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Earnings", "relevance_score": "0.928139"}, {"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.166107, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.943973", "ticker_sentiment_score": "0.292579", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AWON", "relevance_score": "0.151539", "ticker_sentiment_score": "-0.045766", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Earns Sell Rating from Analysts at StockNews.com", "url": "https://www.etfdailynews.com/2023/02/09/bio-path-nasdaqbpth-earns-sell-rating-from-analysts-at-stocknews-com/", "time_published": "20230209T084243", "authors": ["MarketBeat News"], "summary": "Bio-Path ( NASDAQ:BPTH ) Earns Sell Rating from Analysts at ... ETF Daily News ...", "banner_image": "https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.etfdailynews.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Manufacturing", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "0.917436"}], "overall_sentiment_score": 0.147563, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.89699", "ticker_sentiment_score": "0.257118", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CVS", "relevance_score": "0.129516", "ticker_sentiment_score": "0.130073", "ticker_sentiment_label": "Neutral"}, {"ticker": "DQ", "relevance_score": "0.129516", "ticker_sentiment_score": "0.130073", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Earns Sell Rating from Analysts at StockNews.com", "url": "https://www.defenseworld.net/2023/02/09/bio-path-nasdaqbpth-earns-sell-rating-from-analysts-at-stocknews-com.html", "time_published": "20230209T084241", "authors": ["Defense World Staff"], "summary": "Bio-Path ( NASDAQ:BPTH ) Earns Sell Rating from Analysts at ... Defense World ...", "banner_image": "https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Manufacturing", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "0.917436"}], "overall_sentiment_score": 0.147563, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.89699", "ticker_sentiment_score": "0.257118", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CVS", "relevance_score": "0.129516", "ticker_sentiment_score": "0.130073", "ticker_sentiment_label": "Neutral"}, {"ticker": "DQ", "relevance_score": "0.129516", "ticker_sentiment_score": "0.130073", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Now Covered by StockNews.com", "url": "https://www.defenseworld.net/2023/02/01/bio-path-nasdaqbpth-now-covered-by-stocknews-com-2.html", "time_published": "20230201T082845", "authors": ["Defense World Staff"], "summary": "Research analysts at StockNews.com assumed coverage on shares of Bio-Path ( NASDAQ:BPTH - Get Rating ) in a research report issued to clients and investors on Wednesday. The firm set a \"sell\" rating on the stock. Shares of BPTH opened at $2.08 on Wednesday.", "banner_image": "https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Earnings", "relevance_score": "0.967321"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.230968, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "VZ", "relevance_score": "0.132368", "ticker_sentiment_score": "0.211169", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BPTH", "relevance_score": "0.904419", "ticker_sentiment_score": "0.395015", "ticker_sentiment_label": "Bullish"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Now Covered by StockNews.com", "url": "https://www.etfdailynews.com/2023/02/01/bio-path-nasdaqbpth-now-covered-by-stocknews-com-2/", "time_published": "20230201T082843", "authors": ["MarketBeat News"], "summary": "Research analysts at StockNews.com assumed coverage on shares of Bio-Path ( NASDAQ:BPTH - Get Rating ) in a research report issued to clients and investors on Wednesday. The firm set a \"sell\" rating on the stock. Shares of BPTH opened at $2.08 on Wednesday.", "banner_image": "https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.etfdailynews.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Earnings", "relevance_score": "0.967321"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.230968, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "VZ", "relevance_score": "0.132368", "ticker_sentiment_score": "0.211169", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BPTH", "relevance_score": "0.904419", "ticker_sentiment_score": "0.395015", "ticker_sentiment_label": "Bullish"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Now Covered by StockNews.com", "url": "https://reporter.am/2023/01/24/bio-path-nasdaqbpth-now-covered-by-stocknews-com.html", "time_published": "20230124T082846", "authors": ["AM Reporter Staff"], "summary": "Analysts at StockNews.com assumed coverage on shares of Bio-Path ( NASDAQ:BPTH - Get Rating ) in a report released on Tuesday. The brokerage set a \"sell\" rating on the stock. Shares of BPTH stock opened at $1.93 on Tuesday.", "banner_image": "https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "reporter.am", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.929393"}, {"topic": "Manufacturing", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "0.9545"}], "overall_sentiment_score": 0.162244, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.902573", "ticker_sentiment_score": "0.281764", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AWON", "relevance_score": "0.131643", "ticker_sentiment_score": "0.001196", "ticker_sentiment_label": "Neutral"}, {"ticker": "NOC", "relevance_score": "0.131643", "ticker_sentiment_score": "0.093371", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Earns Sell Rating from Analysts at StockNews.com", "url": "https://reporter.am/2023/01/16/bio-path-nasdaqbpth-earns-sell-rating-from-analysts-at-stocknews-com-2.html", "time_published": "20230116T090642", "authors": ["AM Reporter Staff"], "summary": "Bio-Path ( NASDAQ:BPTH ) Earns Sell Rating from Analysts at ... Armenian Reporter ...", "banner_image": "https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "reporter.am", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Manufacturing", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "0.938238"}], "overall_sentiment_score": 0.189655, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BBBY", "relevance_score": "0.142565", "ticker_sentiment_score": "0.1778", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AWON", "relevance_score": "0.142565", "ticker_sentiment_score": "-0.044163", "ticker_sentiment_label": "Neutral"}, {"ticker": "BPTH", "relevance_score": "0.92757", "ticker_sentiment_score": "0.331395", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GE", "relevance_score": "0.142565", "ticker_sentiment_score": "0.1778", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Earns Sell Rating from Analysts at StockNews.com", "url": "https://www.etfdailynews.com/2023/01/08/bio-path-nasdaqbpth-earns-sell-rating-from-analysts-at-stocknews-com/", "time_published": "20230108T082244", "authors": ["MarketBeat News"], "summary": "Bio-Path ( NASDAQ:BPTH ) Earns Sell Rating from Analysts at ... ETF Daily News ...", "banner_image": "https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.etfdailynews.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.875462"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.135091, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.920636", "ticker_sentiment_score": "0.238509", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "NVDA", "relevance_score": "0.139265", "ticker_sentiment_score": "0.113223", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRWD", "relevance_score": "0.139265", "ticker_sentiment_score": "0.113223", "ticker_sentiment_label": "Neutral"}]}, {"title": "StockNews.com Begins Coverage on Bio-Path  ( NASDAQ:BPTH ) ", "url": "https://www.etfdailynews.com/2022/12/31/stocknews-com-begins-coverage-on-bio-path-nasdaqbpth-2/", "time_published": "20221231T082246", "authors": ["MarketBeat News"], "summary": "StockNews.com initiated coverage on shares of Bio-Path ( NASDAQ:BPTH - Get Rating ) in a report released on Saturday. The firm set a \"sell\" rating on the stock. Shares of Bio-Path stock opened at $1.51 on Friday. The company has a market cap of $10.81 million, a PE ratio of -0.77 and a beta of ...", "banner_image": "https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.etfdailynews.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Manufacturing", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "0.875462"}], "overall_sentiment_score": 0.194243, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.948591", "ticker_sentiment_score": "0.341092", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GNRC", "relevance_score": "0.154455", "ticker_sentiment_score": "0.204432", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AWON", "relevance_score": "0.154455", "ticker_sentiment_score": "0.002625", "ticker_sentiment_label": "Neutral"}]}, {"title": "StockNews.com Begins Coverage on Bio-Path  ( NASDAQ:BPTH ) ", "url": "https://reporter.am/2022/12/31/stocknews-com-begins-coverage-on-bio-path-nasdaqbpth.html", "time_published": "20221231T082244", "authors": ["AM Reporter Staff"], "summary": "Stock analysts at StockNews.com assumed coverage on shares of Bio-Path ( NASDAQ:BPTH - Get Rating ) in a report issued on Saturday. The brokerage set a \"sell\" rating on the stock. BPTH stock opened at $1.51 on Friday. The business has a 50-day moving average price of $1.83 and a 200 day moving ...", "banner_image": "https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "reporter.am", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}, {"topic": "Manufacturing", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "0.928139"}], "overall_sentiment_score": 0.203288, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.935953", "ticker_sentiment_score": "0.354658", "ticker_sentiment_label": "Bullish"}, {"ticker": "GNRC", "relevance_score": "0.146916", "ticker_sentiment_score": "0.198486", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AWON", "relevance_score": "0.146916", "ticker_sentiment_score": "-0.044929", "ticker_sentiment_label": "Neutral"}]}, {"title": "StockNews.com Begins Coverage on Bio-Path  ( NASDAQ:BPTH ) ", "url": "https://www.etfdailynews.com/2022/12/23/stocknews-com-begins-coverage-on-bio-path-nasdaqbpth/", "time_published": "20221223T082446", "authors": ["MarketBeat News"], "summary": "Research analysts at StockNews.com assumed coverage on shares of Bio-Path ( NASDAQ:BPTH - Get Rating ) in a report released on Friday. The firm set a \"sell\" rating on the stock. BPTH stock opened at $1.37 on Friday. The company has a market cap of $9.81 million, a price-to-earnings ratio of ...", "banner_image": "https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.etfdailynews.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Earnings", "relevance_score": "0.976671"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.187844, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.908087", "ticker_sentiment_score": "0.326046", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MULN", "relevance_score": "0.133841", "ticker_sentiment_score": "0.151783", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "StockNews.com Begins Coverage on Bio-Path  ( NASDAQ:BPTH ) ", "url": "https://reporter.am/2022/12/23/stocknews-com-begins-coverage-on-bio-path-nasdaqbpth-2.html", "time_published": "20221223T082444", "authors": ["AM Reporter Staff"], "summary": "Research analysts at StockNews.com assumed coverage on shares of Bio-Path ( NASDAQ:BPTH - Get Rating ) in a report released on Friday. The firm set a \"sell\" rating on the stock. BPTH stock opened at $1.37 on Friday. The company has a market cap of $9.81 million, a price-to-earnings ratio of ...", "banner_image": "https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "reporter.am", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Earnings", "relevance_score": "0.976671"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.187844, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.908087", "ticker_sentiment_score": "0.326046", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MULN", "relevance_score": "0.133841", "ticker_sentiment_score": "0.151783", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Earns Sell Rating from Analysts at StockNews.com", "url": "https://www.etfdailynews.com/2022/12/15/bio-path-nasdaqbpth-earns-sell-rating-from-analysts-at-stocknews-com-2/", "time_published": "20221215T084845", "authors": ["MarketBeat News"], "summary": "Research analysts at StockNews.com assumed coverage on shares of Bio-Path ( NASDAQ:BPTH - Get Rating ) in a research report issued to clients and investors on Thursday. The brokerage set a \"sell\" rating on the stock. Shares of Bio-Path stock opened at $1.55 on Thursday.", "banner_image": "https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.etfdailynews.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.183332, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.971549", "ticker_sentiment_score": "0.324799", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "VIRT", "relevance_score": "0.133841", "ticker_sentiment_score": "0.04014", "ticker_sentiment_label": "Neutral"}, {"ticker": "AWON", "relevance_score": "0.133841", "ticker_sentiment_score": "0.002414", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Path Holdings Announces First Patient Dosed in Phase 1/1b Clinical Trial of BP1001-A in Solid Tumors", "url": "https://www.globenewswire.com/news-release/2022/12/07/2569142/0/en/Bio-Path-Holdings-Announces-First-Patient-Dosed-in-Phase-1-1b-Clinical-Trial-of-BP1001-A-in-Solid-Tumors.html", "time_published": "20221207T120000", "authors": ["Bio-Path Holdings", "Inc."], "summary": "Phase 1/1b Clinical Trial Evaluating Ability of BP1001-A to Treat Patients with Solid Tumors, Including Ovarian, Endometrial, Pancreatic and Breast Cancer Phase 1/1b Clinical Trial Evaluating Ability of BP1001-A to Treat Patients with Solid Tumors, Including Ovarian, Endometrial, Pancreatic and ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/249fef91-7e82-4f67-b919-46c0c4d6fb17?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.098561, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.343619", "ticker_sentiment_score": "0.121129", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Earns Sell Rating from Analysts at StockNews.com", "url": "https://reporter.am/2022/12/07/bio-path-nasdaqbpth-earns-sell-rating-from-analysts-at-stocknews-com.html", "time_published": "20221207T084244", "authors": ["AM Reporter Staff"], "summary": "StockNews.com started coverage on shares of Bio-Path ( NASDAQ:BPTH - Get Rating ) in a report released on Wednesday. The firm set a \"sell\" rating on the stock. NASDAQ BPTH opened at $1.53 on Wednesday. Bio-Path has a 1-year low of $1.28 and a 1-year high of $4.94.", "banner_image": "https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "reporter.am", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.214378"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.235418, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "TBBK", "relevance_score": "0.130926", "ticker_sentiment_score": "0.231847", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PDD", "relevance_score": "0.130926", "ticker_sentiment_score": "0.231847", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AWON", "relevance_score": "0.130926", "ticker_sentiment_score": "-0.043404", "ticker_sentiment_label": "Neutral"}, {"ticker": "BPTH", "relevance_score": "0.967875", "ticker_sentiment_score": "0.409582", "ticker_sentiment_label": "Bullish"}, {"ticker": "VIRT", "relevance_score": "0.130926", "ticker_sentiment_score": "0.07722", "ticker_sentiment_label": "Neutral"}]}, {"title": "StockNews.com Begins Coverage on Bio-Path  ( NASDAQ:BPTH ) ", "url": "https://www.etfdailynews.com/2022/11/29/stocknews-com-begins-coverage-on-bio-path-nasdaqbpth/", "time_published": "20221129T082451", "authors": ["MarketBeat News"], "summary": "Investment analysts at StockNews.com initiated coverage on shares of Bio-Path ( NASDAQ:BPTH - Get Rating ) in a report released on Tuesday. The brokerage set a \"sell\" rating on the stock. NASDAQ:BPTH opened at $1.50 on Tuesday.", "banner_image": "https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.etfdailynews.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.161647"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.233374, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.940545", "ticker_sentiment_score": "0.403117", "ticker_sentiment_label": "Bullish"}, {"ticker": "VIRT", "relevance_score": "0.124809", "ticker_sentiment_score": "0.130593", "ticker_sentiment_label": "Neutral"}]}, {"title": "StockNews.com Begins Coverage on Bio-Path  ( NASDAQ:BPTH ) ", "url": "https://reporter.am/2022/11/29/stocknews-com-begins-coverage-on-bio-path-nasdaqbpth.html", "time_published": "20221129T082448", "authors": ["AM Reporter Staff"], "summary": "StockNews.com initiated coverage on shares of Bio-Path ( NASDAQ:BPTH - Get Rating ) in a research report issued on Tuesday. The brokerage set a \"sell\" rating on the stock. Shares of BPTH stock opened at $1.50 on Tuesday. Bio-Path has a 12 month low of $1.28 and a 12 month high of $5.28.", "banner_image": "https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "reporter.am", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Finance", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}], "overall_sentiment_score": 0.236239, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.93513", "ticker_sentiment_score": "0.40662", "ticker_sentiment_label": "Bullish"}, {"ticker": "VIRT", "relevance_score": "0.122269", "ticker_sentiment_score": "0.112985", "ticker_sentiment_label": "Neutral"}]}, {"title": "Analyzing Bio-Path Holdings's Short Interest - Bio-Path Holdings  ( NASDAQ:BPTH ) ", "url": "https://www.benzinga.com/short-sellers/22/11/29872564/analyzing-bio-path-holdingss-short-interest", "time_published": "20221128T163720", "authors": ["Benzinga Insights"], "summary": "Bio-Path Holdings's BPTH short percent of float has fallen 10.42% since its last report. The company recently reported that it has 34 thousand shares sold short, which is 0.43% of all regular shares that are available for trading.", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/movers_image_22360.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}], "overall_sentiment_score": 0.239316, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.426824", "ticker_sentiment_score": "0.247129", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Stocks That Hit 52-Week Lows On Tuesday - SoundHound AI  ( NASDAQ:SOUN ) , Sonnet BioTherapeutics  ( NASDAQ:SONN ) ", "url": "https://www.benzinga.com/news/22/11/29825126/stocks-that-hit-52-week-lows-on-tuesday", "time_published": "20221122T154845", "authors": ["Benzinga Insights"], "summary": "During Tuesday's trading, 160 companies set new 52-week lows. Tesla TSLA is the largest company in terms of market cap to set a new 52-week low this morning. The smallest company by market cap to set a new 52-week low was Baudax Bio BXRX.", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/movers_image_21987.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Blockchain", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.108138, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "APP", "relevance_score": "0.028072", "ticker_sentiment_score": "-0.121459", "ticker_sentiment_label": "Neutral"}, {"ticker": "BXRX", "relevance_score": "0.05611", "ticker_sentiment_score": "-0.12291", "ticker_sentiment_label": "Neutral"}, {"ticker": "BZFD", "relevance_score": "0.028072", "ticker_sentiment_score": "-0.107471", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCDA", "relevance_score": "0.028072", "ticker_sentiment_score": "0.004831", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOCL", "relevance_score": "0.028072", "ticker_sentiment_score": "0.005814", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.05611", "ticker_sentiment_score": "-0.052018", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTAIF", "relevance_score": "0.014038", "ticker_sentiment_score": "0.004495", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBET", "relevance_score": "0.028072", "ticker_sentiment_score": "0.07886", "ticker_sentiment_label": "Neutral"}, {"ticker": "WKSP", "relevance_score": "0.028072", "ticker_sentiment_score": "0.004783", "ticker_sentiment_label": "Neutral"}, {"ticker": "INSG", "relevance_score": "0.028072", "ticker_sentiment_score": "-0.107471", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBON", "relevance_score": "0.042098", "ticker_sentiment_score": "-0.084647", "ticker_sentiment_label": "Neutral"}, {"ticker": "BOXL", "relevance_score": "0.028072", "ticker_sentiment_score": "0.004831", "ticker_sentiment_label": "Neutral"}, {"ticker": "RENT", "relevance_score": "0.028072", "ticker_sentiment_score": "0.004783", "ticker_sentiment_label": "Neutral"}, {"ticker": "QS", "relevance_score": "0.028072", "ticker_sentiment_score": "-0.09609", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSNL", "relevance_score": "0.028072", "ticker_sentiment_score": "-0.09609", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSGM", "relevance_score": "0.028072", "ticker_sentiment_score": "0.004818", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABSI", "relevance_score": "0.028072", "ticker_sentiment_score": "-0.121459", "ticker_sentiment_label": "Neutral"}, {"ticker": "JSPR", "relevance_score": "0.028072", "ticker_sentiment_score": "0.003835", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARBE", "relevance_score": "0.028072", "ticker_sentiment_score": "-0.108546", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASTR", "relevance_score": "0.028072", "ticker_sentiment_score": "0.004831", "ticker_sentiment_label": "Neutral"}, {"ticker": "TOI", "relevance_score": "0.028072", "ticker_sentiment_score": "0.004783", "ticker_sentiment_label": "Neutral"}, {"ticker": "CURO", "relevance_score": "0.028072", "ticker_sentiment_score": "-0.107471", "ticker_sentiment_label": "Neutral"}, {"ticker": "AUPH", "relevance_score": "0.028072", "ticker_sentiment_score": "0.004831", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOV", "relevance_score": "0.028072", "ticker_sentiment_score": "-0.108546", "ticker_sentiment_label": "Neutral"}, {"ticker": "GROV", "relevance_score": "0.028072", "ticker_sentiment_score": "-0.114135", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMPL", "relevance_score": "0.028072", "ticker_sentiment_score": "0.003835", "ticker_sentiment_label": "Neutral"}, {"ticker": "WORX", "relevance_score": "0.028072", "ticker_sentiment_score": "-0.108546", "ticker_sentiment_label": "Neutral"}, {"ticker": "EAR", "relevance_score": "0.028072", "ticker_sentiment_score": "0.07886", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKLI", "relevance_score": "0.028072", "ticker_sentiment_score": "-0.101774", "ticker_sentiment_label": "Neutral"}, {"ticker": "REVB", "relevance_score": "0.028072", "ticker_sentiment_score": "0.004831", "ticker_sentiment_label": "Neutral"}, {"ticker": "POWW", "relevance_score": "0.028072", "ticker_sentiment_score": "0.005814", "ticker_sentiment_label": "Neutral"}, {"ticker": "SONN", "relevance_score": "0.028072", "ticker_sentiment_score": "0.005814", "ticker_sentiment_label": "Neutral"}, {"ticker": "EXAI", "relevance_score": "0.028072", "ticker_sentiment_score": "0.004831", "ticker_sentiment_label": "Neutral"}, {"ticker": "HOWL", "relevance_score": "0.028072", "ticker_sentiment_score": "0.004818", "ticker_sentiment_label": "Neutral"}, {"ticker": "MPLN", "relevance_score": "0.028072", "ticker_sentiment_score": "-0.107471", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRAY", "relevance_score": "0.028072", "ticker_sentiment_score": "0.004831", "ticker_sentiment_label": "Neutral"}, {"ticker": "PGY", "relevance_score": "0.028072", "ticker_sentiment_score": "0.004831", "ticker_sentiment_label": "Neutral"}, {"ticker": "IONM", "relevance_score": "0.028072", "ticker_sentiment_score": "-0.106255", "ticker_sentiment_label": "Neutral"}, {"ticker": "OWLT", "relevance_score": "0.028072", "ticker_sentiment_score": "0.004783", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBS", "relevance_score": "0.028072", "ticker_sentiment_score": "-0.120816", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLTH", "relevance_score": "0.028072", "ticker_sentiment_score": "0.005814", "ticker_sentiment_label": "Neutral"}, {"ticker": "BPTH", "relevance_score": "0.028072", "ticker_sentiment_score": "0.004818", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISUN", "relevance_score": "0.028072", "ticker_sentiment_score": "0.004831", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDW", "relevance_score": "0.028072", "ticker_sentiment_score": "-0.107471", "ticker_sentiment_label": "Neutral"}, {"ticker": "SALM", "relevance_score": "0.028072", "ticker_sentiment_score": "-0.09609", "ticker_sentiment_label": "Neutral"}, {"ticker": "BKKT", "relevance_score": "0.028072", "ticker_sentiment_score": "-0.101774", "ticker_sentiment_label": "Neutral"}, {"ticker": "USM", "relevance_score": "0.028072", "ticker_sentiment_score": "0.005814", "ticker_sentiment_label": "Neutral"}, {"ticker": "HUDI", "relevance_score": "0.028072", "ticker_sentiment_score": "-0.111299", "ticker_sentiment_label": "Neutral"}, {"ticker": "SCPS", "relevance_score": "0.028072", "ticker_sentiment_score": "0.004783", "ticker_sentiment_label": "Neutral"}, {"ticker": "MIND", "relevance_score": "0.028072", "ticker_sentiment_score": "0.004783", "ticker_sentiment_label": "Neutral"}, {"ticker": "TIL", "relevance_score": "0.028072", "ticker_sentiment_score": "-0.101774", "ticker_sentiment_label": "Neutral"}, {"ticker": "RLMD", "relevance_score": "0.028072", "ticker_sentiment_score": "0.004818", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATXI", "relevance_score": "0.028072", "ticker_sentiment_score": "-0.107471", "ticker_sentiment_label": "Neutral"}, {"ticker": "RIOT", "relevance_score": "0.028072", "ticker_sentiment_score": "-0.108546", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLBZ", "relevance_score": "0.028072", "ticker_sentiment_score": "0.004831", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMFR", "relevance_score": "0.028072", "ticker_sentiment_score": "-0.107471", "ticker_sentiment_label": "Neutral"}, {"ticker": "VINC", "relevance_score": "0.028072", "ticker_sentiment_score": "0.005814", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMTD", "relevance_score": "0.028072", "ticker_sentiment_score": "0.07886", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLDP", "relevance_score": "0.028072", "ticker_sentiment_score": "-0.09609", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMWB", "relevance_score": "0.028072", "ticker_sentiment_score": "0.004783", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNCE", "relevance_score": "0.028072", "ticker_sentiment_score": "-0.107471", "ticker_sentiment_label": "Neutral"}, {"ticker": "RARE", "relevance_score": "0.028072", "ticker_sentiment_score": "-0.107471", "ticker_sentiment_label": "Neutral"}, {"ticker": "UPWK", "relevance_score": "0.028072", "ticker_sentiment_score": "-0.120816", "ticker_sentiment_label": "Neutral"}, {"ticker": "WISA", "relevance_score": "0.028072", "ticker_sentiment_score": "-0.108546", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONDS", "relevance_score": "0.028072", "ticker_sentiment_score": "0.005814", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPK", "relevance_score": "0.028072", "ticker_sentiment_score": "0.004783", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLTA", "relevance_score": "0.028072", "ticker_sentiment_score": "-0.108546", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDHL", "relevance_score": "0.028072", "ticker_sentiment_score": "-0.09609", "ticker_sentiment_label": "Neutral"}, {"ticker": "VCSA", "relevance_score": "0.028072", "ticker_sentiment_score": "0.004818", "ticker_sentiment_label": "Neutral"}, {"ticker": "NUVB", "relevance_score": "0.028072", "ticker_sentiment_score": "-0.108546", "ticker_sentiment_label": "Neutral"}, {"ticker": "EYPT", "relevance_score": "0.028072", "ticker_sentiment_score": "0.004783", "ticker_sentiment_label": "Neutral"}, {"ticker": "HOTH", "relevance_score": "0.028072", "ticker_sentiment_score": "-0.121459", "ticker_sentiment_label": "Neutral"}, {"ticker": "LUCY", "relevance_score": "0.028072", "ticker_sentiment_score": "-0.107471", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDT", "relevance_score": "0.028072", "ticker_sentiment_score": "-0.101774", "ticker_sentiment_label": "Neutral"}, {"ticker": "AUR", "relevance_score": "0.028072", "ticker_sentiment_score": "-0.120816", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLND", "relevance_score": "0.028072", "ticker_sentiment_score": "0.004783", "ticker_sentiment_label": "Neutral"}, {"ticker": "TVTX", "relevance_score": "0.028072", "ticker_sentiment_score": "0.005814", "ticker_sentiment_label": "Neutral"}, {"ticker": "AEMD", "relevance_score": "0.028072", "ticker_sentiment_score": "0.07886", "ticker_sentiment_label": "Neutral"}, {"ticker": "RSLS", "relevance_score": "0.028072", "ticker_sentiment_score": "-0.107471", "ticker_sentiment_label": "Neutral"}, {"ticker": "EQOS", "relevance_score": "0.028072", "ticker_sentiment_score": "0.005814", "ticker_sentiment_label": "Neutral"}, {"ticker": "IREN", "relevance_score": "0.028072", "ticker_sentiment_score": "-0.09609", "ticker_sentiment_label": "Neutral"}, {"ticker": "LVLU", "relevance_score": "0.028072", "ticker_sentiment_score": "-0.107471", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSP", "relevance_score": "0.028072", "ticker_sentiment_score": "0.004805", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACHR", "relevance_score": "0.028072", "ticker_sentiment_score": "0.004818", "ticker_sentiment_label": "Neutral"}, {"ticker": "NAUT", "relevance_score": "0.028072", "ticker_sentiment_score": "-0.107471", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOEV", "relevance_score": "0.028072", "ticker_sentiment_score": "-0.101774", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNPO", "relevance_score": "0.028072", "ticker_sentiment_score": "0.004831", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLPG", "relevance_score": "0.028072", "ticker_sentiment_score": "-0.107471", "ticker_sentiment_label": "Neutral"}, {"ticker": "STTK", "relevance_score": "0.028072", "ticker_sentiment_score": "-0.09609", "ticker_sentiment_label": "Neutral"}, {"ticker": "GMDA", "relevance_score": "0.028072", "ticker_sentiment_score": "0.004783", "ticker_sentiment_label": "Neutral"}, {"ticker": "HOUS", "relevance_score": "0.028072", "ticker_sentiment_score": "-0.09609", "ticker_sentiment_label": "Neutral"}, {"ticker": "TTCF", "relevance_score": "0.028072", "ticker_sentiment_score": "0.003835", "ticker_sentiment_label": "Neutral"}, {"ticker": "LVWR", "relevance_score": "0.028072", "ticker_sentiment_score": "-0.101774", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADCT", "relevance_score": "0.028072", "ticker_sentiment_score": "-0.107471", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLGN", "relevance_score": "0.028072", "ticker_sentiment_score": "-0.101774", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNSE", "relevance_score": "0.028072", "ticker_sentiment_score": "0.004831", "ticker_sentiment_label": "Neutral"}, {"ticker": "BHR", "relevance_score": "0.028072", "ticker_sentiment_score": "0.004818", "ticker_sentiment_label": "Neutral"}, {"ticker": "AEVA", "relevance_score": "0.028072", "ticker_sentiment_score": "0.004818", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMEH", "relevance_score": "0.028072", "ticker_sentiment_score": "-0.114135", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOUN", "relevance_score": "0.028072", "ticker_sentiment_score": "-0.107471", "ticker_sentiment_label": "Neutral"}, {"ticker": "NKLA", "relevance_score": "0.028072", "ticker_sentiment_score": "-0.107471", "ticker_sentiment_label": "Neutral"}, {"ticker": "RELI", "relevance_score": "0.028072", "ticker_sentiment_score": "0.004783", "ticker_sentiment_label": "Neutral"}, {"ticker": "MASS", "relevance_score": "0.028072", "ticker_sentiment_score": "-0.101774", "ticker_sentiment_label": "Neutral"}, {"ticker": "SDGR", "relevance_score": "0.028072", "ticker_sentiment_score": "0.004831", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNCE", "relevance_score": "0.028072", "ticker_sentiment_score": "0.004818", "ticker_sentiment_label": "Neutral"}, {"ticker": "STOK", "relevance_score": "0.028072", "ticker_sentiment_score": "0.004818", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRAX", "relevance_score": "0.028072", "ticker_sentiment_score": "-0.107471", "ticker_sentiment_label": "Neutral"}, {"ticker": "EAST", "relevance_score": "0.028072", "ticker_sentiment_score": "-0.09609", "ticker_sentiment_label": "Neutral"}, {"ticker": "RIDE", "relevance_score": "0.028072", "ticker_sentiment_score": "0.004818", "ticker_sentiment_label": "Neutral"}, {"ticker": "LIFE", "relevance_score": "0.028072", "ticker_sentiment_score": "0.003835", "ticker_sentiment_label": "Neutral"}, {"ticker": "TYDE", "relevance_score": "0.028072", "ticker_sentiment_score": "0.07886", "ticker_sentiment_label": "Neutral"}, {"ticker": "VYNT", "relevance_score": "0.028072", "ticker_sentiment_score": "-0.101774", "ticker_sentiment_label": "Neutral"}, {"ticker": "RMBL", "relevance_score": "0.028072", "ticker_sentiment_score": "-0.101774", "ticker_sentiment_label": "Neutral"}, {"ticker": "KZIA", "relevance_score": "0.028072", "ticker_sentiment_score": "-0.101774", "ticker_sentiment_label": "Neutral"}, {"ticker": "EXFY", "relevance_score": "0.028072", "ticker_sentiment_score": "0.004818", "ticker_sentiment_label": "Neutral"}, {"ticker": "QUMU", "relevance_score": "0.028072", "ticker_sentiment_score": "0.004831", "ticker_sentiment_label": "Neutral"}, {"ticker": "BRMK", "relevance_score": "0.028072", "ticker_sentiment_score": "-0.107471", "ticker_sentiment_label": "Neutral"}, {"ticker": "BSEAF", "relevance_score": "0.014038", "ticker_sentiment_score": "0.004474", "ticker_sentiment_label": "Neutral"}, {"ticker": "LCID", "relevance_score": "0.028072", "ticker_sentiment_score": "-0.092309", "ticker_sentiment_label": "Neutral"}, {"ticker": "SCLX", "relevance_score": "0.028072", "ticker_sentiment_score": "-0.09609", "ticker_sentiment_label": "Neutral"}, {"ticker": "MKFG", "relevance_score": "0.028072", "ticker_sentiment_score": "0.004783", "ticker_sentiment_label": "Neutral"}, {"ticker": "NAOV", "relevance_score": "0.028072", "ticker_sentiment_score": "0.004783", "ticker_sentiment_label": "Neutral"}, {"ticker": "XPON", "relevance_score": "0.028072", "ticker_sentiment_score": "0.004818", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRNA", "relevance_score": "0.028072", "ticker_sentiment_score": "0.004783", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:SNT", "relevance_score": "0.014038", "ticker_sentiment_score": "0.003524", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:AMPL", "relevance_score": "0.014038", "ticker_sentiment_score": "0.003549", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:AUR", "relevance_score": "0.014038", "ticker_sentiment_score": "-0.111061", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Now Covered by Analysts at StockNews.com", "url": "https://www.etfdailynews.com/2022/11/21/bio-path-nasdaqbpth-now-covered-by-analysts-at-stocknews-com/", "time_published": "20221121T083043", "authors": ["MarketBeat News"], "summary": "Stock analysts at StockNews.com started coverage on shares of Bio-Path ( NASDAQ:BPTH - Get Rating ) in a note issued to investors on Monday. The brokerage set a \"sell\" rating on the stock. Shares of BPTH opened at $1.48 on Monday. Bio-Path has a 1 year low of $1.29 and a 1 year high of $5.28.", "banner_image": "https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.etfdailynews.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.214378"}, {"topic": "Real Estate & Construction", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.190072, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "SOFI", "relevance_score": "0.127456", "ticker_sentiment_score": "0.129494", "ticker_sentiment_label": "Neutral"}, {"ticker": "AWON", "relevance_score": "0.127456", "ticker_sentiment_score": "0.002357", "ticker_sentiment_label": "Neutral"}, {"ticker": "BPTH", "relevance_score": "0.962982", "ticker_sentiment_score": "0.335331", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "VIRT", "relevance_score": "0.127456", "ticker_sentiment_score": "0.092889", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Path Holdings Reports Third Quarter 2022 Financial Results", "url": "https://www.globenewswire.com/news-release/2022/11/15/2555958/0/en/Bio-Path-Holdings-Reports-Third-Quarter-2022-Financial-Results.html", "time_published": "20221115T120000", "authors": ["Inc.", "Bio-Path Holdings"], "summary": "Conference Call to be Held Today at 8:30 A.M. ET Conference Call to be Held Today at 8:30 A.M. ET ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/249fef91-7e82-4f67-b919-46c0c4d6fb17?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Earnings", "relevance_score": "0.451494"}, {"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.744043"}], "overall_sentiment_score": 0.143027, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.435328", "ticker_sentiment_score": "0.180663", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Now Covered by StockNews.com", "url": "https://www.etfdailynews.com/2022/11/13/bio-path-nasdaqbpth-now-covered-by-stocknews-com/", "time_published": "20221113T081048", "authors": ["MarketBeat News"], "summary": "Research analysts at StockNews.com started coverage on shares of Bio-Path ( NASDAQ:BPTH - Get Rating ) in a research report issued to clients and investors on Sunday. The brokerage set a \"sell\" rating on the stock. Shares of BPTH stock opened at $1.53 on Friday.", "banner_image": "https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.etfdailynews.com", "topics": [{"topic": "Earnings", "relevance_score": "0.857896"}, {"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}], "overall_sentiment_score": 0.136379, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.913524", "ticker_sentiment_score": "0.239272", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "HBI", "relevance_score": "0.136113", "ticker_sentiment_score": "0.094672", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Path Holdings to Announce Third Quarter 2022 Financial Results on November 15, 2022 - Bio-Path Holdings  ( NASDAQ:BPTH ) ", "url": "https://www.benzinga.com/pressreleases/22/11/g29610530/bio-path-holdings-to-announce-third-quarter-2022-financial-results-on-november-15-2022", "time_published": "20221108T120000", "authors": ["Globe Newswire"], "summary": "HOUSTON, Nov. 08, 2022 ( GLOBE NEWSWIRE ) -- Bio-Path Holdings, Inc., BPTH a biotechnology company leveraging its proprietary DNAbilize\u00ae antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced that it will host a live conference call ...", "banner_image": "", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "1.0"}], "overall_sentiment_score": 0.091128, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.682689", "ticker_sentiment_score": "0.122499", "ticker_sentiment_label": "Neutral"}]}, {"title": "StockNews.com Initiates Coverage on Bio-Path  ( NASDAQ:BPTH ) ", "url": "https://www.etfdailynews.com/2022/10/28/stocknews-com-initiates-coverage-on-bio-path-nasdaqbpth/", "time_published": "20221028T062645", "authors": ["MarketBeat News"], "summary": "Analysts at StockNews.com started coverage on shares of Bio-Path ( NASDAQ:BPTH - Get Rating ) in a research note issued on Friday. The firm set a \"sell\" rating on the stock. Bio-Path stock opened at $3.31 on Friday. The company has a market cap of $23.70 million, a PE ratio of -1.87 and a beta ...", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?w=250&h=150&zc=2&src=https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.etfdailynews.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Earnings", "relevance_score": "0.875462"}, {"topic": "Energy & Transportation", "relevance_score": "0.5"}], "overall_sentiment_score": 0.250387, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.929273", "ticker_sentiment_score": "0.428981", "ticker_sentiment_label": "Bullish"}, {"ticker": "UPS", "relevance_score": "0.143415", "ticker_sentiment_score": "0.271972", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AWON", "relevance_score": "0.143415", "ticker_sentiment_score": "-0.045546", "ticker_sentiment_label": "Neutral"}]}, {"title": "StockNews.com Initiates Coverage on Bio-Path  ( NASDAQ:BPTH ) ", "url": "https://reporter.am/2022/10/28/stocknews-com-initiates-coverage-on-bio-path-nasdaqbpth-2.html", "time_published": "20221028T062640", "authors": ["AM Reporter Staff"], "summary": "Equities researchers at StockNews.com started coverage on shares of Bio-Path ( NASDAQ:BPTH - Get Rating ) in a report released on Friday. The brokerage set a \"sell\" rating on the stock. Bio-Path stock opened at $3.31 on Friday.", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?w=250&h=150&zc=2&src=https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "reporter.am", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}, {"topic": "Earnings", "relevance_score": "0.857896"}, {"topic": "Energy & Transportation", "relevance_score": "0.5"}], "overall_sentiment_score": 0.238238, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.922387", "ticker_sentiment_score": "0.408376", "ticker_sentiment_label": "Bullish"}, {"ticker": "UPS", "relevance_score": "0.140076", "ticker_sentiment_score": "0.26853", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Bio-Path Holdings Announces First Patient Dosed in Phase 1/1b Study of BP1002 in Refractory/Relapsed Acute Myeloid Leukemia Patients", "url": "https://www.globenewswire.com/news-release/2022/10/24/2539808/0/en/Bio-Path-Holdings-Announces-First-Patient-Dosed-in-Phase-1-1b-Study-of-BP1002-in-Refractory-Relapsed-Acute-Myeloid-Leukemia-Patients.html", "time_published": "20221024T110000", "authors": ["Bio-Path Holdings", "Inc."], "summary": "BP1002 Offers Unique Opportunity for Venetoclax-Resistant Patients by Utilizing RNAi to Limit Cell's Ability to Produce Bcl-2 Protein BP1002 Offers Unique Opportunity for Venetoclax-Resistant Patients by Utilizing RNAi to Limit Cell's Ability to Produce Bcl-2 Protein ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/249fef91-7e82-4f67-b919-46c0c4d6fb17?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.124225, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.328455", "ticker_sentiment_score": "0.179202", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Earns Sell Rating from Analysts at StockNews.com", "url": "https://reporter.am/2022/09/26/bio-path-nasdaqbpth-earns-sell-rating-from-analysts-at-stocknews-com-2.html", "time_published": "20220926T062841", "authors": ["AM Reporter Staff"], "summary": "StockNews.com initiated coverage on shares of Bio-Path ( NASDAQ:BPTH - Get Rating ) in a report issued on Monday. The firm set a \"sell\" rating on the stock. BPTH opened at $3.18 on Monday. Bio-Path has a 1-year low of $2.68 and a 1-year high of $5.41.", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png&w=240&h=240&zc=2", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "reporter.am", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "0.904684"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.194027, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.929273", "ticker_sentiment_score": "0.337403", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AWON", "relevance_score": "0.143415", "ticker_sentiment_score": "-0.044311", "ticker_sentiment_label": "Neutral"}, {"ticker": "DDOG", "relevance_score": "0.143415", "ticker_sentiment_score": "0.20407", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Earns Sell Rating from Analysts at StockNews.com", "url": "https://reporter.am/2022/09/11/bio-path-nasdaqbpth-earns-sell-rating-from-analysts-at-stocknews-com.html", "time_published": "20220911T083441", "authors": ["AM Reporter Staff"], "summary": "StockNews.com began coverage on shares of Bio-Path ( NASDAQ:BPTH - Get Rating ) in a research report report published on Saturday morning. The firm issued a sell rating on the stock.", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?w=250&h=150&zc=2&src=https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "reporter.am", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.238206, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.939207", "ticker_sentiment_score": "0.410382", "ticker_sentiment_label": "Bullish"}, {"ticker": "DOCU", "relevance_score": "0.124164", "ticker_sentiment_score": "0.20154", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "VIRT", "relevance_score": "0.124164", "ticker_sentiment_score": "0.15757", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Research Coverage Started at StockNews.com", "url": "https://www.etfdailynews.com/2022/09/10/bio-path-nasdaqbpth-research-coverage-started-at-stocknews-com/", "time_published": "20220910T061245", "authors": ["MarketBeat News"], "summary": "StockNews.com started coverage on shares of Bio-Path ( NASDAQ:BPTH - Get Rating ) in a note issued to investors on Saturday. The brokerage set a \"sell\" rating on the stock. Separately, HC Wainwright cut their target price on Bio-Path from $12.00 to $9.00 and set a \"buy\" rating on the stock in a ...", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?w=250&h=150&zc=2&src=https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.etfdailynews.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.240495, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.956692", "ticker_sentiment_score": "0.415995", "ticker_sentiment_label": "Bullish"}, {"ticker": "DOCU", "relevance_score": "0.123526", "ticker_sentiment_score": "0.201071", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "VIRT", "relevance_score": "0.123526", "ticker_sentiment_score": "0.192382", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Bio-Path Holdings to Present at H.C. Wainwright 24th Annual Global Investment Conference", "url": "https://www.globenewswire.com/news-release/2022/09/06/2510176/0/en/Bio-Path-Holdings-to-Present-at-H-C-Wainwright-24th-Annual-Global-Investment-Conference.html", "time_published": "20220906T110000", "authors": ["Bio-Path Holdings", "Inc."], "summary": "HOUSTON, Sept. 06, 2022 ( GLOBE NEWSWIRE ) -- Bio-Path Holdings, Inc., ( NASDAQ: BPTH ) a biotechnology company leveraging its proprietary DNAbilize\u00ae antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced that Peter Nielsen, Chief ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/249fef91-7e82-4f67-b919-46c0c4d6fb17?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "1.0"}], "overall_sentiment_score": 0.096184, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.592095", "ticker_sentiment_score": "0.090442", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Coverage Initiated at StockNews.com", "url": "https://reporter.am/2022/08/27/bio-path-nasdaqbpth-coverage-initiated-at-stocknews-com.html", "time_published": "20220827T072642", "authors": ["AM Reporter Staff"], "summary": "Stock analysts at StockNews.com started coverage on shares of Bio-Path ( NASDAQ:BPTH - Get Rating ) in a report issued on Thursday. The firm set a \"sell\" rating on the stock.", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?w=250&h=150&zc=2&src=https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "reporter.am", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Finance", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.244682, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.965957", "ticker_sentiment_score": "0.423827", "ticker_sentiment_label": "Bullish"}, {"ticker": "VIRT", "relevance_score": "0.129516", "ticker_sentiment_score": "0.182185", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AWON", "relevance_score": "0.129516", "ticker_sentiment_score": "-0.043176", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Now Covered by StockNews.com", "url": "https://reporter.am/2022/08/19/bio-path-nasdaqbpth-now-covered-by-stocknews-com-2.html", "time_published": "20220819T081642", "authors": ["AM Reporter Staff"], "summary": "Investment analysts at StockNews.com began coverage on shares of Bio-Path ( NASDAQ:BPTH - Get Rating ) in a research report issued to clients and investors on Wednesday. The firm set a \"sell\" rating on the stock.", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?w=250&h=150&zc=2&src=https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "reporter.am", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Energy & Transportation", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.23131, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BJ", "relevance_score": "0.12165", "ticker_sentiment_score": "0.166451", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "COST", "relevance_score": "0.12165", "ticker_sentiment_score": "0.166451", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SBUX", "relevance_score": "0.12165", "ticker_sentiment_score": "0.166451", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BPTH", "relevance_score": "0.933751", "ticker_sentiment_score": "0.398931", "ticker_sentiment_label": "Bullish"}, {"ticker": "VIRT", "relevance_score": "0.12165", "ticker_sentiment_score": "0.164182", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "VRRM", "relevance_score": "0.12165", "ticker_sentiment_score": "0.166451", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "StockNews.com Begins Coverage on Bio-Path  ( NASDAQ:BPTH ) ", "url": "https://www.etfdailynews.com/2022/08/17/stocknews-com-begins-coverage-on-bio-path-nasdaqbpth/", "time_published": "20220817T062845", "authors": ["MarketBeat News"], "summary": "Analysts at StockNews.com started coverage on shares of Bio-Path ( NASDAQ:BPTH - Get Rating ) in a report issued on Wednesday. The brokerage set a \"sell\" rating on the stock.", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?w=250&h=150&zc=2&src=https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.etfdailynews.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.161647"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.197938, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.948339", "ticker_sentiment_score": "0.34622", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "VIRT", "relevance_score": "0.128822", "ticker_sentiment_score": "0.135413", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Research Coverage Started at StockNews.com", "url": "https://www.defenseworld.net/2022/08/17/bio-path-nasdaqbpth-research-coverage-started-at-stocknews-com-2.html", "time_published": "20220817T062842", "authors": ["admin"], "summary": "Equities research analysts at StockNews.com initiated coverage on shares of Bio-Path ( NASDAQ:BPTH - Get Rating ) in a report released on Wednesday. The firm set a \"sell\" rating on the stock.", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?w=250&h=150&zc=2&src=https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.222468, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.961964", "ticker_sentiment_score": "0.387857", "ticker_sentiment_label": "Bullish"}, {"ticker": "VIRT", "relevance_score": "0.126784", "ticker_sentiment_score": "0.15018", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Bio-Path Holdings to Announce Second Quarter 2022 Financial Results on August 16, 2022", "url": "https://www.globenewswire.com/news-release/2022/08/09/2494661/0/en/Bio-Path-Holdings-to-Announce-Second-Quarter-2022-Financial-Results-on-August-16-2022.html", "time_published": "20220809T110000", "authors": ["Bio-Path Holdings", "Inc."], "summary": "HOUSTON, Aug. 09, 2022 ( GLOBE NEWSWIRE ) -- Bio-Path Holdings, Inc., ( NASDAQ: BPTH ) a biotechnology company leveraging its proprietary DNAbilize\u00ae antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced that it will host a live ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/249fef91-7e82-4f67-b919-46c0c4d6fb17?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "1.0"}], "overall_sentiment_score": 0.100607, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.636698", "ticker_sentiment_score": "0.125688", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Earns Sell Rating from Analysts at StockNews.com", "url": "https://www.etfdailynews.com/2022/08/09/bio-path-nasdaqbpth-earns-sell-rating-from-analysts-at-stocknews-com/", "time_published": "20220809T063249", "authors": ["MarketBeat News"], "summary": "Stock analysts at StockNews.com started coverage on shares of Bio-Path ( NASDAQ:BPTH - Get Rating ) in a report issued on Tuesday. The firm set a \"sell\" rating on the stock.", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?w=250&h=150&zc=2&src=https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.etfdailynews.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Finance", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.962106"}], "overall_sentiment_score": 0.20619, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "AWON", "relevance_score": "0.11983", "ticker_sentiment_score": "-0.040562", "ticker_sentiment_label": "Neutral"}, {"ticker": "BPTH", "relevance_score": "0.929556", "ticker_sentiment_score": "0.358281", "ticker_sentiment_label": "Bullish"}, {"ticker": "ETSY", "relevance_score": "0.11983", "ticker_sentiment_score": "0.184449", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "VIRT", "relevance_score": "0.236972", "ticker_sentiment_score": "0.107593", "ticker_sentiment_label": "Neutral"}, {"ticker": "WMT", "relevance_score": "0.11983", "ticker_sentiment_score": "0.184449", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Earns Sell Rating from Analysts at StockNews.com", "url": "https://www.defenseworld.net/2022/08/09/bio-path-nasdaqbpth-earns-sell-rating-from-analysts-at-stocknews-com.html", "time_published": "20220809T063242", "authors": ["admin"], "summary": "Investment analysts at StockNews.com assumed coverage on shares of Bio-Path ( NASDAQ:BPTH - Get Rating ) in a report issued on Tuesday. The firm set a \"sell\" rating on the stock.", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?w=250&h=150&zc=2&src=https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.989041"}], "overall_sentiment_score": 0.255226, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.92528", "ticker_sentiment_score": "0.43572", "ticker_sentiment_label": "Bullish"}, {"ticker": "ETSY", "relevance_score": "0.118064", "ticker_sentiment_score": "0.237373", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "WMT", "relevance_score": "0.118064", "ticker_sentiment_score": "0.237373", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Earns Sell Rating from Analysts at StockNews.com", "url": "https://reporter.am/2022/08/02/bio-path-nasdaqbpth-earns-sell-rating-from-analysts-at-stocknews-com.html", "time_published": "20220802T092242", "authors": ["AM Reporter Staff"], "summary": "StockNews.com began coverage on shares of Bio-Path ( NASDAQ:BPTH - Get Rating ) in a report released on Monday. The brokerage issued a sell rating on the stock. Separately, HC Wainwright decreased their target price on Bio-Path from $12.00 to $9.00 and set a buy rating for the company in a ...", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?w=250&h=150&zc=2&src=https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "reporter.am", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.977154"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.23827, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.937859", "ticker_sentiment_score": "0.410282", "ticker_sentiment_label": "Bullish"}, {"ticker": "VIRT", "relevance_score": "0.244109", "ticker_sentiment_score": "0.16154", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "NWL", "relevance_score": "0.123526", "ticker_sentiment_score": "0.194555", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Research Coverage Started at StockNews.com", "url": "https://www.etfdailynews.com/2022/08/01/bio-path-nasdaqbpth-research-coverage-started-at-stocknews-com/", "time_published": "20220801T062841", "authors": ["MarketBeat News"], "summary": "Equities researchers at StockNews.com started coverage on shares of Bio-Path ( NASDAQ:BPTH - Get Rating ) in a research report issued to clients and investors on Monday. The firm set a \"sell\" rating on the stock.", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?w=250&h=150&zc=2&src=https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.etfdailynews.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.996023"}, {"topic": "Manufacturing", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.114979, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.916507", "ticker_sentiment_score": "0.203018", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BA", "relevance_score": "0.114682", "ticker_sentiment_score": "0.077294", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Now Covered by Analysts at StockNews.com", "url": "https://reporter.am/2022/07/26/bio-path-nasdaqbpth-now-covered-by-analysts-at-stocknews-com.html", "time_published": "20220726T064642", "authors": ["AM Reporter Staff"], "summary": "Equities researchers at StockNews.com began coverage on shares of Bio-Path ( NASDAQ:BPTH - Get Rating ) in a research report issued to clients and investors on Sunday. The brokerage set a \"sell\" rating on the stock.", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?w=250&h=150&zc=2&src=https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "reporter.am", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.995077"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}], "overall_sentiment_score": 0.203311, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "AA", "relevance_score": "0.114682", "ticker_sentiment_score": "0.162754", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BPTH", "relevance_score": "0.916507", "ticker_sentiment_score": "0.352544", "ticker_sentiment_label": "Bullish"}, {"ticker": "VIRT", "relevance_score": "0.227007", "ticker_sentiment_score": "0.179814", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PPG", "relevance_score": "0.114682", "ticker_sentiment_score": "0.162754", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Research Coverage Started at StockNews.com", "url": "https://reporter.am/2022/07/12/bio-path-nasdaqbpth-research-coverage-started-at-stocknews-com.html", "time_published": "20220712T065844", "authors": ["AM Reporter Staff"], "summary": "StockNews.com started coverage on shares of Bio-Path ( NASDAQ:BPTH - Get Rating ) in a report issued on Friday morning. The firm issued a sell rating on the stock.", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?w=250&h=150&zc=2&src=https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "reporter.am", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.962106"}, {"topic": "Manufacturing", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.164238, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.932362", "ticker_sentiment_score": "0.288094", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "FIVE", "relevance_score": "0.121037", "ticker_sentiment_score": "0.101382", "ticker_sentiment_label": "Neutral"}, {"ticker": "PEP", "relevance_score": "0.121037", "ticker_sentiment_score": "0.101382", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Coverage Initiated by Analysts at StockNews.com", "url": "https://www.etfdailynews.com/2022/07/08/bio-path-nasdaqbpth-coverage-initiated-by-analysts-at-stocknews-com/", "time_published": "20220708T052449", "authors": ["MarketBeat News"], "summary": "StockNews.com started coverage on shares of Bio-Path ( NASDAQ:BPTH - Get Rating ) in a note issued to investors on Friday. The brokerage set a \"sell\" rating on the stock. Separately, HC Wainwright cut their price target on shares of Bio-Path from $12.00 to $9.00 and set a \"buy\" rating on the ...", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?w=250&h=150&zc=2&src=https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.etfdailynews.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.929393"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.001358, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.895798", "ticker_sentiment_score": "0.001358", "ticker_sentiment_label": "Neutral"}, {"ticker": "VIRT", "relevance_score": "0.232328", "ticker_sentiment_score": "-0.000169", "ticker_sentiment_label": "Neutral"}, {"ticker": "RBLX", "relevance_score": "0.117429", "ticker_sentiment_score": "0.004669", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:NANO", "relevance_score": "0.117429", "ticker_sentiment_score": "0.004669", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Research Coverage Started at StockNews.com", "url": "https://www.defenseworld.net/2022/06/22/bio-path-nasdaqbpth-research-coverage-started-at-stocknews-com-5.html", "time_published": "20220622T052041", "authors": ["admin"], "summary": "Investment analysts at StockNews.com assumed coverage on shares of Bio-Path ( NASDAQ:BPTH - Get Rating ) in a research report issued on Wednesday. The brokerage set a \"sell\" rating on the stock.", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?w=250&h=150&zc=2&src=https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.011707, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.866386", "ticker_sentiment_score": "0.011707", "ticker_sentiment_label": "Neutral"}, {"ticker": "VIRT", "relevance_score": "0.099476", "ticker_sentiment_score": "0.035216", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.197413", "ticker_sentiment_score": "0.035216", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:NANO", "relevance_score": "0.099476", "ticker_sentiment_score": "0.002429", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Coverage Initiated at StockNews.com", "url": "https://www.defenseworld.net/2022/06/06/bio-path-nasdaqbpth-coverage-initiated-at-stocknews-com.html", "time_published": "20220606T051841", "authors": ["admin"], "summary": "StockNews.com started coverage on shares of Bio-Path ( NASDAQ:BPTH - Get Rating ) in a research report issued to clients and investors on Monday. The brokerage set a \"sell\" rating on the stock.", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?w=250&h=150&zc=2&src=https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.005307, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.913524", "ticker_sentiment_score": "0.005307", "ticker_sentiment_label": "Neutral"}, {"ticker": "VIRT", "relevance_score": "0.097457", "ticker_sentiment_score": "0.009779", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.193465", "ticker_sentiment_score": "0.009779", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:NANO", "relevance_score": "0.097457", "ticker_sentiment_score": "0.002616", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Now Covered by Analysts at StockNews.com", "url": "https://www.etfdailynews.com/2022/05/29/bio-path-nasdaqbpth-now-covered-by-analysts-at-stocknews-com/", "time_published": "20220529T050849", "authors": ["MarketBeat News"], "summary": "StockNews.com began coverage on shares of Bio-Path ( NASDAQ:BPTH - Get Rating ) in a note issued to investors on Sunday. The brokerage set a \"sell\" rating on the stock. BPTH has been the topic of several other research reports.", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?w=250&h=150&zc=2&src=https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.etfdailynews.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.003259, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.907304", "ticker_sentiment_score": "0.003259", "ticker_sentiment_label": "Neutral"}, {"ticker": "VIRT", "relevance_score": "0.095593", "ticker_sentiment_score": "0.008258", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.189819", "ticker_sentiment_score": "0.008258", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:NANO", "relevance_score": "0.095593", "ticker_sentiment_score": "0.002265", "ticker_sentiment_label": "Neutral"}]}, {"title": "The Daily Biotech Pulse: Pfizer-BioNTech's COVID-19 Booster For Kids 5-11 Coming Soon, Ultragenyx In-Licenses Gene Therapy For Genetic Disorder, Ampio's AP-013 Trial Under Independent Investigation", "url": "https://www.benzinga.com/general/biotech/22/05/27249090/the-daily-biotech-pulse-pfizer-biontechs-covid-19-booster-for-5-11-year-kids-soon-ultragenyx-in-l", "time_published": "20220517T130455", "authors": ["Vandana Singh"], "summary": "Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus FDA May Authorize Pfizer-BioNTech's COVID-19 Booster For 5-11 Year Kids Soon: NYT The FDA is expected to authorize a booster shot of Pfizer Inc ( NYSE: PFE ) /BioNTech SE's ( NASDAQ: BNTX ) COVID-19", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/05/17/syringe-ge28143bc6_1920.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}], "overall_sentiment_score": 0.007225, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MDWD", "relevance_score": "0.178426", "ticker_sentiment_score": "0.036063", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTE", "relevance_score": "0.08978", "ticker_sentiment_score": "-0.000874", "ticker_sentiment_label": "Neutral"}, {"ticker": "CABA", "relevance_score": "0.08978", "ticker_sentiment_score": "0.003528", "ticker_sentiment_label": "Neutral"}, {"ticker": "RARE", "relevance_score": "0.178426", "ticker_sentiment_score": "0.016429", "ticker_sentiment_label": "Neutral"}, {"ticker": "NYT", "relevance_score": "0.044961", "ticker_sentiment_score": "-0.08853", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLU", "relevance_score": "0.134314", "ticker_sentiment_score": "0.06262", "ticker_sentiment_label": "Neutral"}, {"ticker": "DHKCF", "relevance_score": "0.044961", "ticker_sentiment_score": "0.017821", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGTC", "relevance_score": "0.178426", "ticker_sentiment_score": "-0.003384", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.08978", "ticker_sentiment_score": "-0.08853", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNTX", "relevance_score": "0.08978", "ticker_sentiment_score": "-0.08853", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKTX", "relevance_score": "0.08978", "ticker_sentiment_score": "-0.000643", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYTK", "relevance_score": "0.08978", "ticker_sentiment_score": "0.002596", "ticker_sentiment_label": "Neutral"}, {"ticker": "GENE", "relevance_score": "0.044961", "ticker_sentiment_score": "-0.007529", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABEO", "relevance_score": "0.08978", "ticker_sentiment_score": "0.003513", "ticker_sentiment_label": "Neutral"}, {"ticker": "RGNX", "relevance_score": "0.08978", "ticker_sentiment_score": "0.000613", "ticker_sentiment_label": "Neutral"}, {"ticker": "GILD", "relevance_score": "0.08978", "ticker_sentiment_score": "0.099815", "ticker_sentiment_label": "Neutral"}, {"ticker": "VBLT", "relevance_score": "0.08978", "ticker_sentiment_score": "-0.000669", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLPH", "relevance_score": "0.08978", "ticker_sentiment_score": "0.001392", "ticker_sentiment_label": "Neutral"}, {"ticker": "BPTH", "relevance_score": "0.08978", "ticker_sentiment_score": "0.001205", "ticker_sentiment_label": "Neutral"}, {"ticker": "MNKD", "relevance_score": "0.134314", "ticker_sentiment_score": "0.064551", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVO", "relevance_score": "0.08978", "ticker_sentiment_score": "0.017821", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZEAL", "relevance_score": "0.08978", "ticker_sentiment_score": "0.009211", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Path Holdings: Q1 Earnings Insights", "url": "https://www.benzinga.com/news/earnings/22/05/27245924/bio-path-holdings-q1-earnings-insights", "time_published": "20220517T114658", "authors": ["Benzinga Insights"], "summary": "Bio-Path Holdings ( NASDAQ:BPTH ) reported its Q1 earnings results on Tuesday, May 17, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings Bio-Path Holdings missed estimated earnings by 4.44%, reporting ...Full story available on Benzinga.com", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/earnings_image_6679.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.839681"}, {"topic": "Retail & Wholesale", "relevance_score": "1.0"}], "overall_sentiment_score": -0.113331, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.908999", "ticker_sentiment_score": "-0.013119", "ticker_sentiment_label": "Neutral"}]}, {"title": "Earnings Scheduled For May 17, 2022", "url": "https://www.benzinga.com/news/earnings/22/05/27243756/earnings-scheduled-for-may-17-2022", "time_published": "20220517T084725", "authors": ["Benzinga Insights"], "summary": "Companies Reporting Before The Bell \u2022 On Holding ( NYSE:ONON ) is likely to report earnings for its first quarter. \u2022 IHS Holding ( NYSE:IHS ) is likely to report quarterly earnings at $0.04 per share on revenue of $430.44 million. \u2022 JD.com ( NASDAQ:JD ) is likely to report quarterly earnings a", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/earnings_image_6670.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Retail & Wholesale", "relevance_score": "0.2"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Real Estate & Construction", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}], "overall_sentiment_score": -0.033343, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MDWD", "relevance_score": "0.121435", "ticker_sentiment_score": "-0.034551", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRMR", "relevance_score": "0.121435", "ticker_sentiment_score": "-2.4e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCS", "relevance_score": "0.121435", "ticker_sentiment_score": "-0.000448", "ticker_sentiment_label": "Neutral"}, {"ticker": "GNLN", "relevance_score": "0.121435", "ticker_sentiment_score": "-0.058843", "ticker_sentiment_label": "Neutral"}, {"ticker": "ROCR", "relevance_score": "0.060895", "ticker_sentiment_score": "-0.076631", "ticker_sentiment_label": "Neutral"}, {"ticker": "XNET", "relevance_score": "0.121435", "ticker_sentiment_score": "-0.074082", "ticker_sentiment_label": "Neutral"}, {"ticker": "JBI", "relevance_score": "0.121435", "ticker_sentiment_score": "-0.000311", "ticker_sentiment_label": "Neutral"}, {"ticker": "OBSV", "relevance_score": "0.121435", "ticker_sentiment_score": "-0.038506", "ticker_sentiment_label": "Neutral"}, {"ticker": "SE", "relevance_score": "0.121435", "ticker_sentiment_score": "-0.262481", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "IHS", "relevance_score": "0.121435", "ticker_sentiment_score": "0.002112", "ticker_sentiment_label": "Neutral"}, {"ticker": "NXGN", "relevance_score": "0.121435", "ticker_sentiment_score": "-0.001084", "ticker_sentiment_label": "Neutral"}, {"ticker": "KEYS", "relevance_score": "0.121435", "ticker_sentiment_score": "-0.001152", "ticker_sentiment_label": "Neutral"}, {"ticker": "DOCS", "relevance_score": "0.121435", "ticker_sentiment_score": "0.000481", "ticker_sentiment_label": "Neutral"}, {"ticker": "VBLT", "relevance_score": "0.121435", "ticker_sentiment_score": "-0.008769", "ticker_sentiment_label": "Neutral"}, {"ticker": "BPTH", "relevance_score": "0.121435", "ticker_sentiment_score": "-0.023857", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGYS", "relevance_score": "0.121435", "ticker_sentiment_score": "0.000461", "ticker_sentiment_label": "Neutral"}, {"ticker": "QUIK", "relevance_score": "0.121435", "ticker_sentiment_score": "-0.023064", "ticker_sentiment_label": "Neutral"}, {"ticker": "OTMO", "relevance_score": "0.121435", "ticker_sentiment_score": "0.000698", "ticker_sentiment_label": "Neutral"}, {"ticker": "TEDU", "relevance_score": "0.121435", "ticker_sentiment_score": "-0.03854", "ticker_sentiment_label": "Neutral"}, {"ticker": "VOD", "relevance_score": "0.121435", "ticker_sentiment_score": "0.001569", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALLT", "relevance_score": "0.121435", "ticker_sentiment_score": "-0.031468", "ticker_sentiment_label": "Neutral"}, {"ticker": "EDAP", "relevance_score": "0.121435", "ticker_sentiment_score": "-0.059561", "ticker_sentiment_label": "Neutral"}, {"ticker": "LVLU", "relevance_score": "0.121435", "ticker_sentiment_score": "0.002219", "ticker_sentiment_label": "Neutral"}, {"ticker": "REE", "relevance_score": "0.121435", "ticker_sentiment_score": "-0.001933", "ticker_sentiment_label": "Neutral"}, {"ticker": "JD", "relevance_score": "0.121435", "ticker_sentiment_score": "-0.001784", "ticker_sentiment_label": "Neutral"}, {"ticker": "HD", "relevance_score": "0.121435", "ticker_sentiment_score": "-0.002295", "ticker_sentiment_label": "Neutral"}, {"ticker": "KMDA", "relevance_score": "0.121435", "ticker_sentiment_score": "-9.2e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "RSKD", "relevance_score": "0.121435", "ticker_sentiment_score": "-0.137122", "ticker_sentiment_label": "Neutral"}, {"ticker": "WMT", "relevance_score": "0.121435", "ticker_sentiment_score": "-0.002523", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Research Coverage Started at StockNews.com", "url": "https://www.defenseworld.net/2022/05/05/bio-path-nasdaqbpth-research-coverage-started-at-stocknews-com.html", "time_published": "20220505T053041", "authors": ["admin"], "summary": "StockNews.com started coverage on shares of Bio-Path  ( NASDAQ:BPTH - Get Rating )  in a research report issued on Thursday. The firm set a \"sell\" rating on the stock.", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?w=250&h=150&zc=2&src=https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.87644"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.011032, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.886691", "ticker_sentiment_score": "0.011032", "ticker_sentiment_label": "Neutral"}, {"ticker": "SITE", "relevance_score": "0.114463", "ticker_sentiment_score": "0.000786", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.226583", "ticker_sentiment_score": "0.028612", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:NANO", "relevance_score": "0.114463", "ticker_sentiment_score": "0.000786", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Now Covered by Analysts at StockNews.com", "url": "https://www.defenseworld.net/2022/04/27/bio-path-nasdaqbpth-now-covered-by-analysts-at-stocknews-com.html", "time_published": "20220427T052241", "authors": ["admin"], "summary": "StockNews.com began coverage on shares of Bio-Path  ( NASDAQ:BPTH - Get Rating )  in a research report issued to clients and investors on Wednesday. The firm set a \"sell\" rating on the stock.", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?w=250&h=150&zc=2&src=https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}], "overall_sentiment_score": 0.015738, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ATVI", "relevance_score": "0.216087", "ticker_sentiment_score": "0.002577", "ticker_sentiment_label": "Neutral"}, {"ticker": "BPTH", "relevance_score": "0.868503", "ticker_sentiment_score": "0.015738", "ticker_sentiment_label": "Neutral"}, {"ticker": "SSD", "relevance_score": "0.109057", "ticker_sentiment_score": "0.002577", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.216087", "ticker_sentiment_score": "0.047073", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:NANO", "relevance_score": "0.109057", "ticker_sentiment_score": "0.002577", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stocks That Hit 52-Week Lows On Friday", "url": "https://www.benzinga.com/markets/options/22/04/26764450/52-weeks-high-and-low-article", "time_published": "20220422T162629", "authors": ["Benzinga Insights"], "summary": "On Friday, 431 companies hit new 52-week lows.\nNoteworthy Mentions In Today's 52-Week Lows:\nThe largest company by market cap to hit a new 52-week low was Meta Platforms  ( NASDAQ:FB ) .\nThe smallest company by market cap to set a new 52-week low was AnPac Bio-Medical Science  ( NASDAQ:ANPC ) .\nBaby", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/movers_image_7108.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Blockchain", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.008194, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "SSNT", "relevance_score": "0.012589", "ticker_sentiment_score": "0.04002", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGLE", "relevance_score": "0.012589", "ticker_sentiment_score": "0.000288", "ticker_sentiment_label": "Neutral"}, {"ticker": "APP", "relevance_score": "0.012589", "ticker_sentiment_score": "0.055017", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRIP", "relevance_score": "0.006295", "ticker_sentiment_score": "0.003013", "ticker_sentiment_label": "Neutral"}, {"ticker": "WSBF", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.027827", "ticker_sentiment_label": "Neutral"}, {"ticker": "CCNC", "relevance_score": "0.012589", "ticker_sentiment_score": "0.005522", "ticker_sentiment_label": "Neutral"}, {"ticker": "ROIV", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.011696", "ticker_sentiment_label": "Neutral"}, {"ticker": "FRSX", "relevance_score": "0.012589", "ticker_sentiment_score": "0.002197", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANIK", "relevance_score": "0.012589", "ticker_sentiment_score": "0.005764", "ticker_sentiment_label": "Neutral"}, {"ticker": "CUE", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.054565", "ticker_sentiment_label": "Neutral"}, {"ticker": "NCNO", "relevance_score": "0.012589", "ticker_sentiment_score": "0.007951", "ticker_sentiment_label": "Neutral"}, {"ticker": "OLMA", "relevance_score": "0.012589", "ticker_sentiment_score": "0.000488", "ticker_sentiment_label": "Neutral"}, {"ticker": "NMRD", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.001194", "ticker_sentiment_label": "Neutral"}, {"ticker": "RCRT", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.008186", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALEC", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.000888", "ticker_sentiment_label": "Neutral"}, {"ticker": "ORIC", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.008871", "ticker_sentiment_label": "Neutral"}, {"ticker": "INSG", "relevance_score": "0.012589", "ticker_sentiment_score": "0.003844", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNXT", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.003319", "ticker_sentiment_label": "Neutral"}, {"ticker": "CODX", "relevance_score": "0.012589", "ticker_sentiment_score": "0.008938", "ticker_sentiment_label": "Neutral"}, {"ticker": "PASG", "relevance_score": "0.012589", "ticker_sentiment_score": "0.013615", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARRY", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.013281", "ticker_sentiment_label": "Neutral"}, {"ticker": "GROM", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.002015", "ticker_sentiment_label": "Neutral"}, {"ticker": "RSI", "relevance_score": "0.012589", "ticker_sentiment_score": "0.005125", "ticker_sentiment_label": "Neutral"}, {"ticker": "HOVNP", "relevance_score": "0.006295", "ticker_sentiment_score": "-0.00611", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBET", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.001174", "ticker_sentiment_label": "Neutral"}, {"ticker": "WINT", "relevance_score": "0.012589", "ticker_sentiment_score": "0.003037", "ticker_sentiment_label": "Neutral"}, {"ticker": "SURF", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.003905", "ticker_sentiment_label": "Neutral"}, {"ticker": "KIRK", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.01154", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMEA", "relevance_score": "0.012589", "ticker_sentiment_score": "0.004559", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALVR", "relevance_score": "0.012589", "ticker_sentiment_score": "0.007537", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOFI", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.017466", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTBT", "relevance_score": "0.012589", "ticker_sentiment_score": "0.063278", "ticker_sentiment_label": "Neutral"}, {"ticker": "CERS", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.207667", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PACK", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.013536", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASTC", "relevance_score": "0.012589", "ticker_sentiment_score": "0.0022", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARR", "relevance_score": "0.012589", "ticker_sentiment_score": "0.003278", "ticker_sentiment_label": "Neutral"}, {"ticker": "LIQT", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.009744", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIOC", "relevance_score": "0.012589", "ticker_sentiment_score": "0.00362", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGNC", "relevance_score": "0.012589", "ticker_sentiment_score": "0.00151", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLUE", "relevance_score": "0.012589", "ticker_sentiment_score": "0.013598", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDAY", "relevance_score": "0.012589", "ticker_sentiment_score": "0.04606", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGHT", "relevance_score": "0.012589", "ticker_sentiment_score": "0.006001", "ticker_sentiment_label": "Neutral"}, {"ticker": "HIMX", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.023699", "ticker_sentiment_label": "Neutral"}, {"ticker": "IESC", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.181158", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PRGO", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.005214", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDAK", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.006933", "ticker_sentiment_label": "Neutral"}, {"ticker": "NLS", "relevance_score": "0.012589", "ticker_sentiment_score": "0.057322", "ticker_sentiment_label": "Neutral"}, {"ticker": "CWH", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.001105", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKUS", "relevance_score": "0.012589", "ticker_sentiment_score": "0.045251", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTCY", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.017476", "ticker_sentiment_label": "Neutral"}, {"ticker": "NMTR", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.007634", "ticker_sentiment_label": "Neutral"}, {"ticker": "Z", "relevance_score": "0.018882", "ticker_sentiment_score": "0.001113", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADGI", "relevance_score": "0.012589", "ticker_sentiment_score": "0.00271", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDFN", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.004169", "ticker_sentiment_label": "Neutral"}, {"ticker": "CGC", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.006886", "ticker_sentiment_label": "Neutral"}, {"ticker": "SEEL", "relevance_score": "0.012589", "ticker_sentiment_score": "0.001976", "ticker_sentiment_label": "Neutral"}, {"ticker": "MCRB", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.560818", "ticker_sentiment_label": "Bearish"}, {"ticker": "NVTS", "relevance_score": "0.012589", "ticker_sentiment_score": "0.012871", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMAC", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.019326", "ticker_sentiment_label": "Neutral"}, {"ticker": "INST", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.003671", "ticker_sentiment_label": "Neutral"}, {"ticker": "AEXAF", "relevance_score": "0.006295", "ticker_sentiment_score": "-0.000552", "ticker_sentiment_label": "Neutral"}, {"ticker": "DIS", "relevance_score": "0.012589", "ticker_sentiment_score": "0.002236", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRNE", "relevance_score": "0.012589", "ticker_sentiment_score": "0.026752", "ticker_sentiment_label": "Neutral"}, {"ticker": "HYLN", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.018711", "ticker_sentiment_label": "Neutral"}, {"ticker": "EHTH", "relevance_score": "0.012589", "ticker_sentiment_score": "0.037272", "ticker_sentiment_label": "Neutral"}, {"ticker": "CETX", "relevance_score": "0.012589", "ticker_sentiment_score": "0.000217", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLRX", "relevance_score": "0.012589", "ticker_sentiment_score": "0.002872", "ticker_sentiment_label": "Neutral"}, {"ticker": "RIOT", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.023593", "ticker_sentiment_label": "Neutral"}, {"ticker": "EYEN", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.002954", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLBZ", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.005902", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMFR", "relevance_score": "0.012589", "ticker_sentiment_score": "0.00613", "ticker_sentiment_label": "Neutral"}, {"ticker": "TU", "relevance_score": "0.006295", "ticker_sentiment_score": "0.00025", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZNTL", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.005374", "ticker_sentiment_label": "Neutral"}, {"ticker": "GNLN", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.009782", "ticker_sentiment_label": "Neutral"}, {"ticker": "BOLT", "relevance_score": "0.012589", "ticker_sentiment_score": "0.003932", "ticker_sentiment_label": "Neutral"}, {"ticker": "GPS", "relevance_score": "0.012589", "ticker_sentiment_score": "0.018038", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRTS", "relevance_score": "0.012589", "ticker_sentiment_score": "0.011243", "ticker_sentiment_label": "Neutral"}, {"ticker": "INVZ", "relevance_score": "0.012589", "ticker_sentiment_score": "0.003278", "ticker_sentiment_label": "Neutral"}, {"ticker": "CCRD", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.005314", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTSO", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.001463", "ticker_sentiment_label": "Neutral"}, {"ticker": "FORA", "relevance_score": "0.012589", "ticker_sentiment_score": "0.006191", "ticker_sentiment_label": "Neutral"}, {"ticker": "NUVL", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.055877", "ticker_sentiment_label": "Neutral"}, {"ticker": "XRAY", "relevance_score": "0.012589", "ticker_sentiment_score": "0.006364", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTHX", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.248444", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "EB", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.008884", "ticker_sentiment_label": "Neutral"}, {"ticker": "ICAD", "relevance_score": "0.012589", "ticker_sentiment_score": "0.005195", "ticker_sentiment_label": "Neutral"}, {"ticker": "PIXY", "relevance_score": "0.012589", "ticker_sentiment_score": "0.000616", "ticker_sentiment_label": "Neutral"}, {"ticker": "DKNG", "relevance_score": "0.012589", "ticker_sentiment_score": "0.038037", "ticker_sentiment_label": "Neutral"}, {"ticker": "LABP", "relevance_score": "0.012589", "ticker_sentiment_score": "0.00382", "ticker_sentiment_label": "Neutral"}, {"ticker": "BRCN", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.005224", "ticker_sentiment_label": "Neutral"}, {"ticker": "CIM", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.024596", "ticker_sentiment_label": "Neutral"}, {"ticker": "STSS", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.000223", "ticker_sentiment_label": "Neutral"}, {"ticker": "AYTU", "relevance_score": "0.012589", "ticker_sentiment_score": "0.002702", "ticker_sentiment_label": "Neutral"}, {"ticker": "YETI", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.00638", "ticker_sentiment_label": "Neutral"}, {"ticker": "LCFY", "relevance_score": "0.012589", "ticker_sentiment_score": "0.004135", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTEM", "relevance_score": "0.012589", "ticker_sentiment_score": "0.009861", "ticker_sentiment_label": "Neutral"}, {"ticker": "VXRT", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.010216", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWIM", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.003836", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNEJF", "relevance_score": "0.012589", "ticker_sentiment_score": "0.005471", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONCT", "relevance_score": "0.012589", "ticker_sentiment_score": "0.005971", "ticker_sentiment_label": "Neutral"}, {"ticker": "MYOV", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.015233", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARVL", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.005942", "ticker_sentiment_label": "Neutral"}, {"ticker": "CZR", "relevance_score": "0.012589", "ticker_sentiment_score": "0.003375", "ticker_sentiment_label": "Neutral"}, {"ticker": "APRE", "relevance_score": "0.012589", "ticker_sentiment_score": "0.002011", "ticker_sentiment_label": "Neutral"}, {"ticker": "FB", "relevance_score": "0.025174", "ticker_sentiment_score": "0.023313", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMVT", "relevance_score": "0.012589", "ticker_sentiment_score": "0.000444", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGNX", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.029535", "ticker_sentiment_label": "Neutral"}, {"ticker": "VZIO", "relevance_score": "0.012589", "ticker_sentiment_score": "0.027942", "ticker_sentiment_label": "Neutral"}, {"ticker": "FDMT", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.009669", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTON", "relevance_score": "0.012589", "ticker_sentiment_score": "0.054059", "ticker_sentiment_label": "Neutral"}, {"ticker": "CBAY", "relevance_score": "0.012589", "ticker_sentiment_score": "0.006852", "ticker_sentiment_label": "Neutral"}, {"ticker": "GSHD", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.015145", "ticker_sentiment_label": "Neutral"}, {"ticker": "MASI", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.024883", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.001085", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRTX", "relevance_score": "0.012589", "ticker_sentiment_score": "0.000518", "ticker_sentiment_label": "Neutral"}, {"ticker": "BFLY", "relevance_score": "0.012589", "ticker_sentiment_score": "0.010341", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGMO", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.003332", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHOP", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.009446", "ticker_sentiment_label": "Neutral"}, {"ticker": "AWH", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.002622", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSAT", "relevance_score": "0.012589", "ticker_sentiment_score": "0.033108", "ticker_sentiment_label": "Neutral"}, {"ticker": "HARP", "relevance_score": "0.012589", "ticker_sentiment_score": "0.002506", "ticker_sentiment_label": "Neutral"}, {"ticker": "TLS", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.019667", "ticker_sentiment_label": "Neutral"}, {"ticker": "FLNC", "relevance_score": "0.012589", "ticker_sentiment_score": "0.031989", "ticker_sentiment_label": "Neutral"}, {"ticker": "NBRV", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.002136", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRLD", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.010073", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLGG", "relevance_score": "0.012589", "ticker_sentiment_score": "0.040503", "ticker_sentiment_label": "Neutral"}, {"ticker": "DMTK", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.033483", "ticker_sentiment_label": "Neutral"}, {"ticker": "LPRO", "relevance_score": "0.012589", "ticker_sentiment_score": "0.01059", "ticker_sentiment_label": "Neutral"}, {"ticker": "OMCL", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.004584", "ticker_sentiment_label": "Neutral"}, {"ticker": "ORMP", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.002445", "ticker_sentiment_label": "Neutral"}, {"ticker": "QUMU", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.028206", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWKS", "relevance_score": "0.012589", "ticker_sentiment_score": "0.007002", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALLO", "relevance_score": "0.012589", "ticker_sentiment_score": "0.003576", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELOX", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.00577", "ticker_sentiment_label": "Neutral"}, {"ticker": "WPRT", "relevance_score": "0.012589", "ticker_sentiment_score": "0.008531", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALLK", "relevance_score": "0.012589", "ticker_sentiment_score": "0.000172", "ticker_sentiment_label": "Neutral"}, {"ticker": "CPNG", "relevance_score": "0.012589", "ticker_sentiment_score": "0.005556", "ticker_sentiment_label": "Neutral"}, {"ticker": "VQS", "relevance_score": "0.012589", "ticker_sentiment_score": "0.000542", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTH", "relevance_score": "0.012589", "ticker_sentiment_score": "0.033799", "ticker_sentiment_label": "Neutral"}, {"ticker": "OCN", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.000454", "ticker_sentiment_label": "Neutral"}, {"ticker": "OTRK", "relevance_score": "0.012589", "ticker_sentiment_score": "0.0038", "ticker_sentiment_label": "Neutral"}, {"ticker": "REKR", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.025588", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANPC", "relevance_score": "0.025174", "ticker_sentiment_score": "0.035638", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRRK", "relevance_score": "0.012589", "ticker_sentiment_score": "0.016927", "ticker_sentiment_label": "Neutral"}, {"ticker": "XPON", "relevance_score": "0.012589", "ticker_sentiment_score": "0.011874", "ticker_sentiment_label": "Neutral"}, {"ticker": "AHG", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.012297", "ticker_sentiment_label": "Neutral"}, {"ticker": "VERO", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.006878", "ticker_sentiment_label": "Neutral"}, {"ticker": "RIVN", "relevance_score": "0.012589", "ticker_sentiment_score": "0.003093", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENVX", "relevance_score": "0.012589", "ticker_sentiment_score": "0.011344", "ticker_sentiment_label": "Neutral"}, {"ticker": "EDSA", "relevance_score": "0.012589", "ticker_sentiment_score": "0.003232", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANAB", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.005612", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBBK", "relevance_score": "0.012589", "ticker_sentiment_score": "0.00713", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRSR", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.369351", "ticker_sentiment_label": "Bearish"}, {"ticker": "SBUX", "relevance_score": "0.012589", "ticker_sentiment_score": "0.033597", "ticker_sentiment_label": "Neutral"}, {"ticker": "NUZE", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.051845", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADMP", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.033236", "ticker_sentiment_label": "Neutral"}, {"ticker": "IRBT", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.001635", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLS", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.315281", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CYRX", "relevance_score": "0.012589", "ticker_sentiment_score": "0.00353", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSNL", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.033412", "ticker_sentiment_label": "Neutral"}, {"ticker": "NKTX", "relevance_score": "0.012589", "ticker_sentiment_score": "0.004799", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSGM", "relevance_score": "0.012589", "ticker_sentiment_score": "0.006859", "ticker_sentiment_label": "Neutral"}, {"ticker": "JSPR", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.001649", "ticker_sentiment_label": "Neutral"}, {"ticker": "MREO", "relevance_score": "0.012589", "ticker_sentiment_score": "9.4e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVRO", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.000955", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRTX", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.017962", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMG", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.369194", "ticker_sentiment_label": "Bearish"}, {"ticker": "CRDF", "relevance_score": "0.012589", "ticker_sentiment_score": "0.000458", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACLX", "relevance_score": "0.012589", "ticker_sentiment_score": "0.006727", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMPS", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.006561", "ticker_sentiment_label": "Neutral"}, {"ticker": "MITO", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.000115", "ticker_sentiment_label": "Neutral"}, {"ticker": "CABO", "relevance_score": "0.012589", "ticker_sentiment_score": "0.002655", "ticker_sentiment_label": "Neutral"}, {"ticker": "KERN", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.053433", "ticker_sentiment_label": "Neutral"}, {"ticker": "KMX", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.012706", "ticker_sentiment_label": "Neutral"}, {"ticker": "IBRX", "relevance_score": "0.012589", "ticker_sentiment_score": "0.068075", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLK", "relevance_score": "0.031465", "ticker_sentiment_score": "-0.003981", "ticker_sentiment_label": "Neutral"}, {"ticker": "NBEV", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.000144", "ticker_sentiment_label": "Neutral"}, {"ticker": "WEN", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.025063", "ticker_sentiment_label": "Neutral"}, {"ticker": "CELC", "relevance_score": "0.012589", "ticker_sentiment_score": "0.00534", "ticker_sentiment_label": "Neutral"}, {"ticker": "MNPR", "relevance_score": "0.012589", "ticker_sentiment_score": "0.001248", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATOS", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.000552", "ticker_sentiment_label": "Neutral"}, {"ticker": "SCYX", "relevance_score": "0.012589", "ticker_sentiment_score": "0.003683", "ticker_sentiment_label": "Neutral"}, {"ticker": "AERC", "relevance_score": "0.012589", "ticker_sentiment_score": "0.008628", "ticker_sentiment_label": "Neutral"}, {"ticker": "OCUP", "relevance_score": "0.012589", "ticker_sentiment_score": "0.000769", "ticker_sentiment_label": "Neutral"}, {"ticker": "AJX", "relevance_score": "0.012589", "ticker_sentiment_score": "0.646094", "ticker_sentiment_label": "Bullish"}, {"ticker": "OCUL", "relevance_score": "0.012589", "ticker_sentiment_score": "0.02295", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGEN", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.031165", "ticker_sentiment_label": "Neutral"}, {"ticker": "OOMA", "relevance_score": "0.012589", "ticker_sentiment_score": "0.007986", "ticker_sentiment_label": "Neutral"}, {"ticker": "TYRA", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.03969", "ticker_sentiment_label": "Neutral"}, {"ticker": "SKYT", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.016877", "ticker_sentiment_label": "Neutral"}, {"ticker": "AFCG", "relevance_score": "0.012589", "ticker_sentiment_score": "0.0065", "ticker_sentiment_label": "Neutral"}, {"ticker": "COOK", "relevance_score": "0.012589", "ticker_sentiment_score": "0.008612", "ticker_sentiment_label": "Neutral"}, {"ticker": "PINS", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.002318", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRPL", "relevance_score": "0.012589", "ticker_sentiment_score": "0.003783", "ticker_sentiment_label": "Neutral"}, {"ticker": "BPTH", "relevance_score": "0.012589", "ticker_sentiment_score": "0.008217", "ticker_sentiment_label": "Neutral"}, {"ticker": "INMD", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.016722", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRGA", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.007052", "ticker_sentiment_label": "Neutral"}, {"ticker": "NXPL", "relevance_score": "0.012589", "ticker_sentiment_score": "0.017228", "ticker_sentiment_label": "Neutral"}, {"ticker": "LBRDP", "relevance_score": "0.012589", "ticker_sentiment_score": "0.00176", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGFY", "relevance_score": "0.012589", "ticker_sentiment_score": "0.010775", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVTX", "relevance_score": "0.012589", "ticker_sentiment_score": "0.042436", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOPA", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.010251", "ticker_sentiment_label": "Neutral"}, {"ticker": "BGCP", "relevance_score": "0.012589", "ticker_sentiment_score": "0.001663", "ticker_sentiment_label": "Neutral"}, {"ticker": "SELB", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.001529", "ticker_sentiment_label": "Neutral"}, {"ticker": "MORF", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.004261", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMBC", "relevance_score": "0.012589", "ticker_sentiment_score": "0.002195", "ticker_sentiment_label": "Neutral"}, {"ticker": "GGR", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.015191", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALPP", "relevance_score": "0.012589", "ticker_sentiment_score": "0.004674", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOCO", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.003547", "ticker_sentiment_label": "Neutral"}, {"ticker": "RMO", "relevance_score": "0.012589", "ticker_sentiment_score": "0.001112", "ticker_sentiment_label": "Neutral"}, {"ticker": "USAU", "relevance_score": "0.012589", "ticker_sentiment_score": "0.000765", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLBY", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.001849", "ticker_sentiment_label": "Neutral"}, {"ticker": "IART", "relevance_score": "0.012589", "ticker_sentiment_score": "0.009061", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADPT", "relevance_score": "0.012589", "ticker_sentiment_score": "0.006914", "ticker_sentiment_label": "Neutral"}, {"ticker": "CHRS", "relevance_score": "0.012589", "ticker_sentiment_score": "0.006347", "ticker_sentiment_label": "Neutral"}, {"ticker": "RCKT", "relevance_score": "0.012589", "ticker_sentiment_score": "0.019645", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPRO", "relevance_score": "0.012589", "ticker_sentiment_score": "0.011275", "ticker_sentiment_label": "Neutral"}, {"ticker": "FUBO", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.002501", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRDY", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.006808", "ticker_sentiment_label": "Neutral"}, {"ticker": "OSTK", "relevance_score": "0.012589", "ticker_sentiment_score": "0.006961", "ticker_sentiment_label": "Neutral"}, {"ticker": "ORTX", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.211815", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PEGY", "relevance_score": "0.012589", "ticker_sentiment_score": "0.004639", "ticker_sentiment_label": "Neutral"}, {"ticker": "IHRT", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.017445", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNR", "relevance_score": "0.012589", "ticker_sentiment_score": "0.016432", "ticker_sentiment_label": "Neutral"}, {"ticker": "CPS", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.009416", "ticker_sentiment_label": "Neutral"}, {"ticker": "GHG", "relevance_score": "0.012589", "ticker_sentiment_score": "0.00373", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALT", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.031937", "ticker_sentiment_label": "Neutral"}, {"ticker": "LUCD", "relevance_score": "0.012589", "ticker_sentiment_score": "0.006571", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOVX", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.000226", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPI", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.029997", "ticker_sentiment_label": "Neutral"}, {"ticker": "DTIL", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.012843", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTKB", "relevance_score": "0.012589", "ticker_sentiment_score": "0.001975", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENJY", "relevance_score": "0.012589", "ticker_sentiment_score": "0.106522", "ticker_sentiment_label": "Neutral"}, {"ticker": "ME", "relevance_score": "0.006295", "ticker_sentiment_score": "-0.130957", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRXP", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.002716", "ticker_sentiment_label": "Neutral"}, {"ticker": "NDLS", "relevance_score": "0.012589", "ticker_sentiment_score": "0.004082", "ticker_sentiment_label": "Neutral"}, {"ticker": "RBLX", "relevance_score": "0.012589", "ticker_sentiment_score": "0.001979", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACOR", "relevance_score": "0.012589", "ticker_sentiment_score": "0.002127", "ticker_sentiment_label": "Neutral"}, {"ticker": "FSRD", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.000724", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMK", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.039246", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTLA", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.001283", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSHA", "relevance_score": "0.012589", "ticker_sentiment_score": "0.00793", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGTA", "relevance_score": "0.012589", "ticker_sentiment_score": "0.060536", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRPO", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.025237", "ticker_sentiment_label": "Neutral"}, {"ticker": "KRON", "relevance_score": "0.012589", "ticker_sentiment_score": "0.007236", "ticker_sentiment_label": "Neutral"}, {"ticker": "DNLI", "relevance_score": "0.012589", "ticker_sentiment_score": "0.004036", "ticker_sentiment_label": "Neutral"}, {"ticker": "BRKR", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.003901", "ticker_sentiment_label": "Neutral"}, {"ticker": "FGI", "relevance_score": "0.012589", "ticker_sentiment_score": "0.000523", "ticker_sentiment_label": "Neutral"}, {"ticker": "PEGA", "relevance_score": "0.012589", "ticker_sentiment_score": "0.006817", "ticker_sentiment_label": "Neutral"}, {"ticker": "WEAV", "relevance_score": "0.012589", "ticker_sentiment_score": "0.008455", "ticker_sentiment_label": "Neutral"}, {"ticker": "AUDC", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.010403", "ticker_sentiment_label": "Neutral"}, {"ticker": "BEAM", "relevance_score": "0.012589", "ticker_sentiment_score": "0.004871", "ticker_sentiment_label": "Neutral"}, {"ticker": "AUTL", "relevance_score": "0.012589", "ticker_sentiment_score": "0.003643", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDLX", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.007628", "ticker_sentiment_label": "Neutral"}, {"ticker": "KIND", "relevance_score": "0.012589", "ticker_sentiment_score": "0.50686", "ticker_sentiment_label": "Bullish"}, {"ticker": "GOEV", "relevance_score": "0.012589", "ticker_sentiment_score": "0.000334", "ticker_sentiment_label": "Neutral"}, {"ticker": "RGEN", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.256995", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "EEX", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.00637", "ticker_sentiment_label": "Neutral"}, {"ticker": "RVSN", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.008417", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATRA", "relevance_score": "0.012589", "ticker_sentiment_score": "0.003479", "ticker_sentiment_label": "Neutral"}, {"ticker": "CHTR", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.011615", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNPO", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.007526", "ticker_sentiment_label": "Neutral"}, {"ticker": "SAM", "relevance_score": "0.012589", "ticker_sentiment_score": "0.000678", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRM", "relevance_score": "0.012589", "ticker_sentiment_score": "0.004845", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRCH", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.268489", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "VAPO", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.009243", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.012589", "ticker_sentiment_score": "0.0058", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRAR", "relevance_score": "0.012589", "ticker_sentiment_score": "0.045139", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRIS", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.007101", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPRT", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.002131", "ticker_sentiment_label": "Neutral"}, {"ticker": "DDI", "relevance_score": "0.012589", "ticker_sentiment_score": "0.001979", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANGN", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.021568", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNSE", "relevance_score": "0.012589", "ticker_sentiment_score": "0.000518", "ticker_sentiment_label": "Neutral"}, {"ticker": "EXPI", "relevance_score": "0.012589", "ticker_sentiment_score": "0.005179", "ticker_sentiment_label": "Neutral"}, {"ticker": "INPX", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.008001", "ticker_sentiment_label": "Neutral"}, {"ticker": "LDI", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.000743", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANGI", "relevance_score": "0.012589", "ticker_sentiment_score": "0.008306", "ticker_sentiment_label": "Neutral"}, {"ticker": "VKTX", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.004909", "ticker_sentiment_label": "Neutral"}, {"ticker": "GAME", "relevance_score": "0.012589", "ticker_sentiment_score": "0.016677", "ticker_sentiment_label": "Neutral"}, {"ticker": "COSM", "relevance_score": "0.012589", "ticker_sentiment_score": "0.009832", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELYM", "relevance_score": "0.012589", "ticker_sentiment_score": "0.002674", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVAX", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.0001", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRAY", "relevance_score": "0.012589", "ticker_sentiment_score": "0.009599", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBLN", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.04487", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSTV", "relevance_score": "0.012589", "ticker_sentiment_score": "0.010249", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSTX", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.024202", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVYA", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.006879", "ticker_sentiment_label": "Neutral"}, {"ticker": "FNHC", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.045502", "ticker_sentiment_label": "Neutral"}, {"ticker": "RMBL", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.041902", "ticker_sentiment_label": "Neutral"}, {"ticker": "AAOI", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.008505", "ticker_sentiment_label": "Neutral"}, {"ticker": "GNUS", "relevance_score": "0.012589", "ticker_sentiment_score": "0.033762", "ticker_sentiment_label": "Neutral"}, {"ticker": "HGTY", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.003595", "ticker_sentiment_label": "Neutral"}, {"ticker": "CFSB", "relevance_score": "0.012589", "ticker_sentiment_score": "0.001962", "ticker_sentiment_label": "Neutral"}, {"ticker": "OYST", "relevance_score": "0.012589", "ticker_sentiment_score": "0.000924", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACRX", "relevance_score": "0.012589", "ticker_sentiment_score": "0.001609", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKRO", "relevance_score": "0.012589", "ticker_sentiment_score": "0.006543", "ticker_sentiment_label": "Neutral"}, {"ticker": "WTRH", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.35552", "ticker_sentiment_label": "Bearish"}, {"ticker": "LEV", "relevance_score": "0.012589", "ticker_sentiment_score": "0.004599", "ticker_sentiment_label": "Neutral"}, {"ticker": "RPID", "relevance_score": "0.012589", "ticker_sentiment_score": "0.023936", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:BGN", "relevance_score": "0.006295", "ticker_sentiment_score": "0.004599", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Research Coverage Started at StockNews.com", "url": "https://decaymag.com/2022/04/20/bio-path-nasdaqbpth-research-coverage-started-at-stocknews-com.html", "time_published": "20220420T073041", "authors": ["admin"], "summary": "StockNews.com initiated coverage on shares of Bio-Path  ( NASDAQ:BPTH - Get Rating )  in a research report report published on Tuesday morning. The brokerage issued a sell rating on the stock.", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?w=250&h=150&zc=2&src=https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "decaymag.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Finance", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}], "overall_sentiment_score": 0.001773, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.883396", "ticker_sentiment_score": "0.001773", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.224591", "ticker_sentiment_score": "0.014721", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:NANO", "relevance_score": "0.113436", "ticker_sentiment_score": "0.002066", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stocks That Hit 52-Week Lows On Monday", "url": "https://www.benzinga.com/news/22/04/26669813/stocks-that-hit-52-week-lows-on-monday", "time_published": "20220418T154044", "authors": [], "summary": "On Monday, 466 companies hit new 52-week lows.\nNoteworthy Highlights From Today's 52-Week Lows:\nThe largest company by market cap to set a new 52-week low was Walt Disney  ( NYSE:DIS ) .\nThe smallest company on a market cap basis to set a new 52-week low was InVivo Therapeutics Hldg  ( NASDAQ:NVIV )", "banner_image": "https://cdn.benzinga.com/files/imagecache/story_image_685x375C/images/story/2022/movers_image_6728.jpeg", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.017864, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "VIAV", "relevance_score": "0.005428", "ticker_sentiment_score": "0.002621", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOFO", "relevance_score": "0.005428", "ticker_sentiment_score": "0.003856", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHYF", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.213067", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SESN", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000595", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTBC", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.293142", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ACCO", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.007652", "ticker_sentiment_label": "Neutral"}, {"ticker": "FRSX", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.012013", "ticker_sentiment_label": "Neutral"}, {"ticker": "TGTX", "relevance_score": "0.005428", "ticker_sentiment_score": "0.023223", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANIK", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.002695", "ticker_sentiment_label": "Neutral"}, {"ticker": "CUE", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.010655", "ticker_sentiment_label": "Neutral"}, {"ticker": "STT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.007513", "ticker_sentiment_label": "Neutral"}, {"ticker": "OLMA", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.022953", "ticker_sentiment_label": "Neutral"}, {"ticker": "PNR", "relevance_score": "0.005428", "ticker_sentiment_score": "-4.9e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "RCRT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.00106", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALEC", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.012709", "ticker_sentiment_label": "Neutral"}, {"ticker": "FARO", "relevance_score": "0.005428", "ticker_sentiment_score": "0.001331", "ticker_sentiment_label": "Neutral"}, {"ticker": "INSG", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.272565", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "BTCM", "relevance_score": "0.005428", "ticker_sentiment_score": "0.002319", "ticker_sentiment_label": "Neutral"}, {"ticker": "WING", "relevance_score": "0.005428", "ticker_sentiment_score": "0.015021", "ticker_sentiment_label": "Neutral"}, {"ticker": "RSI", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.021725", "ticker_sentiment_label": "Neutral"}, {"ticker": "HOVNP", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.011478", "ticker_sentiment_label": "Neutral"}, {"ticker": "NODK", "relevance_score": "0.005428", "ticker_sentiment_score": "1.1e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "SURF", "relevance_score": "0.005428", "ticker_sentiment_score": "0.000121", "ticker_sentiment_label": "Neutral"}, {"ticker": "RBOT", "relevance_score": "0.005428", "ticker_sentiment_score": "0.011872", "ticker_sentiment_label": "Neutral"}, {"ticker": "CURI", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.006403", "ticker_sentiment_label": "Neutral"}, {"ticker": "NAII", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.013529", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARAV", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.002946", "ticker_sentiment_label": "Neutral"}, {"ticker": "BDSX", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.002512", "ticker_sentiment_label": "Neutral"}, {"ticker": "METX", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.00156", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALVR", "relevance_score": "0.005428", "ticker_sentiment_score": "0.001026", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTBT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.008567", "ticker_sentiment_label": "Neutral"}, {"ticker": "CERS", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.006455", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWVL", "relevance_score": "0.005428", "ticker_sentiment_score": "0.000145", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNEY", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.393211", "ticker_sentiment_label": "Bearish"}, {"ticker": "NDRA", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.001256", "ticker_sentiment_label": "Neutral"}, {"ticker": "STRR", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.168617", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ALGS", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000859", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTTX", "relevance_score": "0.005428", "ticker_sentiment_score": "0.072563", "ticker_sentiment_label": "Neutral"}, {"ticker": "VICR", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.002619", "ticker_sentiment_label": "Neutral"}, {"ticker": "CALA", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.001674", "ticker_sentiment_label": "Neutral"}, {"ticker": "HIMX", "relevance_score": "0.005428", "ticker_sentiment_score": "0.003807", "ticker_sentiment_label": "Neutral"}, {"ticker": "PAVM", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000646", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALTG-P-A", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000193", "ticker_sentiment_label": "Neutral"}, {"ticker": "BQ", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000507", "ticker_sentiment_label": "Neutral"}, {"ticker": "STRY", "relevance_score": "0.005428", "ticker_sentiment_score": "0.024824", "ticker_sentiment_label": "Neutral"}, {"ticker": "MKSI", "relevance_score": "0.005428", "ticker_sentiment_score": "-8.3e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "SFE", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.005213", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDAK", "relevance_score": "0.005428", "ticker_sentiment_score": "0.000999", "ticker_sentiment_label": "Neutral"}, {"ticker": "CWH", "relevance_score": "0.005428", "ticker_sentiment_score": "0.001442", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRBK", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000264", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKUS", "relevance_score": "0.005428", "ticker_sentiment_score": "0.019851", "ticker_sentiment_label": "Neutral"}, {"ticker": "XPO", "relevance_score": "0.005428", "ticker_sentiment_score": "0.005448", "ticker_sentiment_label": "Neutral"}, {"ticker": "LRCX", "relevance_score": "0.005428", "ticker_sentiment_score": "0.001483", "ticker_sentiment_label": "Neutral"}, {"ticker": "TURN", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.00029", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADGI", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.148476", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDFN", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.031319", "ticker_sentiment_label": "Neutral"}, {"ticker": "PGRU", "relevance_score": "0.005428", "ticker_sentiment_score": "0.001445", "ticker_sentiment_label": "Neutral"}, {"ticker": "SEEL", "relevance_score": "0.005428", "ticker_sentiment_score": "5.6e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMED", "relevance_score": "0.005428", "ticker_sentiment_score": "0.034663", "ticker_sentiment_label": "Neutral"}, {"ticker": "ST", "relevance_score": "0.005428", "ticker_sentiment_score": "0.001707", "ticker_sentiment_label": "Neutral"}, {"ticker": "INST", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000889", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISO", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000759", "ticker_sentiment_label": "Neutral"}, {"ticker": "COHU", "relevance_score": "0.005428", "ticker_sentiment_score": "0.000175", "ticker_sentiment_label": "Neutral"}, {"ticker": "KWR", "relevance_score": "0.005428", "ticker_sentiment_score": "0.000293", "ticker_sentiment_label": "Neutral"}, {"ticker": "BEN", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.003698", "ticker_sentiment_label": "Neutral"}, {"ticker": "LII", "relevance_score": "0.005428", "ticker_sentiment_score": "0.019272", "ticker_sentiment_label": "Neutral"}, {"ticker": "NNDM", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.012305", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVOL", "relevance_score": "0.005428", "ticker_sentiment_score": "0.005128", "ticker_sentiment_label": "Neutral"}, {"ticker": "DIS", "relevance_score": "0.010855", "ticker_sentiment_score": "0.013698", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRNE", "relevance_score": "0.005428", "ticker_sentiment_score": "0.021159", "ticker_sentiment_label": "Neutral"}, {"ticker": "FTHM", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.029413", "ticker_sentiment_label": "Neutral"}, {"ticker": "IPGP", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.001813", "ticker_sentiment_label": "Neutral"}, {"ticker": "CKPT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.014272", "ticker_sentiment_label": "Neutral"}, {"ticker": "EHTH", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.011583", "ticker_sentiment_label": "Neutral"}, {"ticker": "LGMK", "relevance_score": "0.005428", "ticker_sentiment_score": "0.010204", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIOL", "relevance_score": "0.005428", "ticker_sentiment_score": "0.001225", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTRE", "relevance_score": "0.005428", "ticker_sentiment_score": "0.014752", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLBZ", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.014443", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMFR", "relevance_score": "0.005428", "ticker_sentiment_score": "0.001214", "ticker_sentiment_label": "Neutral"}, {"ticker": "REV", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.300391", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ETNB", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.218213", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ZNTL", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000217", "ticker_sentiment_label": "Neutral"}, {"ticker": "BOLT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.035983", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISPO", "relevance_score": "0.005428", "ticker_sentiment_score": "0.002199", "ticker_sentiment_label": "Neutral"}, {"ticker": "ITW", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.002407", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLYC", "relevance_score": "0.005428", "ticker_sentiment_score": "0.007737", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTSO", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.031658", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYN", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.02329", "ticker_sentiment_label": "Neutral"}, {"ticker": "FORA", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.052558", "ticker_sentiment_label": "Neutral"}, {"ticker": "RFL", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.012134", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTHX", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.011935", "ticker_sentiment_label": "Neutral"}, {"ticker": "ICAD", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.005133", "ticker_sentiment_label": "Neutral"}, {"ticker": "BWV", "relevance_score": "0.005428", "ticker_sentiment_score": "0.00035", "ticker_sentiment_label": "Neutral"}, {"ticker": "GBCI", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.005416", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTLO", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.010832", "ticker_sentiment_label": "Neutral"}, {"ticker": "CIM", "relevance_score": "0.005428", "ticker_sentiment_score": "0.001718", "ticker_sentiment_label": "Neutral"}, {"ticker": "STSS", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.009318", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANNX", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.013213", "ticker_sentiment_label": "Neutral"}, {"ticker": "LCFY", "relevance_score": "0.005428", "ticker_sentiment_score": "0.002222", "ticker_sentiment_label": "Neutral"}, {"ticker": "CIR", "relevance_score": "0.005428", "ticker_sentiment_score": "0.002273", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPGN", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.00501", "ticker_sentiment_label": "Neutral"}, {"ticker": "VVNT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.012228", "ticker_sentiment_label": "Neutral"}, {"ticker": "NUTX", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.014175", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNEJF", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.005016", "ticker_sentiment_label": "Neutral"}, {"ticker": "SANW", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.00084", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONCT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.00258", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACHL", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.00077", "ticker_sentiment_label": "Neutral"}, {"ticker": "DAKT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.201905", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "HTH", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.018219", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISPC", "relevance_score": "0.005428", "ticker_sentiment_score": "0.013285", "ticker_sentiment_label": "Neutral"}, {"ticker": "FBIO", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.007266", "ticker_sentiment_label": "Neutral"}, {"ticker": "VZIO", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.004162", "ticker_sentiment_label": "Neutral"}, {"ticker": "VAXX", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.022314", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVR", "relevance_score": "0.005428", "ticker_sentiment_score": "6e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "TTCF", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.001694", "ticker_sentiment_label": "Neutral"}, {"ticker": "FDMT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.00084", "ticker_sentiment_label": "Neutral"}, {"ticker": "PGEN", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.004346", "ticker_sentiment_label": "Neutral"}, {"ticker": "MASI", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000535", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALKT", "relevance_score": "0.005428", "ticker_sentiment_score": "0.000246", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.0434", "ticker_sentiment_score": "-0.032182", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGMO", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.014396", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVIV", "relevance_score": "0.005428", "ticker_sentiment_score": "0.005773", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLGC", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.010281", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLNS", "relevance_score": "0.005428", "ticker_sentiment_score": "0.002196", "ticker_sentiment_label": "Neutral"}, {"ticker": "DFFN", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.012272", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSAT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.002797", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCRT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.001501", "ticker_sentiment_label": "Neutral"}, {"ticker": "FLNC", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.010843", "ticker_sentiment_label": "Neutral"}, {"ticker": "NKTR", "relevance_score": "0.010855", "ticker_sentiment_score": "-0.016624", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRLD", "relevance_score": "0.005428", "ticker_sentiment_score": "0.004914", "ticker_sentiment_label": "Neutral"}, {"ticker": "OMCL", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.005187", "ticker_sentiment_label": "Neutral"}, {"ticker": "ORMP", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.001495", "ticker_sentiment_label": "Neutral"}, {"ticker": "NLTX", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.004864", "ticker_sentiment_label": "Neutral"}, {"ticker": "STEP", "relevance_score": "0.005428", "ticker_sentiment_score": "0.009875", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWKS", "relevance_score": "0.005428", "ticker_sentiment_score": "0.000128", "ticker_sentiment_label": "Neutral"}, {"ticker": "WPRT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.003774", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSTL", "relevance_score": "0.005428", "ticker_sentiment_score": "0.003205", "ticker_sentiment_label": "Neutral"}, {"ticker": "FWBI", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.218246", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "OTRK", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000812", "ticker_sentiment_label": "Neutral"}, {"ticker": "EFTR", "relevance_score": "0.005428", "ticker_sentiment_score": "0.009878", "ticker_sentiment_label": "Neutral"}, {"ticker": "CARR", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.001383", "ticker_sentiment_label": "Neutral"}, {"ticker": "UTRS", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.021764", "ticker_sentiment_label": "Neutral"}, {"ticker": "SDIG", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.012451", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENVX", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.003243", "ticker_sentiment_label": "Neutral"}, {"ticker": "FNCH", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.024154", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBBK", "relevance_score": "0.010855", "ticker_sentiment_score": "-0.003513", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRM", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000456", "ticker_sentiment_label": "Neutral"}, {"ticker": "COMM", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.002645", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXDX", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.00915", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVFM", "relevance_score": "0.005428", "ticker_sentiment_score": "0.001263", "ticker_sentiment_label": "Neutral"}, {"ticker": "IRBT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.001791", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZYNE", "relevance_score": "0.005428", "ticker_sentiment_score": "0.012632", "ticker_sentiment_label": "Neutral"}, {"ticker": "NSTS", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.001613", "ticker_sentiment_label": "Neutral"}, {"ticker": "WSKEF", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.006448", "ticker_sentiment_label": "Neutral"}, {"ticker": "FIXX", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.013727", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTHR", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.004002", "ticker_sentiment_label": "Neutral"}, {"ticker": "NKTX", "relevance_score": "0.005428", "ticker_sentiment_score": "0.020798", "ticker_sentiment_label": "Neutral"}, {"ticker": "HYRE", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.011236", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSGM", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.002607", "ticker_sentiment_label": "Neutral"}, {"ticker": "JSPR", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.001081", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVRO", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.003031", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRDF", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.002874", "ticker_sentiment_label": "Neutral"}, {"ticker": "MATW", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.014647", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATNF", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.025859", "ticker_sentiment_label": "Neutral"}, {"ticker": "KERN", "relevance_score": "0.005428", "ticker_sentiment_score": "0.005691", "ticker_sentiment_label": "Neutral"}, {"ticker": "KMX", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.004298", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLXT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.031145", "ticker_sentiment_label": "Neutral"}, {"ticker": "IBRX", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.005207", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLON", "relevance_score": "0.005428", "ticker_sentiment_score": "0.008014", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZYME", "relevance_score": "0.005428", "ticker_sentiment_score": "0.001234", "ticker_sentiment_label": "Neutral"}, {"ticker": "EPZM", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.00633", "ticker_sentiment_label": "Neutral"}, {"ticker": "MAS", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000877", "ticker_sentiment_label": "Neutral"}, {"ticker": "XGN", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.034691", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZY", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.005096", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLK", "relevance_score": "0.075873", "ticker_sentiment_score": "-0.020157", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMAT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.422547", "ticker_sentiment_label": "Bearish"}, {"ticker": "IDYA", "relevance_score": "0.005428", "ticker_sentiment_score": "0.000207", "ticker_sentiment_label": "Neutral"}, {"ticker": "ROCK", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.014477", "ticker_sentiment_label": "Neutral"}, {"ticker": "SCYX", "relevance_score": "0.005428", "ticker_sentiment_score": "0.012332", "ticker_sentiment_label": "Neutral"}, {"ticker": "AERC", "relevance_score": "0.005428", "ticker_sentiment_score": "0.000505", "ticker_sentiment_label": "Neutral"}, {"ticker": "KRNT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000697", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGEN", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.004763", "ticker_sentiment_label": "Neutral"}, {"ticker": "BGRY", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.21154", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SKYT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.002215", "ticker_sentiment_label": "Neutral"}, {"ticker": "ESE", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.003718", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKA", "relevance_score": "0.005428", "ticker_sentiment_score": "0.011845", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIEN", "relevance_score": "0.005428", "ticker_sentiment_score": "0.001918", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSA", "relevance_score": "0.005428", "ticker_sentiment_score": "0.003493", "ticker_sentiment_label": "Neutral"}, {"ticker": "PINS", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.001372", "ticker_sentiment_label": "Neutral"}, {"ticker": "BPTH", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.216618", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "INMD", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.028707", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDNT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.002589", "ticker_sentiment_label": "Neutral"}, {"ticker": "SAVA", "relevance_score": "0.005428", "ticker_sentiment_score": "0.000291", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISUN", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.016146", "ticker_sentiment_label": "Neutral"}, {"ticker": "SITE", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.007096", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMSC", "relevance_score": "0.005428", "ticker_sentiment_score": "0.003183", "ticker_sentiment_label": "Neutral"}, {"ticker": "NXPL", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.008084", "ticker_sentiment_label": "Neutral"}, {"ticker": "FUV", "relevance_score": "0.005428", "ticker_sentiment_score": "0.001675", "ticker_sentiment_label": "Neutral"}, {"ticker": "GGG", "relevance_score": "0.005428", "ticker_sentiment_score": "0.006956", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVTX", "relevance_score": "0.005428", "ticker_sentiment_score": "0.00195", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMBIL", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000167", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOTZ", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.026958", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLSE", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000638", "ticker_sentiment_label": "Neutral"}, {"ticker": "SELB", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.001126", "ticker_sentiment_label": "Neutral"}, {"ticker": "SFNC", "relevance_score": "0.010855", "ticker_sentiment_score": "0.182297", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GGR", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.002554", "ticker_sentiment_label": "Neutral"}, {"ticker": "ETSY", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.029415", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOCO", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000584", "ticker_sentiment_label": "Neutral"}, {"ticker": "RMO", "relevance_score": "0.005428", "ticker_sentiment_score": "0.003726", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLBY", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000855", "ticker_sentiment_label": "Neutral"}, {"ticker": "KTRA", "relevance_score": "0.005428", "ticker_sentiment_score": "0.003329", "ticker_sentiment_label": "Neutral"}, {"ticker": "CREX", "relevance_score": "0.005428", "ticker_sentiment_score": "0.003361", "ticker_sentiment_label": "Neutral"}, {"ticker": "KBNT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.016527", "ticker_sentiment_label": "Neutral"}, {"ticker": "VINC", "relevance_score": "0.005428", "ticker_sentiment_score": "0.009244", "ticker_sentiment_label": "Neutral"}, {"ticker": "ORTX", "relevance_score": "0.005428", "ticker_sentiment_score": "0.000528", "ticker_sentiment_label": "Neutral"}, {"ticker": "CPS", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.011111", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALT", "relevance_score": "0.005428", "ticker_sentiment_score": "0.001247", "ticker_sentiment_label": "Neutral"}, {"ticker": "LUCD", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.013516", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLCN", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000703", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLTA", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.24229", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "APYX", "relevance_score": "0.005428", "ticker_sentiment_score": "0.003348", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRVN", "relevance_score": "0.005428", "ticker_sentiment_score": "0.017793", "ticker_sentiment_label": "Neutral"}, {"ticker": "DTIL", "relevance_score": "0.005428", "ticker_sentiment_score": "0.000686", "ticker_sentiment_label": "Neutral"}, {"ticker": "AIKI", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.001314", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACOR", "relevance_score": "0.005428", "ticker_sentiment_score": "0.001623", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMK", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.013866", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGTA", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.026143", "ticker_sentiment_label": "Neutral"}, {"ticker": "KRON", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.015312", "ticker_sentiment_label": "Neutral"}, {"ticker": "YELL", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.019485", "ticker_sentiment_label": "Neutral"}, {"ticker": "FGI", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.00075", "ticker_sentiment_label": "Neutral"}, {"ticker": "MX", "relevance_score": "0.005428", "ticker_sentiment_score": "0.025877", "ticker_sentiment_label": "Neutral"}, {"ticker": "BEAM", "relevance_score": "0.005428", "ticker_sentiment_score": "3.7e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "DTC", "relevance_score": "0.005428", "ticker_sentiment_score": "0.004797", "ticker_sentiment_label": "Neutral"}, {"ticker": "DCT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.006973", "ticker_sentiment_label": "Neutral"}, {"ticker": "PXLW", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.012472", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNSO", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.272945", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "FAMI", "relevance_score": "0.005428", "ticker_sentiment_score": "0.013901", "ticker_sentiment_label": "Neutral"}, {"ticker": "RGEN", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.004544", "ticker_sentiment_label": "Neutral"}, {"ticker": "RVSN", "relevance_score": "0.005428", "ticker_sentiment_score": "0.002467", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATRC", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.008006", "ticker_sentiment_label": "Neutral"}, {"ticker": "LFUS", "relevance_score": "0.005428", "ticker_sentiment_score": "0.000546", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATRA", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.00496", "ticker_sentiment_label": "Neutral"}, {"ticker": "KLTR", "relevance_score": "0.005428", "ticker_sentiment_score": "0.000815", "ticker_sentiment_label": "Neutral"}, {"ticker": "MIXT", "relevance_score": "0.005428", "ticker_sentiment_score": "0.000996", "ticker_sentiment_label": "Neutral"}, {"ticker": "XBIT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.023", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRCH", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.017485", "ticker_sentiment_label": "Neutral"}, {"ticker": "VAPO", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000564", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.005428", "ticker_sentiment_score": "0.022374", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRIS", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.00834", "ticker_sentiment_label": "Neutral"}, {"ticker": "FHI", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.054091", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNSE", "relevance_score": "0.005428", "ticker_sentiment_score": "0.006165", "ticker_sentiment_label": "Neutral"}, {"ticker": "EXPI", "relevance_score": "0.005428", "ticker_sentiment_score": "-6e-06", "ticker_sentiment_label": "Neutral"}, {"ticker": "XNCR", "relevance_score": "0.005428", "ticker_sentiment_score": "0.017634", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNBR", "relevance_score": "0.005428", "ticker_sentiment_score": "0.001634", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANGI", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000368", "ticker_sentiment_label": "Neutral"}, {"ticker": "OB", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.006809", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVLO", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.003146", "ticker_sentiment_label": "Neutral"}, {"ticker": "COSM", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.067704", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRTK", "relevance_score": "0.005428", "ticker_sentiment_score": "0.02", "ticker_sentiment_label": "Neutral"}, {"ticker": "DELL", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.00953", "ticker_sentiment_label": "Neutral"}, {"ticker": "KBAL", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.013699", "ticker_sentiment_label": "Neutral"}, {"ticker": "NXTP", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.00091", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVYA", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000528", "ticker_sentiment_label": "Neutral"}, {"ticker": "RMBL", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000163", "ticker_sentiment_label": "Neutral"}, {"ticker": "AAOI", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.009025", "ticker_sentiment_label": "Neutral"}, {"ticker": "RPHM", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.003913", "ticker_sentiment_label": "Neutral"}, {"ticker": "NEOG", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.002153", "ticker_sentiment_label": "Neutral"}, {"ticker": "YORW", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.0031", "ticker_sentiment_label": "Neutral"}, {"ticker": "LMDX", "relevance_score": "0.005428", "ticker_sentiment_score": "0.004918", "ticker_sentiment_label": "Neutral"}, {"ticker": "LYLT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000963", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKRO", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.007987", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLRE", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.00352", "ticker_sentiment_label": "Neutral"}, {"ticker": "TEL", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.156421", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "RUBY", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000733", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:NANO", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.012305", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Path  ( NASDAQ:BPTH )  Earns Sell Rating from Analysts at StockNews.com", "url": "https://www.defenseworld.net/2022/04/14/bio-path-nasdaqbpth-earns-sell-rating-from-analysts-at-stocknews-com.html", "time_published": "20220414T061041", "authors": ["admin"], "summary": "StockNews.com started coverage on shares of Bio-Path  ( NASDAQ:BPTH - Get Rating )  in a research report sent to investors on Monday morning. The brokerage issued a sell rating on the stock.", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?w=250&h=150&zc=2&src=https://www.marketbeat.com/logos/bio-path-holdings-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.003557, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ROST", "relevance_score": "0.107303", "ticker_sentiment_score": "0.002292", "ticker_sentiment_label": "Neutral"}, {"ticker": "STT", "relevance_score": "0.107303", "ticker_sentiment_score": "0.003939", "ticker_sentiment_label": "Neutral"}, {"ticker": "BPTH", "relevance_score": "0.9205", "ticker_sentiment_score": "0.003557", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.212674", "ticker_sentiment_score": "0.003939", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:NANO", "relevance_score": "0.107303", "ticker_sentiment_score": "0.002292", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why Bio-Path Holdings Shares Are Rising After Hours", "url": "https://www.benzinga.com/general/biotech/22/04/26604438/why-bio-path-holdings-shares-are-rising-after-hours", "time_published": "20220412T205527", "authors": ["Adam Eckert"], "summary": "Bio-Path Holdings Inc  ( NASDAQ: BPTH )  shares are trading higher in Tuesday's after-hours session following the company's BP1003 data presentation at the 2022 American Association for Cancer Research Annual Meeting.\nBio-Path presented a poster at the annual meeting titled \"Targeting STAT3 with nov", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/04/12/stock-1863880_1280_0.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Retail & Wholesale", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": -0.016051, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.742397", "ticker_sentiment_score": "0.022265", "ticker_sentiment_label": "Neutral"}]}, {"title": "The Daily Biotech Pulse: Valneva Gains On COVID Shot Regulatory Update, Lucira Health And Clearside Jump On Earnings, BeiGene Drug Snags Approval In China", "url": "https://www.benzinga.com/general/biotech/22/03/26098907/the-daily-biotech-pulse-valneva-gains-on-covid-shot-regulatory-update-lucira-health-and-clearside", "time_published": "20220311T125204", "authors": [], "summary": "Here's a roundup of top developments in the biotech space over the last 24 hours.\nStocks In Focus\nValneva Says Confident Of Conditional Approval For COVID Vaccine Candidate In Europe\nValneva SE  ( NASDAQ: VALN )  received a small set of additional questions from the European Medicines Agency's Commi", "banner_image": "https://cdn.benzinga.com/files/imagecache/story_image_685x375C/images/story/2012/lab-5740505_1920_9.jpg", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}, {"topic": "Earnings", "relevance_score": "0.905476"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": -0.003561, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PLXP", "relevance_score": "0.146425", "ticker_sentiment_score": "0.000227", "ticker_sentiment_label": "Neutral"}, {"ticker": "BGNE", "relevance_score": "0.146425", "ticker_sentiment_score": "-0.004485", "ticker_sentiment_label": "Neutral"}, {"ticker": "LHDX", "relevance_score": "0.146425", "ticker_sentiment_score": "-0.007112", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLSD", "relevance_score": "0.146425", "ticker_sentiment_score": "0.008008", "ticker_sentiment_label": "Neutral"}, {"ticker": "VALN", "relevance_score": "0.218095", "ticker_sentiment_score": "0.021828", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBS", "relevance_score": "0.218095", "ticker_sentiment_score": "0.006744", "ticker_sentiment_label": "Neutral"}, {"ticker": "LPTX", "relevance_score": "0.146425", "ticker_sentiment_score": "0.000414", "ticker_sentiment_label": "Neutral"}, {"ticker": "BPTH", "relevance_score": "0.146425", "ticker_sentiment_score": "0.000279", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Path Holdings: Q4 Earnings Insights", "url": "https://www.benzinga.com/news/earnings/22/03/26099218/bio-path-holdings-q4-earnings-insights", "time_published": "20220311T124939", "authors": [], "summary": "Bio-Path Holdings  ( NASDAQ:BPTH )  reported its Q4 earnings results on Friday, March 11, 2022 at 07:00 AM.\nHere's what investors need to know about the announcement.\nEarnings\nBio-Path Holdings missed estimated earnings by 84.37%, reporting ...Full story available on Benzinga.com", "banner_image": "https://cdn.benzinga.com/files/imagecache/story_image_685x375C/images/story/2022/earnings_image_2741.jpeg", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.891286"}, {"topic": "Retail & Wholesale", "relevance_score": "1.0"}], "overall_sentiment_score": -0.021648, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.65833", "ticker_sentiment_score": "-0.016795", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bio-Path Holdings Reports Full Year 2021 Financial Results", "url": "https://www.globenewswire.com/news-release/2022/03/11/2401728/0/en/Bio-Path-Holdings-Reports-Full-Year-2021-Financial-Results.html", "time_published": "20220311T120000", "authors": ["Inc.", "Bio-Path Holdings"], "summary": "Conference Call to be Held Today at 8:30 A.M. ET Conference Call to be Held Today at 8:30 A.M. ET", "banner_image": "https://ml.globenewswire.com/Resource/Download/249fef91-7e82-4f67-b919-46c0c4d6fb17?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Earnings", "relevance_score": "0.451494"}, {"topic": "Retail & Wholesale", "relevance_score": "1.0"}], "overall_sentiment_score": 0.262225, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BPTH", "relevance_score": "0.359512", "ticker_sentiment_score": "0.368746", "ticker_sentiment_label": "Bullish"}]}, {"title": "Earnings Scheduled For March 11, 2022", "url": "https://www.benzinga.com/news/earnings/22/03/26096627/earnings-scheduled-for-march-11-2022", "time_published": "20220311T090908", "authors": [], "summary": "Companies Reporting Before The Bell\n\u2022 The Real Good Food  ( NASDAQ:RGF )  is estimated to report quarterly loss at $0.19 per share on revenue of $25.29 million.\n\u2022 Smart Share Global  ( NASDAQ:EM )  is expected to report quarterly loss at $0.04 per share on revenue of $129.31 million.\n\u2022 Longeveron  (", "banner_image": "https://cdn.benzinga.com/files/imagecache/story_image_685x375C/images/story/2022/earnings_image_2734.jpeg", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}], "overall_sentiment_score": -0.037141, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EM", "relevance_score": "0.094912", "ticker_sentiment_score": "-0.079709", "ticker_sentiment_label": "Neutral"}, {"ticker": "RLGDF", "relevance_score": "0.094912", "ticker_sentiment_score": "-0.04487", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLDP", "relevance_score": "0.094912", "ticker_sentiment_score": "-0.09689", "ticker_sentiment_label": "Neutral"}, {"ticker": "HSON", "relevance_score": "0.094912", "ticker_sentiment_score": "-0.001068", "ticker_sentiment_label": "Neutral"}, {"ticker": "SUNW", "relevance_score": "0.094912", "ticker_sentiment_score": "-0.090799", "ticker_sentiment_label": "Neutral"}, {"ticker": "WE", "relevance_score": "0.094912", "ticker_sentiment_score": "-3.8e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "DS", "relevance_score": "0.094912", "ticker_sentiment_score": "-0.1196", "ticker_sentiment_label": "Neutral"}, {"ticker": "ODC", "relevance_score": "0.094912", "ticker_sentiment_score": "0.000367", "ticker_sentiment_label": "Neutral"}, {"ticker": "LGVN", "relevance_score": "0.094912", "ticker_sentiment_score": "-0.047752", "ticker_sentiment_label": "Neutral"}, {"ticker": "FUTU", "relevance_score": "0.094912", "ticker_sentiment_score": "-0.001886", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLXP", "relevance_score": "0.094912", "ticker_sentiment_score": "-0.026646", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPNE", "relevance_score": "0.094912", "ticker_sentiment_score": "-0.049989", "ticker_sentiment_label": "Neutral"}, {"ticker": "INSE", "relevance_score": "0.094912", "ticker_sentiment_score": "0.00034", "ticker_sentiment_label": "Neutral"}, {"ticker": "AIRS", "relevance_score": "0.094912", "ticker_sentiment_score": "0.000623", "ticker_sentiment_label": "Neutral"}, {"ticker": "GENI", "relevance_score": "0.094912", "ticker_sentiment_score": "-0.01572", "ticker_sentiment_label": "Neutral"}, {"ticker": "BKE", "relevance_score": "0.094912", "ticker_sentiment_score": "-2.3e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "BPTH", "relevance_score": "0.094912", "ticker_sentiment_score": "-0.004541", "ticker_sentiment_label": "Neutral"}, {"ticker": "RLX", "relevance_score": "0.094912", "ticker_sentiment_score": "-0.0002", "ticker_sentiment_label": "Neutral"}]}]}